<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98020</article-id><article-id pub-id-type="doi">10.7554/eLife.98020</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Unraveling the link between neuropathy target esterase NTE/SWS, lysosomal storage diseases, inflammation, abnormal fatty acid metabolism, and leaky brain barrier</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-362563"><name><surname>Tsap</surname><given-names>Mariana I</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0006-0891-8504</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200865"><name><surname>Yatsenko</surname><given-names>Andriy S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-224649"><name><surname>Hegermann</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-362564"><name><surname>Beckmann</surname><given-names>Bibiana</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-362565"><name><surname>Tsikas</surname><given-names>Dimitrios</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6320-0956</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-164632"><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3855-0345</contrib-id><email>Shcherbata.Halyna@mh-hannover.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Institute of Cell Biochemistry, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Institute of Functional and Applied Anatomy, Research Core Unit Electron Microscopy, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Institute of Toxicology, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dw1bf40</institution-id><institution>Mount Desert Island Biological Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Bar Harbor</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kapahi</surname><given-names>Pankaj</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kapahi</surname><given-names>Pankaj</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>04</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e98020</elocation-id><history><date date-type="received" iso-8601-date="2024-03-21"><day>21</day><month>03</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-04-12"><day>12</day><month>04</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-08-12"><day>12</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.11.552934"/></event></pub-history><permissions><copyright-statement>Â© 2024, Tsap et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Tsap et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98020-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98020-figures-v2.pdf"/><abstract><p>Mutations in <italic>Drosophila</italic> Swiss cheese (SWS) gene or its vertebrate orthologue neuropathy target esterase (NTE) lead to progressive neuronal degeneration in flies and humans. Despite its enzymatic function as a phospholipase is well established, the molecular mechanism responsible for maintaining nervous system integrity remains unclear. In this study, we found that NTE/SWS is present in surface glia that forms the blood-brain barrier (BBB) and that NTE/SWS is important to maintain its structure and permeability. Importantly, BBB glia-specific expression of <italic>Drosophila NTE/SWS</italic> or human NTE in the <italic>sws</italic> mutant background fully rescues surface glial organization and partially restores BBB integrity, suggesting a conserved function of NTE/SWS. Interestingly, <italic>sws</italic> mutant glia showed abnormal organization of plasma membrane domains and tight junction rafts accompanied by the accumulation of lipid droplets, lysosomes, and multilamellar bodies. Since the observed cellular phenotypes closely resemble the characteristics described in a group of metabolic disorders known as lysosomal storage diseases (LSDs), our data established a novel connection between NTE/SWS and these conditions. We found that mutants with defective BBB exhibit elevated levels of fatty acids, which are precursors of eicosanoids and are involved in the inflammatory response. Also, as a consequence of a permeable BBB, several innate immunity factors are upregulated in an age-dependent manner, while BBB glia-specific expression of NTE/SWS normalizes inflammatory response. Treatment with anti-inflammatory agents prevents the abnormal architecture of the BBB, suggesting that inflammation contributes to the maintenance of a healthy brain barrier. Considering the link between a malfunctioning BBB and various neurodegenerative diseases, gaining a deeper understanding of the molecular mechanisms causing inflammation due to a defective BBB could help to promote the use of anti-inflammatory therapies for age-related neurodegeneration.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neurodegeneration</kwd><kwd>lysosomal storage diseases</kwd><kwd>NTE/SWS neuropathy target esterase</kwd><kwd>inflammation</kwd><kwd>free fatty acids</kwd><kwd>brain-blood barrier</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001663</institution-id><institution>Volkswagen Foundation</institution></institution-wrap></funding-source><award-id>90218</award-id><principal-award-recipient><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001663</institution-id><institution>Volkswagen Foundation</institution></institution-wrap></funding-source><award-id>97750</award-id><principal-award-recipient><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>521749003</award-id><principal-award-recipient><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>INST 192/574-1 FUGG</award-id><principal-award-recipient><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004410</institution-id><institution>European Molecular Biology Organization</institution></institution-wrap></funding-source><award-id>Young Investigator Programme</award-id><principal-award-recipient><name><surname>Shcherbata</surname><given-names>Halyna R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value><italic>Drosophila</italic> model reveals that NTE/SWS-associated neurodegeneration is a lysosomal storage disorder accompanied by a leaky brain permeability barrier, abnormal fatty acid metabolism, and inflammation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Aging is the major risk factor for neurodegenerative conditions, a group of disorders characterized by the progressive degeneration and dysfunction of the nervous system, which includes Alzheimerâs and Parkinsonâs disease, amyotrophic lateral sclerosis, frontotemporal dementia, and many others. These diseases typically result in the gradual loss of cognitive function, movement control, and other neurological functions. The exact causes of neurodegenerative diseases are often complex and not fully understood, but they can involve a combination of genetic, environmental, and lifestyle factors.</p><p>Growing evidence suggests that inflammation plays a crucial role in age-related neurodegenerative diseases (<xref ref-type="bibr" rid="bib146">Zuo et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Rojas-Gutierrez et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib144">Zhang et al., 2023</xref>). Older organisms frequently develop chronic, low-grade inflammation, a condition often named inflammaging, which is characterized by a sustained increase in inflammatory markers without apparent infection or injury (<xref ref-type="bibr" rid="bib20">Chitnis and Weiner, 2017</xref>; <xref ref-type="bibr" rid="bib34">Franceschi et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">McGeer and McGeer, 2004</xref>; <xref ref-type="bibr" rid="bib66">Li et al., 2023</xref>). This phenomenon presents a potential target for anti-inflammatory therapy in neurodegenerative disorders. Strategies involving modulation of inflammatory signaling pathways have shown promise in both animal models and clinical trials, offering hopeful prospects for neurodegenerative disease therapy (<xref ref-type="bibr" rid="bib144">Zhang et al., 2023</xref>). While research aims to identify therapeutic targets to alleviate the impact of inflammaging on neurological health, a more in-depth understanding of the molecular mechanisms underlying inflammaging is needed.</p><p>One feature associated with neuroinflammatory degenerative diseases is dysfunction of the blood-brain barrier (BBB) (<xref ref-type="bibr" rid="bib118">Takata et al., 2021</xref>). Disruption of the BBB has been observed in patients with numerous neurodegenerative diseases (<xref ref-type="bibr" rid="bib115">Sweeney et al., 2018</xref>; <xref ref-type="bibr" rid="bib111">Spencer et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Munji et al., 2019</xref>; <xref ref-type="bibr" rid="bib9">Blyth et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Gray and Woulfe, 2015</xref>; <xref ref-type="bibr" rid="bib145">Zhou et al., 2023</xref>; <xref ref-type="bibr" rid="bib131">Whitson et al., 2022</xref>). Since the BBB plays a crucial role in maintaining the homeostasis of the brain environment, its disruption allows the infiltration of immune cells and molecules that can trigger and sustain inflammatory responses within the brain (<xref ref-type="bibr" rid="bib102">Segarra et al., 2021</xref>).</p><p>Furthermore, dysfunction in lysosomal pathways also has been implicated in Alzheimerâs and Parkinsonâs disease and many other neurodegenerative disorders (<xref ref-type="bibr" rid="bib46">Issa et al., 2018</xref>). The lysosome-endosomal system is tightly associated with the maintenance of cell homeostasis and viability, regulation of cell death, oncogenesis, autophagy, and inflammation (<xref ref-type="bibr" rid="bib87">Peng et al., 2019</xref>). In particular, lysosomes are cellular organelles responsible for degrading cellular waste and maintaining cellular health. Dysfunction of lysosomal processes can lead to the accumulation of damaged cellular components and trigger inflammatory responses, contributing to the overall inflammaging phenomenon (<xref ref-type="bibr" rid="bib87">Peng et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Aman et al., 2021</xref>).</p><p>Fatty acid metabolism is another aspect linked to inflammaging (<xref ref-type="bibr" rid="bib12">Calder, 2020</xref>; <xref ref-type="bibr" rid="bib19">Chew et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Emre et al., 2021</xref>). Changes in lipid composition and metabolism, particularly an increase in pro-inflammatory fatty acids, have been observed in inflammaging. These alterations can contribute to the perpetuation of inflammatory signaling and potentially impact neurodegenerative conditions (<xref ref-type="bibr" rid="bib26">Dumas et al., 2023</xref>; <xref ref-type="bibr" rid="bib35">Freitas et al., 2017</xref>). Thus, understanding the interplay between the BBB, lysosomes, fatty acid metabolism and inflammaging is crucial for unraveling the intricate mechanisms involved in age-related neurodegenerative diseases.</p><p>In addition, human age-related neurodegenerative diseases can be accelerated by different stresses, which include a wide array of factors such as infection, trauma, diet, or exposure to toxic substances. Interestingly, abnormalities in the human neuropathy target esterase (NTE), encoded by PNPLA6 (patatin-like phospholipase domain containing 6), gene are linked to both neurodegeneration types: toxin-induced and hereditary. NTE is a transmembrane protein anchored to the cytoplasmic face of the endoplasmic reticulum and acts as a phospholipase that regulates lipid membrane homeostasis (<xref ref-type="bibr" rid="bib39">Glynn, 2005</xref>; <xref ref-type="bibr" rid="bib91">Read et al., 2009</xref>; <xref ref-type="bibr" rid="bib71">Lush et al., 1998</xref>). Continuous inhibition of NTE activity by the organophosphorus compound tri-ortho-cresyl phosphate causes axonal degeneration in the central nervous system (CNS) and peripheral nervous system (PNS), a neuropathy that was consequently named organophosphate-induced delayed neuropathy, OPIDN (<xref ref-type="bibr" rid="bib94">Richardson et al., 2013</xref>; <xref ref-type="bibr" rid="bib95">Richardson et al., 2020</xref>). Moreover, mutations in the NTE gene cause Gordon-Holmes or Boucher-NeuhÃ¤user syndromes (<xref ref-type="bibr" rid="bib23">Deik et al., 2014</xref>; <xref ref-type="bibr" rid="bib116">Synofzik et al., 2014</xref>; <xref ref-type="bibr" rid="bib117">Synofzik et al., 2015</xref>; <xref ref-type="bibr" rid="bib121">Topaloglu et al., 2014</xref>) and a motor neuron disease called hereditary spastic paraplegia type 39 (HSP 39), in which distal parts of long spinal axons degenerate, leading to limb weakness and paralysis (<xref ref-type="bibr" rid="bib75">McFerrin et al., 2017</xref>; <xref ref-type="bibr" rid="bib89">Rainier et al., 2008</xref>). Genetically, HSP classification is based on the genes of origin called spastic paraplegia genes, which is a large group (&gt;80) of genes (<xref ref-type="bibr" rid="bib33">Fereshtehnejad et al., 2023</xref>). Over the past few years, research has shown that HSP is associated with endo-lysosomal system abnormalities (<xref ref-type="bibr" rid="bib2">Allison et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Lim et al., 2015</xref>; <xref ref-type="bibr" rid="bib83">Namekawa et al., 2007</xref>; <xref ref-type="bibr" rid="bib93">RenvoisÃ© et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Chang et al., 2014</xref>).</p><p>Human studies play a crucial role in understanding the real-world impact of aging and neurodegeneration. However, for various reasons like a long lifespan, ethical considerations, heterogeneity, cohort effects, limited controls, etc., humans may not always be ideal subjects for age-related research. To address these challenges, human studies are often complemented by research in model organisms, providing a comprehensive perspective on aging mechanisms and interventions. In particular, modeling human neurodegenerative diseases in various model organisms can provide us with needed knowledge about the first hallmarks of neurodegeneration and also signaling mechanisms that are disrupted upon aging. It was shown that NTE is widely expressed in the mouse brain, and its activity is essential for lipid homeostasis in the nervous system (<xref ref-type="bibr" rid="bib38">Glynn et al., 1998</xref>; <xref ref-type="bibr" rid="bib80">Moser et al., 2000</xref>). NTE deficiency results in the distal degeneration of the longest spinal axons, accompanied by swelling that encompasses accumulated axoplasmic material (<xref ref-type="bibr" rid="bib91">Read et al., 2009</xref>). Specific deletion of NTE in the neuronal tissue induces neurodegeneration (<xref ref-type="bibr" rid="bib1">Akassoglou et al., 2004</xref>). Despite its known molecular function, the mechanism by which it maintains nervous system integrity during hereditary and toxin-induced neurodegeneration remains unknown. <italic>Drosophila melanogaster</italic> is an excellent genetic model organism to investigate the molecular mechanisms of age-dependent neurodegenerative diseases, and it has been widely used to identify potential drug targets against neurodegenerative diseases (<xref ref-type="bibr" rid="bib73">Ma et al., 2022</xref>; <xref ref-type="bibr" rid="bib58">Kretzschmar, 2022</xref>). Moreover, the fly nervous system is a great system to shed light on the evolutionarily conserved signaling pathways underlying disease pathology. In <italic>Drosophila</italic>, more than 70% of genes related to human diseased are conserved (<xref ref-type="bibr" rid="bib125">Ugur et al., 2016</xref>). Studying human disease-related genes in <italic>Drosophila</italic> avoids the ethical issues of biomedical research involving human subjects.</p><p>Moreover, <italic>Drosophila</italic> serves as a well-defined model to study immune reactivity. Flies exhibit a robust immune response to septic injury, involving hemocytes (macrophage-like cells) that efficiently clear pathogens through phagocytosis. This involves the recruitment of immune cells and the activation of immune-related genes. For instance, the signaling cascade of the glial cells missing transcription factor, which governs immune cell development and is triggered by aging and acute challenges, is conserved from flies to humans (<xref ref-type="bibr" rid="bib86">Pavlidaki et al., 2022</xref>). Additionally, the immune response includes antimicrobial peptides (AMPs) secreted by fat body cells, activated by Toll and immune deficiency (IMD) pathways. The IMD pathway, triggered by Gram-negative bacteria, facilitates macrophage invasion into the inflamed brain, mediated by glia cells (<xref ref-type="bibr" rid="bib22">De Gregorio et al., 2002</xref>). Macrophages in the brain can phagocytose synaptic material, impacting locomotor abilities and longevity, highlighting the delicate balance in evolutionary inflammatory responses (<xref ref-type="bibr" rid="bib133">Winkler et al., 2021</xref>). Together, <italic>Drosophila</italic> satisfies many of the requirements to study human diseases that allows scientists, not only dissection on cellular and molecular levels but also investigation of behavior and neurodegeneration during aging (<xref ref-type="bibr" rid="bib15">Carney et al., 2023</xref>; <xref ref-type="bibr" rid="bib140">Yatsenko and Shcherbata, 2021</xref>; <xref ref-type="bibr" rid="bib139">Yatsenko et al., 2021</xref>). Considering the increasing evidence linking inflammation and neurodegeneration in humans, gaining insights into the interplay between neuroinflammation and neurodegenerative processes in the <italic>Drosophila</italic> brain should be beneficial.</p><p>In this study, we used a <italic>Drosophila</italic> NTE/SWS model for human neurodegeneration. Swiss cheese protein (NTE/SWS) is a highly conserved lysophospholipase that can regulate phosphatidylcholine metabolism (<xref ref-type="bibr" rid="bib71">Lush et al., 1998</xref>; <xref ref-type="bibr" rid="bib143">Zaccheo et al., 2004</xref>). It was also shown that NTE/SWS can act as a regulator of the PKA-C3 catalytic subunit of protein kinase A (<xref ref-type="bibr" rid="bib8">Bettencourt da Cruz et al., 2008</xref>; <xref ref-type="bibr" rid="bib130">Wentzell et al., 2014</xref>). Loss of <italic>Drosophila</italic> NTE/SWS and vertebrate NTE has been shown to result in lipid droplet accumulation, which is involved in neurodegeneration pathogenesis (<xref ref-type="bibr" rid="bib18">Chang et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Farmer et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>). Loss of <italic>sws</italic> leads to age-dependent neurodegeneration (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, arrows), CNS vacuolization, and abnormal glial morphology accompanied by the formation of multilayered glial structures in the adult <italic>Drosophila</italic> brain (<xref ref-type="bibr" rid="bib57">Kretzschmar et al., 1997</xref>; <xref ref-type="bibr" rid="bib27">Dutta et al., 2016</xref>). Recent studies have shown that the pan-glial knockdown of <italic>sws</italic> leads to increased levels of reactive oxygen species (ROS), which in turn induces oxidative stress (<xref ref-type="bibr" rid="bib98">Ryabova et al., 2021</xref>). However, the role of NTE/SWS in distinct glial types is not clearly understood.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>NTE/SWS is expressed in <italic>Drosophila</italic> brain and its loss leads to severe neurodegeneration.</title><p>(<bold>AâB</bold>) Hematoxylin and eosin (H&amp;E)-stained paraffin-embedded brain sections of the 30-day-old control (<italic>OregonR x white<sup>1118</sup></italic>, <bold>A</bold>) and 30-day-old <italic>sws<sup>1</sup>/sws<sup>4</sup></italic> transheterozygous flies (<bold>B</bold>). Arrows indicate neurodegeneration at the brain surface. Scale bar: 50 Âµm. (<bold>CâD</bold>) Schemes of glia organization in the adult <italic>Drosophila</italic> brain â perineurial glia (PG, blue), subperineurial glia (SPG, light green), cortex glia (pink), astrocyte-like glia (turquoise), and ensheathing glia (yellow). (<bold>EâF</bold>) Expression pattern of <italic>sws-Gal4</italic> determined by combining of the transcriptional activator Gal4 under control of the <italic>sws</italic> gene promotor (<italic>sws-Gal4</italic>) and the <italic>UAS-CD8::GFP</italic> construct. Fluorescence images of the brain show that <italic>sws</italic> is expressed in all brain cells and strongly expressed in the surface glia (<bold>E</bold> â single section, <bold>F</bold> â Z-stack maximum projection). For NTE/SWS antibody staining pattern, see <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A and B</xref>. Glia cells are marked with Repo (red), <italic>sws</italic> expression is marked by the membrane <italic>CD8::GFP</italic> (green), and nuclei are marked with DAPI (blue). Scale bar: 50 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig1-v2.tif"/></fig><p>Similar to multiple other organisms, the <italic>Drosophila</italic> nervous system is composed of neurons and glial cells. Commonly recognized nomenclature identifies six distinct glial cell types based on morphology and function: perineurial (PG) and subperineurial glia (SPG), cortex glia, astrocyte-like and ensheathing glia, and finally the PNS-specific wrapping glial cells (<xref ref-type="bibr" rid="bib142">Yildirim et al., 2019</xref>; <xref ref-type="bibr" rid="bib122">TrÃ©buchet et al., 2019</xref>). All organisms with a complex nervous system developed BBB to isolate their neurons from blood (<xref ref-type="bibr" rid="bib68">Limmer et al., 2014</xref>). In higher vertebrates, this diffusion barrier is established by polarized endothelial cells that form extensive tight junctions (<xref ref-type="bibr" rid="bib5">Armulik et al., 2010</xref>), whereas in lower vertebrates and invertebrates the BBB is entirely formed by glial cells, which are additionally sealed by septate junctions (SJs) (<xref ref-type="bibr" rid="bib68">Limmer et al., 2014</xref>). The <italic>Drosophila</italic> BBB includes two glial cell layers: the PG cells are primarily involved in nutrient uptake, whereas the main diffusion barrier is made by the SPG, which form pleated SJs (<xref ref-type="bibr" rid="bib6">Babatz et al., 2018</xref>; <xref ref-type="bibr" rid="bib100">Schwabe et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Kremer et al., 2017</xref>). Glial cells in the <italic>Drosophila</italic> BBB play a crucial role in the immune response as they contribute to the maintenance of the BBB and respond to immune challenges (<xref ref-type="bibr" rid="bib133">Winkler et al., 2021</xref>; <xref ref-type="bibr" rid="bib127">van Alphen et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Kounatidis and Chtarbanova, 2018</xref>; <xref ref-type="bibr" rid="bib107">Shu et al., 2023</xref>).</p><p>Here, we showed that NTE/SWS is present in the surface glia of <italic>Drosophila</italic> brain that form the BBB and that NTE/SWS is important for the integrity and permeability of the barrier. Importantly, glia-specific expression of <italic>Drosophila NTE/SWS</italic> or human NTE in the <italic>sws</italic> mutant background fully rescues surface glial organization and partially restores BBB integrity, suggesting a conserved function of NTE/SWS. An important observation upon <italic>sws</italic> deficit was the formation of intracellular accumulations within lysosomes, which is a characteristic feature of lysosomal storage disorders (LSDs). Additionally, NTE/SWS regulates lipid metabolism, distribution of cell junction proteins, and organization of membrane rafts in BBB glia. Moreover, our research revealed that mutants with defective BBB exhibit elevated levels of several innate immunity factors as well as free fatty acids (FFAs), which are known to play a role in inflammatory pathways. Importantly, the BBB phenotype can be alleviated by the administration of anti-inflammatory agents. These findings emphasize the complex interplay between NTE/SWS, BBB function, inflammation, and innate immunity, providing potential avenues for therapeutic interventions in related disorders.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SWS is expressed in the surface glia of <italic>Drosophila</italic> brain</title><p>Our previous data showed that NTE/SWS function is important for both glia and neuronal cells in the brain (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>; <xref ref-type="bibr" rid="bib98">Ryabova et al., 2021</xref>). After downregulation of NTE/SWS in neurons, adult flies show a decrease in longevity, locomotor and memory deficits, and severe progression of neurodegeneration in the brain (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>). We have shown that NTE/SWS plays a role in the development of the learning center of the brain involved in short-term and long-term memory storage, olfactory control, and startle-induced locomotion (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>). In addition, we found that flies with NTE/SWS deficiency in neurons or glia show mitochondrial abnormalities as well as accumulation of ROS and lipid droplets (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>; <xref ref-type="bibr" rid="bib98">Ryabova et al., 2021</xref>). Now we have decided to determine the cell type in which NTE/SWS plays a determining role in the maintenance of brain health.</p><p>Similar to its human counterpart, NTE, which is found in virtually all tissues, including the nervous system (<ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/ENSG00000032444-PNPLA6/tissue">https://www.proteinatlas.org/ENSG00000032444-PNPLA6/tissue</ext-link>), NTE/SWS is ubiquitously expressed in <italic>Drosophila</italic> brain, detected by immunohistochemical analysis using SWS-specific antibodies (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A</xref>). NTE/SWS is a transmembrane phospholipase anchored to the cytoplasmic side of the endoplasmic reticulum to regulate lipid membrane homeostasis. Its cytoplasmic localization makes it difficult to determine precisely in which brain cell type it has more pronounced expression, as neurons and glia have very complex shapes and forms. Therefore, additional markers must be used to discriminate NTE/SWS expression in the brain. To address this, we expressed membrane-bound GFP under control of the <italic>sws</italic> promoter (<italic>sws-Gal4; UAS-CD8::GFP</italic>), which allows labeling of membranes of cells in which the <italic>sws</italic> promoter is active. Importantly, <italic>sws</italic> was strongly expressed in the glia that surround the brain and form the blood-brain selective permeability barrier (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). In <italic>Drosophila</italic>, the BBB is entirely made by two glial cell layers: PG and SPG (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). With the help of sophisticated SJs, SPG cells form a tight barrier that prevents paracellular diffusion and separates the CNS from hemolymph. Since the BBB is protecting the brain from toxic substances, and NTE/SWS deregulation is associated with toxicity-induced neurodegeneration, we investigated whether NTE/SWS has a functional role in BBB maintenance and its selective permeability.</p></sec><sec id="s2-2"><title>Downregulation of NTE/SWS cell-autonomously affects surface glia integrity</title><p>To test if loss of NTE/SWS affects the barrier structure, we analyzed the expression pattern of Coracle (CoraC), which is a major component of SJs (<xref ref-type="bibr" rid="bib141">Yi et al., 2008</xref>). In controls, CoraC is strongly expressed by SPG cells, shown as a smooth line at the brain surface (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, green arrow). Upon <italic>sws</italic> loss, the CoraC pattern at the brain surface was broken and contained lesions and membrane aggregations (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, magenta arrow).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Downregulation of NTE/SWS affects surface glia architecture.</title><p>(<bold>AâD</bold>) Adult brains stained with Coracle (CoraC) (green) and DAPI (magenta). (<bold>A</bold>) In controls (<italic>Oregon R x white<sup>1118</sup></italic>), CoraC expression is pictured as the smooth line at the surface of the brain (green arrow). In <italic>sws<sup>1</sup></italic> mutants (<bold>B</bold>) and in mutants with <italic>sws</italic> downregulation in subperineurial glia (SPG) cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>, <bold>C</bold>) the outer glial cell layer labeled by CoraC is irregular and contains either lesions (blue arrow) or lesions and membrane clusters (magenta arrow). Expression of human NTE (<italic>sws<sup>1</sup>; moody&gt;hNTE</italic>, <bold>D</bold>) in SPG cells in mutant background results in the brain surface appearance which is similar to control (green arrow). Scale bar: 50 Âµm. (<bold>EâG</bold>) Adult brains stained with CoraC (red), GFP (green), and DAPI (blue) to detect SPG cell membranes marked by co-expression of CoraC and <italic>moody&gt;CD8::GFP</italic> (red + green = yellow). (<bold>E</bold>) A smooth line of SPG cell membranes is observed at the surface of control brains (<italic>moody&gt;CD8::GFP</italic>). (<bold>F</bold>) In <italic>sws</italic> loss-of-function mutants (<italic>sws<sup>1</sup>; moody&gt;CD8::GFP</italic>), most of the vacuoles formed near the brain surface are filled with the GFP-positive SPG membranes. (<bold>G</bold>) Downregulation of <italic>sws</italic> specifically in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>) results in the appearance of the same excessive SPG cell membranes inside the brain lesions. Scale bar: 50 Âµm. (<bold>H</bold>) Bar graph shows the percentage of the brain hemispheres with defective brain surface. The percentage of the brain hemispheres with normal brain surface is shown in green, the percentage of the brain hemispheres containing lesions is shown in blue, and the percentage of the brain hemispheres with formed lesions and membrane clusters within the brain surface is shown in purple. Two-way tables and chi-squared test were used for statistical analysis. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, black asterisks â compared to <italic>Gal4-driver x OR</italic>, red asterisks â compared to <italic>Gal4-driver x UAS-sws<sup>RNAi</sup></italic>, number of adult brain hemispheres â¥43, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>NTE/SWS expression pattern, <italic>sws</italic> mRNA levels, and expression patterns of the Gal4 driver lines used in the study.</title><p>(<bold>AâB</bold>) Adult brains stained with anti-SWS antibodies (red) and DAPI (blue). (<bold>AâAÊ¹</bold>) Adult brains stained with anti-SWS antibodies (red) and DAPI (blue) show that NTE/SWS is expressed in most if not all brain cells in the control (<italic>Oregon R</italic>). (<bold>BâBÊ¹</bold>) In <italic>sws<sup>1</sup></italic> mutant brains, NTE/SWS expression is dramatically reduced. Scale bar: 50 Âµm. (<bold>C</bold>) Real-time quantitative PCR (RT-qPCR) analysis of <italic>sws</italic> mRNA levels from flies with glial, neuronal, or glial and neuronal <italic>sws</italic> downregulation (<italic>repo&gt;sws<sup>RNAi</sup>, nSyb&gt;sws<sup>RNAi</sup></italic>, and <italic>repo, nSyb&gt;sws<sup>RNAi</sup></italic>) confirms the efficacy of <italic>sws<sup>RNAi</sup></italic> (red) and <italic>UAS-sws</italic> (blue) constructs. AVE Â± SEM is indicated. Two-tailed Studentâs test was used to test for statistical significance, *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001 (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). (<bold>DâDÊ¹</bold>) Expression pattern of <italic>moody-Gal4</italic> determined by combining of the transcriptional activator Gal4 under control of the <italic>moody</italic> gene promotor (<italic>moody-Gal4</italic>) and the <italic>UAS-CD8::GFP</italic> and <italic>UAS-nLacZ</italic> constructs. Fluorescence images of the brain show that <italic>moody</italic> is strongly expressed in the surface glia. Glia cells are marked with Repo (red), <italic>moody</italic> expression is indicated by the membrane <italic>CD8::GFP</italic> (green) and nuclear Î²-Galactosidase (Î²Gal, white), and nuclei are marked with DAPI (blue). Scale bar: 50 Âµm. (<bold>EâEÊ¹</bold>) Expression pattern of <italic>Gli-Gal4</italic> determined by combining of the transcriptional activator Gal4 under control of the <italic>Gliotactin</italic> gene promotor (<italic>Gli-Gal4</italic>) and the <italic>UAS-CD8::GFP</italic> and <italic>UAS-nLacZ</italic> constructs. Fluorescence images of the brain show that <italic>Gliotactin</italic> is strongly expressed in the surface glia. Glia cells are marked with Repo (red), <italic>Gli</italic> expression is indicated by the membrane CD8::GFP (green) and nuclear Î²-Galactosidase (Î²Gal, white), and nuclei are marked with DAPI (blue). Scale bar: 50 Âµm. (<bold>FâFÊ¹</bold>) Expression pattern of the double driver line (<italic>repo, nSyb-Gal4</italic>) determined by combining of the transcriptional activator Gal4 under control of the glial <italic>repo</italic> and neuronal <italic>nSyb</italic> promotors (<italic>repo, nSyb-Gal4</italic>) driving <italic>UAS-CD8::GFP</italic> and <italic>UAS-nLacZ</italic> transgenic constructs. Fluorescence images of the brain show that Repo and nSyb are strongly expressed thought the entire brain. Neuronal cell nuclei are marked by the nuclear Î²Galactosidase expression driven by <italic>nSyb-Gal4</italic> (Î²Gal, green), glial cell nuclei are marked by expression of the nuclear Î²-Galactosidase (Î²Gal, green) driven by <italic>repo-Gal4</italic> and anti-Repo antibodies (red) (red + green = yellow) (<bold>F</bold>). Fluorescence images of the brain show that <italic>repo, nSyb-Gal4</italic> is strongly expressed in glia and neurons marked by the membrane CD8::GFP (green) (<bold>FÊ¹</bold>). Scale bar: 50 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title><italic>sws</italic> downregulation in neurons does not result in the formation of lesions and membrane clusters within the brain surface, and expression of <italic>Drosophila</italic> NTE/SWS in glia cells rescued glial phenotype.</title><p>(<bold>AâF</bold>) Adult brains stained with Coracle (CoraC) (white). In control (<italic>Oregon R x white<sup>1118</sup></italic>), CoraC expression is pictured as the smooth line at the surface of the brain (green arrow). In <italic>sws<sup>1</sup></italic> mutants (<bold>B</bold>) and in mutants with <italic>sws</italic> downregulation in all glia cells and specifically in subperineurial glia (SPG) cells (<italic>repo&gt;sws<sup>RNAi</sup></italic> and <italic>Gli&gt;sws<sup>RNAi</sup></italic>, <bold>C</bold> and <bold>D</bold> , respectively), the outer glial cell layer labeled by CoraC is irregular and contains lesions and membrane clusters (magenta arrows). Animals with <italic>sws</italic> downregulation in neurons (<italic>nSyb&gt;sws<sup>RNAi</sup></italic>, <bold>E</bold>) do not have lesions and membrane clusters within the brain surface (green arrow). Expression of <italic>Drosophila</italic> NTE/SWS (<italic>sws<sup>1</sup>; moody&gt;sws,</italic> <bold>F</bold>) in SPG cells in mutant background results in the brain surface appearance which is similar to control (green arrow). Scale bar: 50 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 3.</label><caption><title>3D structures of human NTE and <italic>Drosophila</italic> SWS.</title><p>The 3D structures of the human NTE and <italic>Drosophila</italic> NTE/SWS proteins generated using the AlphaFold2 and PyMOL tools. Both proteins contain a highly conserved patatin-like phospholipase domain known as the EST domain. In the NTE/SWS protein, this domain is located between amino acid residues 952 and 1118, while in the NTE protein, it spans residues 981â1147. The EST domain is characterized by a three-layer Î±/Î²/Î± architecture with a central six-stranded Î²-sheet sandwiched essentially between Î±-helices front and back. Comparison of the predicted structures of EST-SWS and EST-NTE show that they overlap. The EST domains in both proteins exhibit a high level of confidence as helices, with pLDDT exceeding 90, indicating high accuracy and reliability in their structural predictions.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Previous characterization of the <italic>sws</italic> loss-of-function mutant showed that NTE/SWS deficiency resulted in the formation of membranous glial structures, especially in the lamina cortex (<xref ref-type="bibr" rid="bib57">Kretzschmar et al., 1997</xref>). Since NTE/SWS is ubiquitously expressed, we utilized the double driver line (<italic>repo, nSyb-Gal4,</italic> <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1F and Fâ²</xref>) to achieve its downregulation in both neuronal and glial cells (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1C</xref>). Since these animals had the same disorganized structure of brain surface as the loss-of-function mutant, we concluded that NTE/SWS functions specifically in the nervous system to preserve brain surface structure. Moreover, downregulation of <italic>sws</italic> in all glial cells (<italic>repo&gt;sws<sup>RNAi</sup></italic>) resulted in the same phenotype (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2C</xref>). At the same time, upon <italic>sws</italic> downregulation in neurons, we did not observe formation of lesions and membrane clusters in the brain surface (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2E</xref>), indicating a cell-autonomous function of NTE/SWS in glia to maintain BBB organization.</p><p>To test if NTE/SWS has a cell-autonomous role in the brain barrier cells, we used already existing SPG driver lines (<italic>moody-Gal4, UAS-CD8::GFP</italic> and <italic>Gli-Gal4, UAS-CD8::GFP</italic>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1D and E</xref>) and <italic>UAS-sws<sup>RNAi</sup></italic>. We found that, similar to pan-glial <italic>sws</italic> knockdown, its downregulation specifically in SPG cells caused the formation of lesions and membrane clusters within the brain surface (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2D</xref>, blue and magenta arrows). Importantly, expression of <italic>Drosophila</italic> or human NTE in these glia cells rescued this phenotype (<xref ref-type="fig" rid="fig2">Figure 2D and H</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2F</xref>), demonstrating the conserved function of this protein in SPG cells for brain surface formation and possibly maintenance of the brain barrier.</p><p>There have been remarkable recent advancements in the field of protein structure prediction, offering valuable tools for exploring three-dimensional structures with unprecedented effectiveness. We used the AlphaFold2 prediction and the PyMol tools (<xref ref-type="bibr" rid="bib47">Jumper et al., 2021</xref>) to display predicted structure models of the human NTE and <italic>Drosophila</italic> NTE/SWS proteins. Both proteins contain a highly conserved patatin-like phospholipase (EST) domain (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>, EST domain in magenta). EST domains in NTE/SWS (952â1118) and human NTE (981â1147) demonstrated a remarkably high level of confidence, exhibiting helical structures with predicted local distance difference test scores (pLDDT) exceeding 90 (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>).The EST domain exhibits a distinctive architectural pattern comprising three layers of Î±/Î²/Î± structure. Its central region is formed by a six-stranded Î²-sheet, flanked by Î±-helices in the front and back. Upon comparing the predicted structures of EST-SWS and EST-NTE, we observed a significant overlap between them (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>). These findings offer additional evidence of the high conservation of functional domains in NTE/SWS and the close relationship between these proteins across different species.</p><p>Together, the remarkable similarities observed between human and <italic>Drosophila</italic> SWE/NTE protein structure along with their shared involvement in the formation and maintenance of the brain barrier in <italic>Drosophila</italic> emphasize their close relationship and suggest a conserved function in BBB maintenance.</p></sec><sec id="s2-3"><title>Downregulation of NTE/SWS results in multilamellar accumulations</title><p>Next, we aimed to understand the nature of the SPG phenotype caused by <italic>sws</italic> deficiency. SPG cells have a very specific shape; they are thin and very large. Fewer than 50 SPG cells surround one adult brain hemisphere and a single SPG cell can cover the size of one half of the imaginal disc of the eye, covering an area equivalent to approximately 10,000 epithelial cells (<xref ref-type="bibr" rid="bib68">Limmer et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Hartenstein, 2011</xref>; <xref ref-type="bibr" rid="bib108">Silies et al., 2007</xref>). Therefore, to better visualize the defects in surface glia organization upon <italic>sws</italic> loss, we introduced <italic>moody-Gal4, UAS-CD8::GFP</italic> (<italic>moody&gt;CD8::GFP</italic>) constructs into the <italic>sws<sup>1</sup></italic> mutant background, which allowed analysis of SPG cell membranes. To our surprise, we observed that almost all lesions that were formed near the brain surface contained membrane material marked by <italic>CD8::GFP</italic> (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). This was in sharp contrast to the control, where SPG membranes formed a distinct GFP-positive line (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Importantly, the same excessive SPG cell membranes were observed inside the lesions formed upon <italic>sws</italic> downregulation explicitly in SPG cells (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), confirming that NTE/SWS is required cell-autonomously in SPG cells for the proper architecture of the surface glia.</p><p>Next, we wanted to understand the origin of these excessive membranes observed in <italic>sws</italic>-deficient glial cells. This task appeared to be quite challenging, as SPG cells form a very thin polarized endothelium, not even reaching 1 Î¼m thickness in most areas (<xref ref-type="bibr" rid="bib68">Limmer et al., 2014</xref>). In addition, SPG cells localize in very close proximity to each other and to neurons, making the analysis of subcellular protein localization challenging. Therefore, to dissect in more detail the <italic>sws</italic>-related phenotype of accumulated SPG membranes inside the lesions on the brain surface, we used an electron microscopy approach.</p><p>We found that <italic>sws</italic> mutants showed the formation of various multilamellar bodies in the brain, which were not observed in the control (<xref ref-type="fig" rid="fig3">Figure 3AâBâ²</xref>). These atypical structures ranged in size from 5 to 15 Î¼m and contained concentrically laminated and multilayered membranes (yellow arrows), lipid droplets (red arrows), and other partially degraded organelles or cytoplasmic constituents. We hypothesized that these inclusions most likely correspond to secondary lysosomes in the phase of digesting endosomal cargo, which are a hallmark of lysosomal storage diseases (LSDs).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Downregulation of NTE/SWS results in intracellular accumulations.</title><p>(<bold>AâC</bold>) Electron microscopy images of the surface area of the adult brains. (<bold>A</bold>) In controls (<italic>white<sup>1118</sup></italic>), glia cells that do not contain any abnormal subcellular structures. Scale bar: 1 Âµm. (<bold>BâBÊ¹</bold>) <italic>sws<sup>1</sup></italic> mutant brains have irregular surface and abnormal accumulation of endomembranous structures (yellow arrows) and lipid droplets (red arrows). Scale bar: 5 Âµm. (<bold>C</bold>) <italic>moody&gt;sws<sup>RNAi</sup></italic> fly brain has same abnormal accumulations of endomembranous structures (yellow arrows) as <italic>sws</italic> mutant. Scale bar: 5 Âµm. (<bold>DâDÊ¹</bold>) Adult brains stained with Rab7 (red) to detect lysosomes and late endosomes, GFP (<italic>moody&gt;CD8::GFP,</italic> green) to mark subperineurial glia (SPG) cell membranes and DAPI (blue) to mark nuclei. (<bold>D</bold>) A smooth line of SPG cell membranes is observed at the surface of control brains (<italic>moody&gt;CD8::GFP,</italic> green), Rab7 is present in relatively small amounts and evenly dispersed throughout in the brain (red). (<bold>DÊ¹</bold>) In <italic>sws</italic> loss-of-function mutants (<italic>sws<sup>1</sup>; moody&gt;CD8::GFP</italic>), Rab7-positive structures colocalized with atypical membrane aggregates of GFP-positive SPG membranes (red + green = yellow). (<bold>DÊ¹</bold>) Downregulation of <italic>sws</italic> specifically in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>) results in the appearance of the same assemblies in the SPG cells (yellow). Scale bar: 50 Âµm. (<bold>EâEÊ¹</bold>) Adult brains stained with CathepsinL (red) to detect lysosomes, GFP (<italic>moody&gt;CD8::GFP,</italic> green) to mark SPG cell membranes, and DAPI (blue) to mark nuclei. (<bold>E</bold>) A smooth line of SPG cell membranes is observed at the surface of control brains (<italic>moody&gt;CD8::GFP,</italic> green), CathepsinL is present in relatively small amounts in the brain (red). (<bold>D</bold>) In <italic>sws</italic> loss-of-function mutants (<italic>sws<sup>1</sup>; moody&gt;CD8::GFP</italic>), CathepsinL-positive structures colocalized with atypical membrane aggregates of GFP-positive SPG membranes (red + green = yellow). (<bold>EÊ¹</bold>) Downregulation of <italic>sws</italic> specifically in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>) results in the appearance of the same assemblies in the SPG cells (yellow). Scale bar: 50 Âµm. (<bold>F</bold>) Bar graph shows the percentage of brains with accumulated Rab7 structures at the brain surface. Two-way tables and chi-squared test were used for statistical analysis. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, black asterisks â compared to <italic>moody-Gal4 x OR</italic>, red asterisks â compared to 1-day-old <italic>moody-Gal4 x UAS-sws<sup>RNAi</sup></italic>, number of adult brain hemispheres â¥44, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). (<bold>G</bold>) Bar graph shows the percentage of brains with accumulated CathepsinL structures at the brain surface. Two-way tables and chi-squared test were used for statistical analysis. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, black asterisks â compared to <italic>moody-Gal4 x OR</italic>, red asterisks â compared to 1-day-old <italic>moody-Gal4 x UAS-sws<sup>RNAi</sup></italic>, number of adult brain hemispheres â¥49, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig3-v2.tif"/></fig><p>To authenticate the nature of membranous accumulation in <italic>sws</italic> mutants, we used endosomal and lysosomal markers. Rab7 is a small GTPase that belongs to the Rab family and controls transport to late endocytic compartments such as late endosomes and lysosomes (<xref ref-type="bibr" rid="bib42">Guerra and Bucci, 2016</xref>). Immunohistochemical analysis demonstrated that in contrast to controls, where Rab7 was present in relatively small and evenly dispersed throughout the brain late endosomes and lysosomes (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, red), in <italic>sws</italic>-deficient brains, accumulation of Rab7-positive compartments was observed. Moreover, Rab7-positive structures colocalized with atypical membrane aggregates of SPG cells (<xref ref-type="fig" rid="fig3">Figure 3Dâ²</xref>, yellow). The same assemblies were observed upon <italic>sws</italic> downregulation in SPG cells (<xref ref-type="fig" rid="fig3">Figure 3Dâ²</xref>, yellow).</p><p>Rab7 controls biogenesis of lysosomes and clustering and fusion of late endosomes and lysosomes (<xref ref-type="bibr" rid="bib32">Feng et al., 2014</xref>). Therefore, to support the idea that these abnormal cellular accumulations are of lysosomal origin, we used an additional marker â CathepsinL â which is a key lysosomal proteolytic enzyme expressed in most eukaryotic cells (<xref ref-type="bibr" rid="bib136">Xu et al., 2021</xref>). We found that <italic>sws</italic> loss or its downregulation in barrier-forming glia cells resulted in the appearance of CathepsinL-positive inclusions that colocalized with GFP-labeled membrane aggregates formed in the mutant SPG cells (<xref ref-type="fig" rid="fig3">Figure 3EâEâ²â²</xref>, yellow). We conclude that the structures observed upon NTE/SWS deregulation are abnormally enlarged lysosomes.</p><p>Next, we quantified the number of brain hemispheres with atypical Rab7- or CathepsinL-positive accumulations. In the control groups, very few (&lt;10%) of the analyzed brains showed accumulation of Rab7 or CathepsinL. However, in mutants with <italic>sws</italic> loss-of-function and with <italic>sws</italic> SPG-specific downregulation, a significant increase in the frequency of brains containing Rab7- or CathepsinL-positive aggregates was observed (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>). Since <italic>sws</italic>-associated neurodegeneration is age-dependent (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Kretzschmar et al., 1997</xref>; <xref ref-type="bibr" rid="bib27">Dutta et al., 2016</xref>; <xref ref-type="bibr" rid="bib113">Sujkowski et al., 2015</xref>; <xref ref-type="bibr" rid="bib114">Sunderhaus et al., 2019</xref>), we tested if abnormal lysosomes positive for Rab7 and CathepsinL increase with age. Analysis of the brains of 15-day-old <italic>sws</italic> downregulation in SPG cells demonstrated ~2-fold increase in the percentage of brains with lysosomal accumulations within the brain surface in comparison to 1-day-old animals (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>). These data demonstrate for the first time that NTE/SWS-associated phenotypes might be additionally characterized by the excessive storage of cellular material in lysosomes that is accelerated by age.</p><p>Importantly, similar abnormal buildup of cellular material in lysosomes have been found in hippocampal neuropil (<xref ref-type="bibr" rid="bib1">Akassoglou et al., 2004</xref>) and spinal axons of NTE-deficient mice (<xref ref-type="bibr" rid="bib91">Read et al., 2009</xref>). While these structures have not been specifically described as lysosomal defects, the presence of similar dense bodies containing concentrically laminated and multilayered membranes in NTE-deficient mice suggests that, similar to <italic>Drosophila</italic>, NTE/SWS-related phenotypes in mammals may also be associated with excessive storage of cellular material in lysosomes. Lysosomal changes and dysfunction have been involved in the initiation and development of numerous diseases, such as cancer, autoimmune, cardiovascular, neurodegenerative, and LSDs (<xref ref-type="bibr" rid="bib14">Cao et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Hebbar et al., 2017</xref>). In particular, LSDs are a group of rare metabolic disorders caused by inherited defects in genes that encode proteins vital for lysosomal homeostasis, such as lysosomal hydrolases or membrane proteins. LSDs often manifest as neurodegenerative disorders. Therefore, next, we wanted to investigate how lysosomal accumulation in SPG cells affects their functions, resulting in progressive brain degeneration.</p></sec><sec id="s2-4"><title>Downregulation of NTE/SWS affects brain permeability barrier</title><p>The main function of SPG cells is to protect the CNS from being exposed to molecules that are harmless to peripheral organs but toxic to brain neurons. SPG cells form a thick polarized endothelium, selective permeability of which is achieved by forming very tight SJs that provide structural strength and a barrier that controls the flow of various solutes from outside the brain (<xref ref-type="bibr" rid="bib68">Limmer et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Hartenstein, 2011</xref>; <xref ref-type="bibr" rid="bib108">Silies et al., 2007</xref>). Since our data show that the expression pattern of a key SJ protein, CoraC, is dramatically perturbed in <italic>sws</italic> mutant brains (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>), we decided to test if deregulation of NTE/SWS can affect the ability of SPG cells to form a selective permeability barrier.</p><p>As a result of abnormal BBB function, the CNS becomes permeable to small molecules such as dextran-coupled dyes. To test BBB permeability, the 10 kDa dextran dye was injected into the abdomen of flies (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). After injection, animals were allowed to recover for at least 12 hr, followed by the dissection and analysis of adult brains. In controls, dextran dye predominantly remained at the outer surface of the brain (<xref ref-type="fig" rid="fig4">Figure 4B and Bâ²</xref>). In contrast, the dye was detected inside almost all of the <italic>sws<sup>1</sup></italic> mutant brains (<xref ref-type="fig" rid="fig4">Figure 4C and Câ²</xref>). Moreover, the downregulation of <italic>sws</italic> in different types of glial cells also caused increased permeability of brain barrier in more than 80% of the analyzed brains (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Expression of <italic>Drosophila</italic> NTE/SWS and human NTE in glia in <italic>sws<sup>1</sup></italic> mutant rescued the organization of the surface glia (<xref ref-type="fig" rid="fig2">Figure 2H</xref>) and partially rescued the barrier phenotype, suggesting that human NTE and <italic>Drosophila</italic> NTE/SWS are important for the BBB integrity in <italic>Drosophila</italic> (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Taken together, our results demonstrate that SPG cells with NTE/SWS deficiency are characterized by defective brain barrier function and lysosomal accumulation of excess cellular material, which includes membranes.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Downregulation of NTE/SWS affects brain permeability barrier.</title><p>(<bold>A</bold>) Scheme of 10 kDa dextran dye permeability assay (see also Materials and methods for a detailed description of the procedure). (<bold>BâC</bold>) Localization of dextran dye more than 12 hr after injection in control (<italic>Oregon R</italic>) flies (<bold>BâBÊ¹</bold>) and in <italic>sws<sup>1</sup></italic> mutant (<bold>CâC</bold>Ê¹). Note that dextran dye can be detected in the cells present inside the mutant brain in contrast to control, where dye stays at the outer surface of the brain. Scale bar: 100 Âµm. (<bold>D</bold>) Bar graph shows the percentage of the brains with the defective permeability barrier. Two-way tables and chi-squared test were used for statistical analysis. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, black asterisks â compared to <italic>Gal4-driver x OR</italic>, red asterisks â compared to <italic>Gal4-driver x UAS-sws<sup>RNAi</sup></italic>, number of adult brain hemispheres â¥44, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig4-v2.tif"/></fig><p>Next, we wanted to understand whether the compromised brain barrier in <italic>sws</italic> mutants triggers the activation of any cellular stress pathways, including apoptosis, ferroptosis, oxidative stress, ER stress, and inflammation. We treated mutant flies for 14 days with different anti-inflammatory substances and stress suppressors and analyzed whether observed glial phenotypes could be suppressed by any medication. We analyzed CoraC expression and compared the frequencies of abnormal brain surface appearance in the drug-treated versus untreated animals (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1A, B</xref>). We revealed that sodium salicylate, a non-steroidal anti-inflammatory drug (NSAID) and rapamycin, which activates autophagy by inhibiting Tor (<xref ref-type="bibr" rid="bib135">Xu et al., 2017</xref>), showed the best ability to suppress surface glia phenotypes in <italic>sws</italic> mutants (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1B, Câ²</xref>). This indicates that an activated inflammatory response is associated with <italic>sws</italic> deficit.</p></sec><sec id="s2-5"><title><italic>moody</italic> flies with a permeable BBB show glial phenotype similar to <italic>sws</italic> mutants</title><p>A leaky BBB allows different toxic substances and bacteria to enter the CNS and affect neurons and glial cells, which can lead to cell death and increased inflammation in mammals (<xref ref-type="bibr" rid="bib51">Kim et al., 2012</xref>). To test if a permeable brain barrier in general is causing inflammation in <italic>Drosophila</italic>, we decided to test if an additional mutant with defective BBB has an increased inflammatory response in the brain. We focused on a <italic>moody<sup>ÎC17</sup></italic> mutant that has been previously shown to have a defective brain barrier (<xref ref-type="bibr" rid="bib7">Bainton et al., 2005</xref>).</p><p>First, we tested whether the <italic>moody</italic> mutant shows a phenotype similar to that observed in <italic>sws</italic> mutants by analysis of the CoraC expression pattern. We observed that the surface brain layer in <italic>moody</italic> mutants or upon <italic>moody</italic> downregulation in SPG by <italic>moody-Gal4</italic> (<italic>moody&gt;moody<sup>RNAi</sup></italic>) contained lesions and had an abnormal membrane assembly, resembling CoraC expression pattern in <italic>sws</italic> mutants (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2AâC</xref> and <xref ref-type="fig" rid="fig2">Figure 2B</xref>, magenta arrows).</p><p>Second, we analyzed if anti-inflammatory factors can reduce glial phenotypes in <italic>moody</italic> mutants, similar to <italic>sws</italic> mutants. We found that in <italic>moody</italic> mutants, the surface glia phenotype analyzed using CoraC as a marker could also be suppressed by NSAID and rapamycin (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1D and Dâ²</xref>). The fact that anti-inflammatory factors can reduce glial phenotypes in both <italic>sws</italic> and <italic>moody</italic> mutants indicates that inflammation, triggered as a result of a compromised brain barrier, plays a role in a feedback loop that exacerbates the abnormal surface glia organization (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). At the same time, inflammation inhibitors only partially rescued the BBB phenotype in <italic>moody</italic> and <italic>sws</italic> mutants, suggesting the involvement of additional pathways in maintaining the BBB.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mutants with defective blood-brain barrier (BBB) have an increased age-dependent inflammatory response and elevated levels of free fatty acid (FFA).</title><p>(<bold>A</bold>) Bar graph shows the reduction in the percentage of the glial phenotype, assayed by Coracle (CoraC) expression pattern, in <italic>sws<sup>1</sup></italic> (red) and <italic>moody<sup>ÎC17</sup></italic> (olive) mutants that were treated with non-steroidal anti-inflammatory drug (NSAID) and rapamycin in comparison to untreated mutants.This suggests that inflammation accelerates surface glia phenotype. Two-way tables and chi-squared test were used for statistical analysis, number of adult brain hemispheres â¥104, p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). (<bold>B</bold>) Real-time quantitative PCR (RT-qPCR) analysis of antimicrobial peptides (AMPs) mRNA levels from relevant controls (green) and <italic>sws<sup>1</sup></italic> (red) and <italic>moody</italic> (olive) mutant fly heads shows significantly upregulated expression of inflammatory response genes: <italic>Attacin A, Cecropin A,</italic> and <italic>Diptericin</italic>. AVE Â± SEM is indicated. Two-tailed Studentâs test was used to test for statistical significance, *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001 (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). (<bold>C</bold>) GS-MS measurements of free fatty acids (FFAs) indicate the relative increase of several FFAs in the heads of <italic>sws<sup>1</sup></italic> (red) and <italic>moody<sup>ÎC17</sup></italic> (olive) mutants compared to relevant controls (<italic>Oregon R</italic> and <italic>white<sup>1118</sup></italic>, green). One-way ANOVA test was used for statistical analysis, *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001 (see <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6a</xref>). (<bold>D</bold>) RT-qPCR analysis of AMP mRNA levels from the heads of 15- and 30-day-old relevant controls (green), <italic>sws<sup>1</sup></italic> (red), and <italic>moody&gt;sws<sup>RNAi</sup></italic> (orange) mutants shows the age-dependent upregulation of the expression of inflammatory response genes (<italic>Attacin A, Cecropin A,</italic> and <italic>Diptericin</italic>). Moreover, expression of <italic>Drosophila</italic> NTE/SWS (<italic>sws<sup>1</sup>; moody&gt;sws,</italic> blue) in subperineurial glia (SPG) cells in mutant background normalizes levels of AMPs. The AVE Â± SEM is shown. Two-tailed Studentâs test was used to test for statistical significance. p&lt;0.05, **p&lt;0.005, ***p&lt;0.001 (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Black asterisks â <italic>sws<sup>1</sup></italic> compared to <italic>Oregon R; moody&gt;sws<sup>RNAi</sup></italic> compared to <italic>moody&gt;/Oregon R</italic> of the same age. Green asterisks â rescue, <italic>sws<sup>1</sup>; moody&gt;sws</italic> compared to <italic>sws<sup>1</sup></italic>. Red asterisks â aging, 30-day-old compared to 15-day-old flies. (<bold>EâF</bold>) Adult brains stained with NimC1 (red), GFP (green), and DAPI (blue) to reveal the macrophage entry in the brain. Note that no macrophages marked by NimC1 (red) are detected in the control brain (<italic>moody&gt;CD8::GFP,</italic> <bold>E</bold>), while NimC1-positive marcrophages are detected in <italic>moody&gt;GFP, sws<sup>RNAi</sup></italic> brain (yellow arrowheads, <bold>F</bold>). Scale bar: 20 Âµm. (<bold>G</bold>) Mutants with defective brain barrier have upregulated innate immunity factors and exhibit elevated levels of FFAs involved in mediating the inflammatory response. Treatment with anti-inflammatory agents alleviates BBB phenotypes, suggesting that a signaling loop that links the condition of the brain barrier permeability, lipid metabolism, and inflammation.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5âsource data 1.</label><caption><title>GS-MS measurements of free fatty acids (FFA).</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-98020-fig5-data1-v2.xls"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title><italic>sws</italic> mutants show increased inflammation and macrophage entry into the brains.</title><p>(<bold>AâB</bold>) Anti-inflammatory drugs partially suppress glial phenotypes in <italic>sws</italic> mutants. (<bold>A</bold>) For the drug feeding assay, vials with sugar-free food with two micropipettes filled with dyed drug solution were used. (<bold>B</bold>) Bar graph shows the changed percentage of the brains of <italic>sws</italic> mutants with the glial phenotype, assayed with Coracle (CoraC), which were treated with different stress and inflammation inhibitors in comparison to untreated mutants. Two-way tables and chi-squared test were used for statistical analysis. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, number of adult brain hemispheres â¥73, at least three biological replicates (see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). (<bold>CâCÊ¹</bold>) Adult brains of <italic>sws</italic> mutants stained with CoraC (white). In <italic>sws<sup>1</sup></italic> mutants treated with control solution (<bold>C</bold>), the outer glial cell layer labeled by CoraC is irregular and contains membrane clusters (red arrowhead). In <italic>sws<sup>1</sup></italic> mutants treated with sodium salicylate (<bold>CÊ¹</bold>) the outer glial cell layer contains lesions (red arrowhead) and less membrane clusters. Scale bar: 50 Âµm. (<bold>DâDÊ¹</bold>) Adult brains of <italic>moody</italic> mutants stained with CoraC (white). In <italic>moody</italic> mutants treated with control solution (<bold>D</bold>), the outer glial cell layer labeled by CoraC is irregular and contains membrane clusters (olive arrowhead). In <italic>moody</italic> mutants treated with sodium salicylate (<bold>DÊ¹</bold>), the outer glial cell layer contains lesions (olive arrowhead) and no membrane clusters. (<bold>E</bold>) <italic>sws</italic> downregulation in glial cells during adulthood, after the BBB is formed, leads to the increased inflammatory response. Real-time quantitative PCR (RT-qPCR) analysis of antimicrobial peptides (AMPs) mRNA levels from control (<italic>tub-Gal80<sup>ts</sup>; repo&gt;/Oregon R</italic>, green) and <italic>tub-Gal80<sup>ts</sup>; repo&gt;sws<sup>RNAi</sup></italic> (red) fly heads shows upregulated expression of inflammatory response genes: <italic>Attacin A, Cecropin A,</italic> and <italic>Diptericin</italic>. AVE Â± SEM is indicated (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). (<bold>FâG</bold>) Larval and adult brains stained with mCherry (white) to reveal the macrophage entry in the brain, indicating that control (<italic>Oregon R/srp(Hemo)3xmCherry</italic>) brains. (<bold>F</bold>) show almost no macrophages marked by mCherry inside the developing and adult brains. Larval and adult brains of <italic>sws<sup>1</sup>; srp(Hemo)3xmCherry</italic>mutants (<bold>G</bold>) show macrophages inside the larval and adult brains (yellow arrowheads). Scale bar: 50 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 2.</label><caption><title><italic>Moody</italic> flies with a permeable blood-brain barrier (BBB) have similar to <italic>sws</italic> mutants brain surface appearance, but distinct septate junction phenotypes, and <italic>moody<sup>ÎC17</sup></italic> mutant shows no accumulation of endosomal-lysosomal pathway components such as Rab7.</title><p>(<bold>AâC</bold>) Adult brains stained with Coracle (CoraC) (white) to reveal brain surface. CoraC expression in control brains (<italic>Oregon R x white<sup>1118</sup></italic>, <bold>A</bold>) is depicted as the smooth line at the surface of the brain (green arrow). In <italic>moody<sup>ÎC17</sup></italic> mutant brains (<bold>B</bold>) and upon <italic>moody</italic> downregulation in subperineurial glia (SPG) cells (<italic>moody&gt;moody<sup>RNAi</sup>,</italic> <bold>C</bold>), CoraC-positive outer cell layer contains lesions and membrane clusters (magenta arrows). Scale bar: 20 Âµm. (<bold>D</bold>) Bar graph shows the percentage of the brains with a defective brain surface. Two-way tables and chi-squared test were used for statistical analysis, ***p&lt;0.001, number of adult brain hemispheres â¥20 (see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). (<bold>EâF</bold>) Electron microscopy images of the adult brain surface area in control (<italic>white<sup>1118</sup></italic>, <bold>E</bold>) and <italic>moody<sup>ÎC17</sup></italic> mutants (<bold>F</bold>). As previously described (<xref ref-type="bibr" rid="bib6">Babatz et al., 2018</xref>), the septate junctions in <italic>moody<sup>ÎC17</sup></italic> mutants cannot properly stretch out during cell growth and appear abnormal when compared to controls (black arrows). Scale bar: 1 Âµm. (<bold>GâH</bold>) Adult brains stained with Rab7 (red), Neurexin IV (NrxIV) (green), and DAPI (blue) show no abnormal accumulation of Rab7 vesicles in the <italic>Oregon R</italic> control (<bold>G</bold>) and <italic>moody<sup>ÎC17</sup></italic> mutant (<bold>H</bold>) brains.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 3.</label><caption><title>Gas chromatography-mass spectrometry (GC-MS) analysis of free fatty acids (FFAs).</title><p>(<bold>A</bold>) GC-MS measurement of arachidonic acid (C20:4) with the internal standard (IS). The peak area ratio (PAR) of <italic>m/z</italic> 303 for 20:4 to <italic>m/z</italic> 295 for the IS was linear in the range 0â4000 pmol of C20:4 at the fixed amount of 10,000 pmol of the IS. The graph shows an example for the quantitative measurement of arachidonic acid (C20:4) with the IS. The peak area ratio of <italic>m/z</italic> 303 for 20:4 to <italic>m/z</italic> 295 for the IS was linear in the range 0â4000 pmol C20:4 at the fixed amount of 10,000 pmol of the IS. C20:4 and IS were baseline-separated by chromatography (14.84 min; RSD, 0% vs 15.14 min; RSD, 0.03%) and entirely by mass spectrometry (<italic>m/z</italic> 295 vs <italic>m/z</italic> 303). The IS was found not to contribute to C20:4 by contaminating arachidonic acids or by its <sup>13</sup>C isotope. On a molar basis, C20:4 produced about 10 times lower peak areas than the IS in a relevant concentration range of arachidonic acid. (<bold>B</bold>) Peak area ratios of FFAs to the IS obtained from GC-MS analysis of a control standard samples that contained 10 nmol arachidonic acid (C20:4) and 10 nmol of the IS. This figure was constructed with the data of <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6c</xref>. Each symbol represents an FFA. The horizontal red line at an FFA/IS value of 0.0065 suggests that FFA/IS values higher than 0.0065 can be considered to present in the control standard sample and/or as laboratory contaminations. For more details, see the text. t<sub>R</sub>, retention time.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig5-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Mutants with defective BBB show upregulation of several innate immunity factors and FFAs</title><p>Next, we tested whether inflammatory pathways are activated in both mutants with permeable barriers. The molecular mechanisms of innate immunity between flies and mammals are highly evolutionarily conserved. For example, <italic>Drosophila</italic> Toll and IMD pathways are nuclear factor kappa B (NF-ÎºB)-based signaling pathways that share similarities with the Toll-like receptor and tumor necrosis factor receptor 1 signaling pathways in mammals (<xref ref-type="bibr" rid="bib86">Pavlidaki et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Kounatidis and Chtarbanova, 2018</xref>; <xref ref-type="bibr" rid="bib13">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Kounatidis et al., 2017</xref>). It has been previously shown that in glial cells, activation of the IMD pathway results in phosphorylation of the NF-ÎºB transcription factor Relish, which is translocated to the nucleus to induce expression of the AMPs Attacin A, Cecropin A, and Diptericin (<xref ref-type="bibr" rid="bib133">Winkler et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Kounatidis and Chtarbanova, 2018</xref>). We performed quantitative PCR (qPCR) analysis and measured the mRNA levels of these AMPs in heads of <italic>sws</italic> and <italic>moody</italic> loss-of-function mutants. We found that the mRNA levels of all three AMPs were significantly upregulated in mutants in comparison to relevant controls (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). These data demonstrate that both mutants with defective BBB exhibit an increased inflammatory response.</p><p>In addition, polyunsaturated fatty acids (PUFAs) have been shown to play a key role in inflammatory processes. Their oxygenated products, called eicosanoids, induce and regulate inflammation via G-protein-coupled receptor (GPCR) signaling pathways (<xref ref-type="bibr" rid="bib112">Stanley and Kim, 2018</xref>). To find out whether levels of polyunsaturated and saturated fatty acids are changed, we measured levels of FFAs from accurately weighed heads of control flies and mutants with defective BBB (<italic>sws<sup>1</sup></italic> and <italic>moody<sup>ÎC17</sup></italic>). FFAs were measured by gas chromatography-mass spectrometry (GC-MS) as described recently (<xref ref-type="bibr" rid="bib129">von Hanstein et al., 2023</xref>). We found that both mutants with defective BBB show upregulated levels of linoleic acid, Î±- and Î³-linolenic acid, eicosanoic acid, arachidonic acid, and eicosapentaenoic acid when compared to controls (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Additionally, levels of other FFAs involved in inflammatory response, 9-cis-tetradecenoic acid, palmitic acid, palmitoleic acid, stearic acid, and oleic acid (<xref ref-type="bibr" rid="bib78">Miao et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Korbecki and Bajdak-Rusinek, 2019</xref>) were elevated upon <italic>sws</italic> or <italic>moody</italic> loss (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). These data show that in both mutants with a compromised BBB, the inflammatory response is accompanied by the accumulation of FFAs.</p><p>Given that the loss of <italic>sws</italic> results in age-dependent neurodegeneration (<xref ref-type="bibr" rid="bib57">Kretzschmar et al., 1997</xref>), we investigated whether the increased inflammatory response is progressing with age. We performed qPCR analysis and quantified mRNA levels of AMPs (Attacin A, Cecropin A, and Diptericin) in the heads of <italic>sws</italic> mutants and flies that had <italic>sws</italic> downregulation only in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>) of 15- and 30-day-old flies. We confirmed that the mRNA levels of all three AMPs were significantly upregulated in mutants of both ages in comparison to the relevant controls (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, black asterisks). Furthermore, we observed a significant age-related increase in the expression of inflammatory genes in both <italic>sws</italic> mutants and flies with <italic>sws</italic> downregulation in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>, <xref ref-type="fig" rid="fig5">Figure 5D</xref>, red asterisks), thereby illustrating the correlation between age-related NTE/SWS neurodegeneration and inflammatory processes. Importantly, expression of <italic>Drosophila</italic> NTE/SWS in SPG cells in <italic>sws<sup>1</sup></italic> mutant background normalized levels of inflammatory genes expression in flies of both ages (15- and 30-day-old flies), confirming that the increased inflammatory response is a consequence of the defective BBB (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, green asterisks). Moreover, downregulating <italic>sws</italic> in glial cells during adulthood, after BBB formation, resulted in an increased inflammatory response (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). Since previous studies have demonstrated the induction of neurodegeneration by the overactivation of innate immune-response pathways, especially elevated expression of AMPs (<xref ref-type="bibr" rid="bib13">Cao et al., 2013</xref>), our data showing increased levels of AMPs in aging flies with a defective BBB further strengthen the connection between the BBB, AMPs, and neuroinflammation and reinforce the causative link between BBB breakdown and inflammaging.</p><p>Upon infections and autoimmune conditions, macrophages have the capability to infiltrate the brain, aiding in pathogen removal but also posing the potential risk of causing tissue damage. It has been recently shown that the IMD pathway attracts and facilitates the invasion of hemolymph-borne macrophages across the BBB into the inflamed brain during pupal stages (<xref ref-type="bibr" rid="bib133">Winkler et al., 2021</xref>). To investigate whether the neuroinflammatory response in <italic>sws</italic> mutants is associated with the entry of macrophages into the brain, we introduced <italic>srp(Hemo)3xmCherry</italic>, which enables the labeling of macrophages (<xref ref-type="bibr" rid="bib16">Cattenoz et al., 2021</xref>), into the <italic>sws<sup>1</sup></italic> mutant background. In contrast to control brains, we observed the presence of macrophages within the brain in both developing and adult brains of <italic>sws<sup>1</sup>; srp(Hemo)3xmCherry</italic> mutants (yellow arrowheads, <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1F and G</xref>). Moreover, using the anti-NimC1 antibody (<xref ref-type="bibr" rid="bib61">Kurucz et al., 2007</xref>), macrophage infiltration into the adult brain was detected in flies with <italic>sws</italic> downregulation specifically in SPG cells (<italic>moody&gt;GFP, sws<sup>RNAi</sup></italic>, yellow arrowheads, <xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). This suggests that the presence of an inflammatory response in mutants with a compromised BBB is associated with macrophage entry into the brain.</p></sec><sec id="s2-7"><title><italic>sws</italic> and <italic>moody</italic> mutants have distinct surface glia phenotypes</title><p>However, while both <italic>sws</italic> and <italic>moody</italic> mutants have defective BBB, the nature of these mutations and their involvement in cellular processes are very different. Moody is a GPCR that is expressed in SPGs and localizes to the sites of SJ formation (<xref ref-type="bibr" rid="bib6">Babatz et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Bainton et al., 2005</xref>; <xref ref-type="bibr" rid="bib99">Schwabe et al., 2005</xref>; <xref ref-type="bibr" rid="bib64">Li et al., 2021a</xref>). Its cellular function is to control continued cell growth of SPG by differentially regulating actomyosin contractility and SJ organization (<xref ref-type="bibr" rid="bib64">Li et al., 2021a</xref>). NTE/SWS is a transmembrane ER protein that hydrolyzes phosphatidylcholine and binds to and inhibits the C3 catalytic subunit of protein kinase A (<xref ref-type="bibr" rid="bib8">Bettencourt da Cruz et al., 2008</xref>). To understand how such different mutations could result in similar outcomes, we first analyzed if <italic>moody</italic> loss would result in lysosomal material accumulation. Electron microscopy analyses demonstrated that unlike in <italic>sws</italic> mutant brains, no intracellular accumulations with extracellular material were observed upon <italic>moody</italic> loss (compare <xref ref-type="fig" rid="fig3">Figure 3B and BÊ¹</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2F</xref>). Furthermore, no accumulation of endosomal-lysosomal pathway components such as Rab7 were detected within SPG cells of <italic>moody</italic> mutants (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2G and H</xref>). At the same time, as previously described (<xref ref-type="bibr" rid="bib6">Babatz et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Bainton et al., 2005</xref>; <xref ref-type="bibr" rid="bib99">Schwabe et al., 2005</xref>; <xref ref-type="bibr" rid="bib64">Li et al., 2021a</xref>), we observed that in the absence of <italic>moody</italic>, SJs were formed, but they were disorganized (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2F</xref>, arrow).</p><p>We compared in greater detail the SJ organization in both mutants using a molecular component of SJs, Neurexin IV (NrxIV). In comparison to the wild type, upon <italic>sws</italic> loss, SJs were not properly assembled and exhibited irregular membrane clusters and disruptions (<xref ref-type="fig" rid="fig6">Figure 6A and C</xref>). In contrast, the <italic>moody</italic> mutant exhibited a frayed SJ phenotype (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Since Moody coordinates the continuous organization of junctional strands in an F-actin-dependent manner, as a result of its loss, SJ strands fail to extend properly during cell growth (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). While the role of Moody in SJ formation is understood (<xref ref-type="bibr" rid="bib6">Babatz et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Bainton et al., 2005</xref>; <xref ref-type="bibr" rid="bib99">Schwabe et al., 2005</xref>; <xref ref-type="bibr" rid="bib64">Li et al., 2021a</xref>), the mechanism by which NTE/SWS may be involved in this process is unclear. The in-depth examination of cell junctional structures in <italic>sws</italic> mutants using electron microscopy revealed their improper assembly, characterized by the accumulation of irregular membrane clusters and disruptions in septa organization (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>, yellow arrowheads). Cell junctions are a special type of plasma membrane domain whose transmembrane proteins form a complex, mechanically stable multiprotein structure (<xref ref-type="bibr" rid="bib37">Giepmans and van Ijzendoorn, 2009</xref>). The lipid component of cell junctions exhibits a typical membrane raft structure (<xref ref-type="bibr" rid="bib63">Lee et al., 2008</xref>; <xref ref-type="bibr" rid="bib106">Shigetomi et al., 2023</xref>; <xref ref-type="bibr" rid="bib84">Nusrat et al., 2000</xref>; <xref ref-type="bibr" rid="bib109">Simons and Vaz, 2004</xref>; <xref ref-type="bibr" rid="bib81">MÃ¼hlig-Versen et al., 2005</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Septate junction and membrane domain organization in mutants with defective brain permeability barrier.</title><p>(<bold>AâC</bold>) Adult brains stained with a septate junction marker Neurexin IV (NrxIV) (white). Scale bar: 50 Âµm. (<bold>A</bold>) In control (<italic>Oregon R</italic>) brain, septate junctions formed by subperineurial glia (SPG) glia are depicted as condensed and distinct strand. The scheme depicts the intact blood-brain barrier (BBB) formed by perineurial glia (PG) and SPG. The SPG cells establish well-formed septate junctions (SJs) and exhibit organized membrane domains. Furthermore, the lysosomes are fully functional. (<bold>B</bold>) In <italic>moody<sup>ÎC17</sup></italic> mutants, due to SPG membrane overgrowth, septate junctions are frayed. The scheme illustrates a defective BBB where the proper extension of septate junction strands during cell growth is impaired, resulting in increased permeability. However, despite this issue, the membrane domains remain well formed, and the lysosomes within the barrier continue to function effectively. (<bold>C</bold>) In <italic>sws<sup>1</sup></italic> mutants, septate junctions and membrane domains are not properly organized. By analyzing SPG membranes in <italic>sws</italic> mutants, abnormal clustering of SJ proteins and disorganized membrane domains are observed. Furthermore, <italic>sws</italic>-deficient brains exhibit excessive storage of cellular material within lysosomes. The scheme shows that NTE/SWS-related lipid dysregulation is accompanied by dysfunctional lysosomes, impaired distribution of cell junction proteins, and disrupted organization of membrane domains in surface glia. (<bold>DâF</bold>) Electron microscopy images of the septate junction area at the surface of the control (<italic>white<sup>1118</sup></italic>, <bold>D</bold>) and <italic>sws<sup>1</sup></italic> mutant (<bold>EâF</bold>) adult brains. Green arrowheads indicate septate junctions in control and yellow arrowheads indicate septate junctions in <italic>sws<sup>1</sup></italic> mutant brains. Scale bar: 250 nm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 1.</label><caption><title>Lysosomal mutants show abnormal septate junction formation.</title><p>(<bold>AâE</bold>) Adult brains stained with Coracle (CoraC) (red), Neurexin IV (NrxIV) (green), and DAPI (blue) to reveal septate junction structures of the surface glia. In control (<italic>moody&gt;/Oregon R,</italic> <bold>A</bold>) brain, septate junctions formed by subperineurial glia (SPG) glia are depicted as condensed and distinct strands. In the lysosomal pathway mutants â <italic>moody&gt;Dysb<sup>RNAi</sup></italic> (<bold>B</bold>), <italic>moody&gt;Npc1a<sup>RNAi</sup></italic> (<bold>C</bold>), <italic>moody&gt;Pldn<sup>RNAi</sup></italic> (<bold>D</bold>), <italic>and moody&gt;spin<sup>RNAi</sup></italic>(<bold>E</bold>) flies, septate junctions are not properly organized (yellow arrows). Scale bar: 20 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98020-fig6-figsupp1-v2.tif"/></fig></fig-group><p>The main feature of membrane rafts is that they contain an enriched fraction of cholesterol and sphingolipids and are able to dynamically orchestrate specific membrane proteins involved in cell adhesion, signal transduction, protein transport, pathogen entry into the cell, etc. Since NTE/SWS regulates lipid membrane homeostasis, we hypothesized that it influences the composition of membrane rafts. Analysis of SPG membranes in <italic>sws</italic>-deficient brains shows abnormal clustering of SJs proteins and disorganized membrane domains, implying that NTE/SWS phospholipase plays a role in organizing SPG membrane architecture (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). As lysosomes play a crucial role in lipid catabolism and transport, any disruptions in their function can have repercussions on cellular lipid homeostasis, thereby influencing the composition of membrane rafts. To investigate whether the observed SJ phenotype in <italic>sws</italic> mutants can be replicated by inducing lysosomal dysfunctions, we downregulated in SPG cells several key lysosomal genes: <italic>moody&gt;Dysb<sup>RNAi</sup></italic>, <italic>moody&gt;Npc1a<sup>RNAi</sup></italic>, <italic>moody&gt;Pldn<sup>RNAi</sup></italic>, <italic>and moody&gt;spin<sup>RNAi</sup></italic>. Significantly, the downregulation of any of these genes led to abnormal formation of SJs and membrane organization in SPG cells (<xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1AâE</xref>). This suggests that the lysosomal control of membrane homeostasis has a significant impact on the appearance of SJs.</p><p>In summary, our data show that the phospholipase NTE/SWS plays a crucial role in lysosome biogenesis and organization of the architectural framework of BBB membranes. We propose that since NTE/SWS regulates lipid membrane homeostasis, its loss results in the disruption of membrane rafts, which includes SJs, leading to brain barrier permeability. As a result, the inflammatory response accompanied by the accumulation of FFAs is activated in mutant brains, leading to progressive neurodegeneration that can be alleviated by the use of anti-inflammatory drugs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The physiological functions of the BBB, maintaining and protecting the homeostasis of the CNS, are evolutionarily conserved across species (<xref ref-type="bibr" rid="bib11">Bundgaard and Abbott, 2008</xref>). Even though there is already plenty of evidence connecting BBB dysfunction to neurodegenerative diseases, the underlying mechanism is not fully understood. The BBB is formed by microvascular endothelial cells lining the cerebral capillaries penetrating the brain and spinal cord of most mammals and other organisms with a well-developed CNS (<xref ref-type="bibr" rid="bib48">Kadry et al., 2020</xref>). Interestingly, NTE is highly expressed not only in the nervous system but also in endothelial cells, suggesting that BBB might be affected upon NTE-associated neurodegenerations (The Human Protein Atlas â <ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/ENSG00000032444-PNPLA6/single+cell+type">https://www.proteinatlas.org/ENSG00000032444-PNPLA6/single+cell+type</ext-link>).</p><p>Here, we made an intriguing discovery regarding the presence of NTE/SWS in the surface glia responsible for forming the BBB, where it plays a crucial role in ensuring the selective permeability of the BBB and the proper organization of surface glia. Moreover, here we discovered that NTE/SWS-associated neurodegeneration is accompanied by abnormal membrane accumulation within defective lysosomes, indicating importance of NTE/SWS in proper function of lysosomes. It has been demonstrated for some LSDs, for example, Krabbeâs disease, to be pathologically characterized by rapidly progressive demyelination of the CNS and PNS and accumulation of macrophages in the demyelinating lesions (<xref ref-type="bibr" rid="bib52">Kondo et al., 2005</xref>). Considering that NTE/SWS is involved in the maturation of non-myelinating Schwann cells during development and de/remyelination after neuronal injury (<xref ref-type="bibr" rid="bib75">McFerrin et al., 2017</xref>), it suggests that lysosomal function of NTE/SWS might be essential for proper myelination in vertebrates. Interestingly, we found that loss of <italic>sws</italic> or its downregulation in barrier-forming glia led to accumulations of Rab7 and CathepsinL in these cells, demonstrating that NTE/SWS-associated neuropathies might be additionally characterized by excessive storage of cellular material in lysosomes. Importantly, neuroinflammation has been reported in several LSDs. The most abundant lysosomal proteases, Cathepsins have been shown to contribute to neuroinflammation as well as to induce neuronal apoptosis (<xref ref-type="bibr" rid="bib123">Tschopp and Schroder, 2010</xref>).</p><p>Over the past few years, there has been a growing appreciation of the organizing principle in cell membranes, especially within the plasma membrane, where such domains are often referred to as âlipid raftsâ. Such lipid rafts were defined as transient, relatively ordered membrane domains, the formation of which is driven by lipid-lipid and lipid-protein interactions (<xref ref-type="bibr" rid="bib103">Sezgin et al., 2017</xref>). Previously, it has been demonstrated that NTE/SWS is crucial for membrane lipid homeostasis, and <italic>sws</italic> mutants exhibit increased levels of phosphatidylcholine (<xref ref-type="bibr" rid="bib81">MÃ¼hlig-Versen et al., 2005</xref>). Phosphatidylcholine, a key component of most organellar membranes, possesses an amphiphilic nature, enabling it to energetically self-assemble into continuous bilayers (<xref ref-type="bibr" rid="bib137">Yang et al., 2018</xref>). This ability to spontaneously self-organize can explain the appearance of multilayered membrane structures in the lysosomes of <italic>sws</italic> mutants. Furthermore, phosphatidylcholine plays a vital role in generating spontaneous curvature, essential for membrane bending and tubulation in vesicular transport processes within the cell (<xref ref-type="bibr" rid="bib30">Epand and Epand, 1994</xref>). Therefore, abnormal levels of phosphatidylcholine may impact the lysosome fission and fusion steps, leading to the accumulation of defective lysosomes in <italic>sws</italic> mutants. Since lysosomes are involved in lipid catabolism and transport, disruptions in their function can additionally affect cellular lipid homeostasis (<xref ref-type="bibr" rid="bib120">Thelen and Zoncu, 2017</xref>). Consequently, alterations in lipid composition due to abnormal NTE/SWS phospholipase function and defective lysosomes in <italic>sws</italic> mutant cells could affect the constitution of the plasma membrane and its ability to form lipid-driven membrane rafts. Lipid rafts are characterized by the clustering of specific membrane lipids through spontaneous separation of glycolipids, sphingolipids, and cholesterol in a liquid-ordered phase (<xref ref-type="bibr" rid="bib40">Grassi et al., 2020</xref>). Their assembly dynamics depend on the relative availability of different lipids and membrane proteins (<xref ref-type="bibr" rid="bib109">Simons and Vaz, 2004</xref>). Lipid rafts play significant roles in multiple cellular processes, including signaling transduction (<xref ref-type="bibr" rid="bib103">Sezgin et al., 2017</xref>). Interestingly, tight junctions are considered as raft-like membrane compartments (<xref ref-type="bibr" rid="bib84">Nusrat et al., 2000</xref>), as they represent membrane microdomains crucial for the spatial organization of cell junctions and regulation of paracellular permeability (<xref ref-type="bibr" rid="bib63">Lee et al., 2008</xref>; <xref ref-type="bibr" rid="bib106">Shigetomi et al., 2023</xref>). Therefore, we propose that abnormal organization of tight junctions in the SPG cells of <italic>sws</italic> mutants is caused by abnormal organization of plasma membrane domains.</p><p>Lysosomes play an essential role in the breakdown and recycling of intracellular and extracellular material, including lipids, proteins, nucleic acids, and carbohydrates. Any dysfunction of lysosomal system components has catastrophic effects and leads to a variety of fatal diseases (<xref ref-type="bibr" rid="bib124">Udayar et al., 2022</xref>). LSDs are often linked to changes in plasma membrane lipid content and lipid raft stoichiometry (<xref ref-type="bibr" rid="bib25">Domon et al., 2011</xref>; <xref ref-type="bibr" rid="bib126">Vainio et al., 2005</xref>), inflammation (<xref ref-type="bibr" rid="bib101">Seehafer et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">DiRosario et al., 2009</xref>), and ER stress responses (<xref ref-type="bibr" rid="bib50">Kim et al., 2006</xref>; <xref ref-type="bibr" rid="bib119">Tessitore et al., 2004</xref>). In the past few years, treatments for LSDs were only able to deal with signs and symptoms of the disorders. One possible approach is to identify an available source for the deficient enzyme using therapeutic methods such as bone marrow transplantation, enzyme replacement therapy (ERT), substrate reduction therapy, chemical chaperone therapy, and gene therapy. At the present time, such strategies are aimed at relieving the severity of symptoms or delaying the diseaseâs progression, yet do not provide a complete cure (<xref ref-type="bibr" rid="bib105">Sheth and Nair, 2020</xref>). However, since we and others <xref ref-type="bibr" rid="bib113">Sujkowski et al., 2015</xref> have shown that overexpression of human NTE can ameliorate mutant phenotype, it can be speculated that, depending on the causative mutation, ERT might be an option as treatment of NTE/SWS-related disorders.</p><p>It has been demonstrated that the ER establishes contacts between its tubules and late endosomes/lysosomes, visualized in unpolarized cells as well as in neurons derived from brain tissue. Moreover, disruption of ER tubules causes accumulation of enlarged and less-motile mature lysosomes in the soma, suggesting that ER shape and proper function orchestrate axonal late endosome/lysosome availability in neurons (<xref ref-type="bibr" rid="bib85">Ãzkan et al., 2021</xref>; <xref ref-type="bibr" rid="bib134">Wu et al., 2017</xref>). Considering the ER localization of NTE/SWS in the cell, we propose that abnormal lipid composition in the membrane upon <italic>sws</italic> loss has a significant effect on lysosome structure and functions. Furthermore, ER forms contact sites with plasma membrane through vesicle-associated membrane protein-associated protein VAP (<xref ref-type="bibr" rid="bib65">Li et al., 2021b</xref>). Loss of VAP results in neurodegeneration, such as sporadic amyotrophic lateral sclerosis or Parkinsonâs disease (<xref ref-type="bibr" rid="bib60">Kun-Rodrigues et al., 2015</xref>; <xref ref-type="bibr" rid="bib4">Anagnostou et al., 2010</xref>). Mitochondria-ER contact sites play a crucial role in many vital cellular homoeostatic functions, including mitochondrial quality control, lipid metabolism, calcium homeostasis, unfolded protein response, and ER stress. Disruptions in these functions are commonly observed in neurodegenerative disorders like Parkinsonâs disease, Alzheimerâs disease, and amyotrophic lateral sclerosis (<xref ref-type="bibr" rid="bib132">Wilson and Metzakopian, 2021</xref>). Interestingly, knockdown of <italic>sws</italic> in neurons reduces mitochondria number in the brain and in wing axons (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>). NTE/SWS-deficient animals show activation of ER stress response, characterized by elevated levels of GRP78 chaperone and increased splicing of XBP, an ER transcription factor that triggers transcriptional ER stress responses. Neuronal overexpressing XBP1 and treating flies with tauroursodeoxycholic acid (TUDCA), a chemical known to attenuate ER stress-mediated cell death, alleviated locomotor deficits and neurodegeneration in <italic>sws</italic> mutants assayed by vacuolization area (<xref ref-type="bibr" rid="bib114">Sunderhaus et al., 2019</xref>). Reduced levels of sarco/endoplasmic reticulum Ca<sup>2+</sup> ATPase observed in <italic>sws</italic> mutants were linked to disrupted lipid compositions as well. Promoting cytoprotective ER stress pathways may provide therapeutic relief for NTE-related neurodegeneration and motor symptoms (<xref ref-type="bibr" rid="bib114">Sunderhaus et al., 2019</xref>).</p><p>Moreover, we found that BBB disruption is accompanied by elevated levels of FFAs, involved in multiple extremely important biological processes. Fatty acids are locally produced in the endothelium and later are transported inside the brain across the BBB (<xref ref-type="bibr" rid="bib88">Pifferi et al., 2021</xref>). We discovered that <italic>Drosophila</italic> mutants with leaky BBB showed upregulated levels of such fatty acids as palmitoleic, oleic, linoleic, linolenic, arachidonic, and eicosapentaenoic acids, suggesting abnormal metabolism of unsaturated fatty acids upon barrier dysfunction. In particular, <italic>sws</italic> loss results in increased levels of some saturated FFAs, including palmitic and stearic acids. FFAs or non-esterified fatty acids are known to be significant sources of ROS, which lead to the event of oxidative stress (<xref ref-type="bibr" rid="bib110">Soardo et al., 2011</xref>), resulting in lipotoxicity associated with ER stress, calcium dysregulation, mitochondrial dysfunction, and cell death (<xref ref-type="bibr" rid="bib72">Ly et al., 2017</xref>). Previously it has been demonstrated ROS accumulation and activated ER stress response upon <italic>sws</italic> loss in neurons and glia (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>; <xref ref-type="bibr" rid="bib98">Ryabova et al., 2021</xref>; <xref ref-type="bibr" rid="bib114">Sunderhaus et al., 2019</xref>), which might be a result of increased levels of FFAs. In addition, neuronal <italic>sws</italic> knockdown results in the upregulation of antioxidant defense genes (<xref ref-type="bibr" rid="bib77">Melentev et al., 2021</xref>). We found that BBB breakdown is accompanied by abnormal fatty acids metabolism, and rapamycin can suppress the abnormal glial phenotype formed in BBB <italic>Drosophila</italic> mutants. Interestingly, saturated FFAs have been shown to lead to target of rapamycin (mTOR) complex 1 activation and cell apoptosis in podocytes (<xref ref-type="bibr" rid="bib138">Yasuda et al., 2014</xref>). Moreover, rapamycin significantly diminishes FFA-induced podocyte apoptosis (<xref ref-type="bibr" rid="bib138">Yasuda et al., 2014</xref>), supporting its potential ability to suppress possible outcomes of FFA upregulation in the <italic>Drosophila</italic> brain, thus improving glial phenotype in mutants with BBB breakdown.</p><p>PUFAs are known to be primary precursors of lipid mediators that are abundant immunomodulators (<xref ref-type="bibr" rid="bib62">Kwon et al., 2020</xref>). Lipid mediators are signaling molecules, such as eicosanoids, and are implicated in inflammation. More recently, lipid molecules that are pro-inflammatory, and those involved in the resolution of inflammation have become important targets of therapeutic intervention in chronic inflammatory conditions. According to published research, PUFAsâ metabolism was additionally associated with Alzheimerâs disease and dementia (<xref ref-type="bibr" rid="bib128">van der Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib90">Rao et al., 2017</xref>). The focus of particular interest has recently been on the PUFAsâ involvement in the continued inflammatory response because, in contrast to acute inflammation, chronic inflammatory processes within the CNS are crucial for the development of brain pathologies (<xref ref-type="bibr" rid="bib92">Regulska et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Funk, 2001</xref>). In our study, we found that brain permeability barrier breakdown is accompanied by abnormal fatty acids metabolism and that an aspirin analogue â an NSAID â showed the best ability to suppress abnormal glial phenotype, indicating that activated inflammatory response possibly plays an important role in maintaining a healthy brain barrier. Thus, feedback signaling loop exists between the condition of the brain permeability barrier, lipid metabolism, and the extent of inflammation. According to the World Health Organization (WHO), the current decade is considered the Decade of Healthy Aging. As the speed of population aging is accelerating worldwide, the proportion of older people will increase from one in eight people aged 60 years or over in 2017 to one in six by 2030 and one in five by 2050 (<xref ref-type="bibr" rid="bib49">Keating, 2022</xref>; <xref ref-type="bibr" rid="bib97">Rudnicka et al., 2020</xref>). Globally, there is a little evidence that older people today are in better health than previous generations (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/home/cms-decommissioning">https://www.who.int/home/cms-decommissioning</ext-link>). If people who enter extended age of life are in good health, they will continue to participate and be an integral part of families and communities and will strengthen societies; however, if the added years are dominated by poor health, social isolation or dependency on care, the implications for older people and for society are much more negative. Therefore, aging of the world population has become one of the most important demographic problems/challenges of modern society. Moreover, the global strategy on aging and health of the older population includes not only treating but also preventing some of the worldâs leading age-related diseases using biomarkers as indicators of any aspects of health change (<xref ref-type="bibr" rid="bib21">Crimmins et al., 2008</xref>). Unfortunately, most neurodegenerative diseases in humans currently have no cure, and only palliative care is available. Current research is primarily focused on promoting the development of therapies that can prevent the onset of a number of age-related neurodegenerative diseases. Specific and effective treatments are urgently needed. However, their advance hinges upon a deeper understanding of the molecular mechanisms underlying progressive neurodegeneration. Understanding the molecular mechanisms of inflammaging activated by abnormal fatty acid metabolism and testing new and available drugs in a model organism such as <italic>Drosophila</italic> may help us to promote the use of anti-inflammatory therapy and dietary supplements for neurodegeneration and get closer to preventing and curing the diseases that lead to malfunctions in the aged brain.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title><italic>Drosophila</italic> stocks</title><p>Fly stocks were maintained at 25Â°C on a standard cornmeal-agar diet in a controlled environment (constant humidity and light-dark cycle). As controls <italic>OregonR</italic> and <italic>w<sup>1118</sup></italic> lines were used. The <italic>sws<sup>1</sup></italic> mutant and the <italic>UAS-sws</italic> lines were gifts from <xref ref-type="bibr" rid="bib57">Kretzschmar et al., 1997</xref>. To obtain <italic>sws</italic> transheterozygotes, <italic>sws<sup>1</sup></italic> and <italic>sws<sup>4</sup>,</italic> obtained from Bloomington Drosophila Stock Center (BDSC 28121), mutant alleles were used. To express transgenes in an <italic>sws</italic>-dependent manner, an <italic>sws</italic> driver line (<italic>sws-Gal4</italic>), obtained from the Kyoto Stock Center (104592), was used. <italic>y* w* P{GawB}sws<sup>NP4072</sup>/FM7</italic>c line was created using the strategy of the Gal4 enhancer trap element P{GawB} insertion (<xref ref-type="bibr" rid="bib10">Brand and Perrimon, 1993</xref>; <xref ref-type="bibr" rid="bib44">Hayashi et al., 2002</xref>). To define an expression pattern of the driver lines, a <italic>UAS-nlsLacZ, UAS-CD8::GFP</italic> transgenic line, kindly donated by Frank Hirth, was used. To induce human NTE gene expression, a <italic>UAS-hNTE</italic> transgenic line (kindly donated by Robert Wessells) was used. To downregulate <italic>sws</italic> expression<italic>, UAS-sws<sup>RNAi</sup></italic> (BDSC 61338) was used. Glia-specific Gal4 driver lines â <italic>repo-Gal4, UAS-CD8::GFP/TM6B</italic>, <italic>Gliotactin-Gal4, UAS-CD8::GFP,</italic> and <italic>moody-Gal4, UAS-CD8::GFP</italic> â were gifts from Mikael Simons. A neuronal Gal4 driver, <italic>nSyb-Gal4</italic> was obtained from BDSC (BDSC 51945). In addition, to phenocopy <italic>sws</italic> loss-of-function in the nervous system, a double driver line was generated (<italic>repo-Gal4, nSyb-Gal4, UAS-CD8::GFP/TM6B, Sb),</italic> which allowed the expression of the transgenes in both neuronal and glial cells. To induce <italic>sws</italic> downregulation in glia after the BBB was formed, we used <italic>tub-Gal80<sup>ts</sup>;repo-Gal4/TM6B</italic> driver line. The <italic>moody<sup>ÎC17</sup></italic> mutant was a gift from Christian KlÃ¤mbt. To downregulate <italic>moody</italic> expression, <italic>UAS-moody<sup>RNAi</sup></italic> (BDSC 66326) was used. <italic>UAS-Dysb<sup>RNAi</sup></italic> (BDSC67316), <italic>UAS-Npc1a<sup>RNAi</sup></italic> (BDSC37504), <italic>UAS-Pldn<sup>RNAi</sup></italic> (BDSC67884), <italic>UAS-spin<sup>RNAi</sup></italic> (BDSC27702) lines were used to analyze SJs of lysosomal storage mutants. <italic>srp(Hemo)3xmCherry</italic> line (kindly donated by Angela Giangrande) was used to analyze the macrophage entry through the BBB.</p></sec><sec id="s4-2"><title>Histology of <italic>Drosophila</italic> brains</title><p>For analysis of adult brain morphology, 7 Î¼m paraffin-embedded sections were cut from fly heads. To prepare <italic>Drosophila</italic> brain sections, the fly heads were immobilized in collars in the required orientation and fixed in Carnoy fixative solution (6:3:1=ethanol:chloroform:acetic acid) at 4Â°C overnight. Tissue dehydration and embedding in paraffin was performed as described previously (<xref ref-type="bibr" rid="bib59">Kucherenko et al., 2010</xref>). Histological sections were prepared using a Hyrax M25 (Zeiss) microtome and stained with hematoxylin and eosin as described previously (<xref ref-type="bibr" rid="bib104">Shcherbata et al., 2007</xref>). All chemicals for these procedures were obtained from Sigma-Aldrich.</p></sec><sec id="s4-3"><title>Immunohistochemistry</title><p>Fly brains of 1- and 15-day-old animals were dissected in 1Ã phosphate buffered saline (1Ã PBS) and then fixed in 4% formaldehyde diluted in 1Ã PBS for 20 min at room temperature. Next, brains were washed with PBT (0.2% Triton X-100 in 1Ã PBS) four times, followed by block with PBTB (2 g/L bovine serum albumin, 5% normal goat serum, 0.5 g/L sodium azide) for 1 hr at room temperature and then incubated at 4Â°C with primary antibodies diluted in PBTB on nutator overnight. The following day, samples were washed with 1Ã PBT four times followed by block for 1 and 2 hr incubation with secondary antibodies at room temperature. Next, samples were washed four times with PBT (one of the washes contained DAPI to mark nuclei). Lastly, medium (70% glycerol, 3% n-propyl gallate in 1Ã PBS) was added to samples for later mounting on the slides. The following primary antibodies were used: mouse anti-Repo (1:50), mouse anti-CoraC (1:50), and mouse anti-Rab7 (1:50), rat anti-DE-Cadherin (1:50) from the Developmental Studies Hybridoma Bank (DSHB); chicken anti-GFP (#ab13970, 1:1000) and rabbit anti-mCherry (#ab167453, 1:1000) from Abcam; mouse Anti-Î²-Galactosidase (#Z3781, 1:200) from Promega; rabbit anti-SWS (1:1000 from Doris Kretzschmar); mouse anti-CathepsinL (#1515-CY-010, 1:400) from R&amp;D Systems; rabbit anti-NrxIV (1:1000 from Christian KlÃ¤mbt); mouse anti-NimC1 (1:300 from IstvÃ¡n AndÃ³). The following secondary antibodies were used: goat anti-chicken Alexa 488 (1:500), goat anti-rat Alexa 488 (1:500), goat anti-rat Alexa 647 (1:500), goat anti-rabbit Alexa 488 (1:500), and goat anti-rabbit Alex 568 (1:500) from Thermo Fisher Scientific; goat anti-mouse IgG2a Cy3 (1:400), goat anti-mouse IgG1 647, and goat anti-mouse IgG1 Cy3 (1:500) from Jackson ImmunoResearch Laboratory. For visualization of cell nuclei, DAPI dye was used (1:1000, Sigma). Samples were analyzed using a confocal microscope (Zeiss LSM 700). For making figures, Adobe Photoshop software was used.</p></sec><sec id="s4-4"><title>RNA preparation and real-time qPCR</title><p>Total RNA was extracted from 15- and 30-day-old fly brains using Trizol reagent (Invitrogen) following the manufacturerâs protocol. To detect <italic>sws</italic> mRNA, the forward and reverse primers <named-content content-type="sequence">AGACATACGCCGTGAATACCG</named-content> and <named-content content-type="sequence">GCGACGACTGTGTGGACTTG</named-content>, respectively, were used. To detect expression of innate immunity factors, the following forward and reverse primers were used: <italic>Attacin A</italic> (forward and reverse primers <named-content content-type="sequence">CACAACTGGCGGAACTTTGG</named-content> and <named-content content-type="sequence">AAACATCCTTCACTCCGGGC</named-content>, respectively), <italic>Cecropin A</italic> (forward and reverse primers <named-content content-type="sequence">AAGCTGGGTGGCTGAAGAAA</named-content> and <named-content content-type="sequence">TGTTGAGCGATTCCCAGTCC</named-content>, respectively), and <italic>Diptericin</italic> (forward and reverse primers <named-content content-type="sequence">TACCCACTCAATCTTCAGGGAG</named-content> and <named-content content-type="sequence">TGGTCCACACCTTCTGGTGA</named-content>, respectively). As an endogenous control for qPCRs, Ribosomal Protein L32 (RpL32) with the following forward and reverse primers <named-content content-type="sequence">AAGATGACCATCCGCCCAGC</named-content> and <named-content content-type="sequence">GTCGATACCCTTGGGCTTGC</named-content>, respectively, was used. The threshold cycle (CT) was defined as the fractional cycle number at which the fluorescence passes a fixed threshold. The ÎCT value was determined by subtracting the average RpL32 mRNA CT value from the average tested CT value of target mRNA, correspondingly. The ÎÎCT value was calculated by subtracting the ÎCT of the control sample from the ÎCT of the experimental sample. The relative amounts of miRNAs or target mRNA is then determined using the expression 2<sup>âÎÎCT</sup>.</p></sec><sec id="s4-5"><title>Permeability assay</title><p>Flies were injected into the abdomen with a solution containing 10 kDa dextran dye labeled with Texas Red (#D1864) from Molecular Probes. Flies were then allowed to recover for more than 12 hr before the dissection, followed by the analysis for dextran dye presence in the brain. Fly heads of 15-day-old animals were dissected in 1Ã PBS and then ï¬xed in 4% formaldehyde diluted in 1Ã PBS for 1 hr at room temperature. Then fly brains were dissected in 1Ã PBS and ï¬xed in 4% formaldehyde diluted in 1Ã PBS for 20 min at room temperature. Next, brains were washed with PBT (0.2% Triton X-100 in 1Ã PBS) four times, followed by block with PBTB (2 g/L bovine serum albumin, 5% normal goat serum, 0.5 g/L sodium azide) for 1 hr at room temperature and then washed two times with PBT (one of the washes contained DAPI to mark nuclei). Lastly, medium (70% glycerol, 3% n-propyl gallate in 1Ã PBS) was added to samples for later mounting on the slides.</p></sec><sec id="s4-6"><title>In vivo <italic>Drosophila</italic> treatments</title><p>TUDCA (#580549), 4-PBA (#567616), valsartan (#PHR1315), fenofibrate (#F6020), sodium salicylate (#S3007), rapamycin (#R0395), deferoxamine mesylate salt (#D9533), liproxstatin-1 (#SML1414), and sphingosine (#860025P) from Sigma-Aldrich were added to 5% glucose solution at a final concentration shown by <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. Then, these glucose-dissolved components were fed by micropipettes to the flies that were kept for 14 days on a diet food without any sugar. To visualize the uptake of chemicals, solutions were also colored by 2.5% wt/vol of Brilliant Blue (#80717) from Sigma-Aldrich.</p></sec><sec id="s4-7"><title>Extraction and derivatization of FFAs from flies</title><p>Accurately weighed heads of 15-day-old flies were treated with 1000 ÂµL aliquots of acetonitrile in autosampler glass vials (1.8 mL), the samples were sealed and vortexed several times and then stored in a refrigerator overnight (4Â°C). Next day, the samples were warmed up to room temperature and centrifuged (10 min, 3345Ã<italic>g</italic>, 4Â°C). Aliquots (950 ÂµL) of the clear supernatants were decanted carefully transferred to autosampler glass vials (1.8 mL). The samples were spiked with 10 ÂµL aliquots of a 1000 ÂµM stock solution of sterculic acid (C19H34O2; 10 nmol; 8-cyclopropen-octadecenoic acid corresponds to C19:1) which served as the internal standard (IS) for all FFAs. The solvent was evaporated entirely under a stream of nitrogen gas. The solid residues were reconstituted in anhydrous acetonitrile (100 ÂµL). Then, 10 ÂµL HÃ¼nig base (<italic>N,N</italic>-diisopropylethylamine) and 10 ÂµL 33 vol% pentafluorobenzyl (PFB) bromide in anhydrous acetonitrile were added. Subsequently, the FFAs were derivatized by heating for 60 min at 30Â°C to generate the PFB esters of the FFAs. Solvents and reagents were evaporated to dryness under a stream of nitrogen gas. The residues were treated with 1000 ÂµL aliquots of toluene and the derivatives were extracted by vortex-mixing for 120 s. After centrifugation (10 min, 3345Ã<italic>g</italic>, 4Â°C), 300 ÂµL aliquots of the clear and colorless supernatants were transferred into microvials placed in autosampler glass vials (1.8 mL) for GC-MS analysis. A standard control sample containing 1 mL acetonitrile, 1 ÂµL 10 mM arachidonic acid (C20:4, 10 nmol), and 10 ÂµL 1 mM IS (10 nmol) was derivatized as described above for the fly samples after were evaporated to dryness under a stream of nitrogen gas. After centrifugation (10 min, 3345Ã<italic>g</italic>, 4Â°C), 100 ÂµL of the clear and colorless supernatant were transferred into an autosampler glass vial (1.8 mL), diluted with toluene (1:10, vol/vol), and subjected to GC-MS analysis as described below.</p></sec><sec id="s4-8"><title>GC-MS analysis of FFAs from flies</title><p>GC-MS analyses were performed on a GC-MS apparatus consisting of a single quadrupole mass spectrometer model ISQ, a Trace 1210 series gas chromatograph, and an AS1310 autosampler from Thermo Fisher (Dreieich, Germany). A fused-silica capillary column Optima 17 (15 m length, 0.25 mm ID, 0.25 Âµm film thickness) from Macherey-Nagel (DÃ¼ren, Germany) was used. Aliquots of 1 ÂµL were injected in the splitless mode. Injector temperature was kept at 280Â°C. Helium was used as the carrier gas at a constant flow rate of 1.0 mL/min. The oven temperature was held at 40Â°C for 0.5 min and ramped to 210Â°C at a rate of 15Â°C/min, and then to 320Â°C at a rate of 35Â°C/min. Interface and ion-source temperatures were set to 300Â°C and 250Â°C, respectively. Electron energy was 70 eV and electron current 50 ÂµA. Methane (constant flow rate of 2.4 mL/min) was used as the reactant gas for negative-ion chemical ionization. The electron multiplier voltage was set to 1300 V. Authentic commercially available reference compounds were used to determine the retention times of the derivatives and to generate their mass spectra. The selected ions [MâPFB] â with mass-to-charge (<italic>m</italic>/<italic>z</italic>) ratios and retention times of the derivatives are summarized in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6b</xref>. Quantitative measurements were performed by selected-ion monitoring (SIM) of the ions listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6bwith a</xref> dwell time of 50 ms and SIM width of 0.5 amu for each ion in three window ranges. The results of the GC-MS analyses of the control standard sample that contained 10 nmol arachidonic acid and 10 nmol IS are summarized in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6c</xref>. The highest peak area ratio of FFA to the internal standard (FFA/IS) was obtained for arachidonic acid (0.098). This in accordance with the ratio observed in the standard curve (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3A</xref>). A lower FFA/IS was obtained for palmitic acid (0.026). As palmitic acid was not externally added to the control standard sample, it is assumed that palmitic fatty acid is ubiquitously present as a contamination in the laboratory materials. An FFA/IS value of 0.027 was obtained for a fatty acid, which co-elutes with nonadecanoic acid (C19:0). As this fatty acid was not externally added to the control standard sample nor it is expected to be a laboratory contamination, it can be hypothesized that it is a contamination in the commercially available preparation of the IS which is a quasi C19:0 fatty acid. The FFA/IS values of the other FFAs are remarkably lower (&lt;0.0065), which suggest that they cannot be considered as appreciable contaminations (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3B</xref>).</p></sec><sec id="s4-9"><title>Transmission electron microscopy</title><p>After dissection, brains of 15-day-old flies were fixed overnight immediately by immersion in 150 mM HEPES containing 1.5% glutaraldehyde and 1.5% formaldehyde at pH 7.35. Preparation for transmission electron microscopy was done as described (<xref ref-type="bibr" rid="bib74">Mariani et al., 2022</xref>). Imaging was done in a Zeiss EM 900 at 80 kV, equipped with a side-mount CCD camera (TRS).</p></sec><sec id="s4-10"><title>Quantification and statistical analysis</title><p>To analyze the activation of the inflammatory response, real-time qPCR analysis of AMPs mRNA levels from heads of each genotype was performed. AVE Â± SEM was calculated. The experiments were performed in at least two biological replicates for each genotype. Two-tailed Studentâs tests were used to test for statistical significance (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To analyze the frequency of brain hemispheres with defective brain surfaces, Z-stack confocal images of the entire adult brain were captured. The brain surface was identified by CoraC expression. The numbers of brain hemispheres exhibiting a normal brain surface, those containing lesions, or those with both lesions and membrane clusters on the brain surface were quantified. For the comparison of observed phenotypes, two-way tables and chi-squared tests were used (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p><p>To assess the frequency of brain hemispheres with the accumulation of Rab7-positive or CathepsinL-positive structures in surface glia, Z-stack confocal images of the entire adult brain were captured. The surface glia were identified by <italic>moody-Gal4, UAS-CD8::GFP</italic> expression. The numbers of brain hemispheres with Rab7 or CathepsinL accumulation in the surface glia were quantified. For the comparison of observed phenotypes, two-way tables and chi-squared tests were used (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><p>To analyze the frequency of brain hemispheres with a permeable BBB, Z-stack confocal images of the entire adult brain were captured. The permeable BBB was identified by 10 kDa dextran dye labeled with Texas Red localization inside the fly brain. The numbers of brain hemispheres with a permeable BBB were quantified. All experiments were performed in at least three biological replicates for each genotype. For the comparison of observed phenotypes, two-way tables and chi-squared tests were used (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>To analyze the frequency of brain hemispheres with defective brain surfaces in in vivo <italic>Drosophila</italic> treatment assays, the brain surface was identified by CoraC expression. The numbers of brain hemispheres with formed lesions and membrane clusters on the brain surface were quantified. The reduction in the percentage of the glial phenotype, assayed by CoraC expression pattern in <italic>sws</italic> and <italic>moody</italic> mutants treated with different chemicals compared to untreated mutants, was quantified. All experiments were performed in at least three biological replicates for each genotype. For the comparison of observed phenotypes, two-way tables and chi-squared tests were used (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>).</p><p>To analyze the changes in FFA levels in fly mutant heads, GS-MS measurements of FFAs were performed. One-way ANOVA tests were used for statistical analysis (*p&lt;0.05, **p&lt;0.005, ***p&lt;0.001, see <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Supervision, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Relative mRNA levels.</title><p><sup>a</sup> â the ÎCT value is determined by subtracting the average CT value of endogenous control gene(Rpl32) from the average mRNA CT value. <sup>b</sup> âthe calculation of ÎÎCT involves subtraction by the ÎCT calibrator value (ÎCT value in control). <sup>c</sup> â the range is given for relative levels determined by evaluating the expression: 2<sup>âÎÎCT</sup>. AVE Â± SEM values are reported from experiments done in at least duplicates. Two-tailed Studentâs test was used to test for statistical significance. p<sup>a</sup> â compared to the relevant control. p<sup>b</sup> â compared to 15-day-old animals of the same genotype. p<sup>c</sup> â compared to <italic>sws<sup>1</sup></italic> mutant of the same age.</p></caption><media xlink:href="elife-98020-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>NTE/SWS expression in the surface glia is important for the integrity of <italic>Drosophila</italic> blood-brain barrier (BBB).</title><p><sup>a</sup> â compared to control (<italic>OR x w<sup>1118</sup></italic>). <sup>b</sup> â compared to <italic>Gal4-driver x OR.</italic> <sup>c</sup> â compared to <italic>Gal4-driver x UAS-sws<sup>RNAi</sup>.</italic> The values are reported from experiments done in triplicates. For statistical analyses of the observed phenotypes, two-way tables and chi-squared test were used.</p></caption><media xlink:href="elife-98020-supp2-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>NTE/SWS deficit in the surface glia results in the accumulation of Rab7- and CathepsinL-positive structures.</title><p><sup>a</sup> â compared to <italic>Gal4-driver x OR</italic> animals of the same age. <sup>b</sup> â compared to 1-day-old animals of the same genotype. The values are reported from experiments done in triplicates. For statistical analyses of the observed phenotypes, two-way tables and chi-squared test were used.</p></caption><media xlink:href="elife-98020-supp3-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>NTE/SWS deficit in the surface glia results in permeable blood-brain barrier (BBB).</title><p><sup>a</sup> â compared to control (<italic>OR x w<sup>1118</sup></italic>). <sup>b</sup> â compared to <italic>Gal4-driver x OR.</italic> <sup>c</sup> âcompared to <italic>Gal4-driver x UAS-sws<sup>RNAi</sup>.</italic> The values are reported from experiments done in triplicates. For statistical analyses of the observed phenotypes, two-way tables and chi-squared test were used.</p></caption><media xlink:href="elife-98020-supp4-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>The effect of treatment with different anti-inflammatory substances and stress suppressors on the frequency of the surface glia phenotype in <italic>sws</italic> and <italic>moody</italic> mutants.</title><p><sup>a</sup> â compared to <italic>sws<sup>1</sup></italic> (no drug treatment)<sup>b</sup> â compared to <italic>moody <sup>ÎC17</sup></italic> (no drug treatment). The values are reported from experiments done in triplicates. For statistical analyses of the observed phenotypes, two-way tables and chi-squared test were used.</p></caption><media xlink:href="elife-98020-supp5-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Mutants with defective BBB show upregulated levels of free fatty acids (FFA).</title><p>(a) <italic>sws</italic> and <italic>moody</italic> mutants show upregulated levels of free fatty acids (FFAs). For statistical analyses one-way ANOVA test was used. C14:1â9-cis-Tetradecenoic acid. C16:0 â Palmitic acid. C16:1 â Palmitoleic acid. C18:0 â Stearic acid. C18:1 â Oleic acid. C18:2 â Linoleic acid. C18:3 â Î±- and Î³-Linolenic acid. C20:0 â Eicosanoic acid. C20:4 â Arachidonic acid. C20:5 â Eicosapentaenoic acid. (b) <italic>sws</italic> and <italic>moody</italic> mutants show upregulated levels of free fatty acids (FFAs). Summary of the ions monitored in the selected-ion monitoring (SIM) modeSIM#1 (12.00â14.50 min): <italic>m/z</italic> 197.4, 199.4, 225.4, 227.4, 253.4, 255.4, 267.4, 269.4. SIM#2 (14.50â15.00 min): <italic>m/z</italic> 281.4, 283.4, 279.4, 295.4, 297.4. SIM#3 (15.00â17.00 min): <italic>m/z</italic> 301.4, 303.4, 309.4, 311.4, 325.4, 337.4, 339.4, 365.4, 367.4.</p></caption><media xlink:href="elife-98020-supp6-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98020-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Doris Kretzschmar, Mikael Simons, Christian KlÃ¤mbt, Hugo Bellen, Angela Giangrande, IstvÃ¡n AndÃ³, and Stanislava Chtarbanova-Rudloff for sharing flies and reagents with us. Marko Shcherbatyy for drawing a scheme. Christian KlÃ¤mbt and Volkan Seyrantepe for contributions to phenotype description. All Shcherbata lab members for critical reading of the manuscript and helpful suggestions. This research was supported by the VolkswagenStiftung (grants 90218 and 97750), the German Research Foundation (DFG) grant numbers 521749003 and INST 192/574-1 FUGG, the Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under grant numbers P20GM103423 and P20GM104318 (to the Mount Desert Island Biological Laboratory), and EMBO YIP.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akassoglou</surname><given-names>K</given-names></name><name><surname>Malester</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Tessarollo</surname><given-names>L</given-names></name><name><surname>Rosenbluth</surname><given-names>J</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration</article-title><source>PNAS</source><volume>101</volume><fpage>5075</fpage><lpage>5080</lpage><pub-id pub-id-type="doi">10.1073/pnas.0401030101</pub-id><pub-id pub-id-type="pmid">15051870</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>R</given-names></name><name><surname>Edgar</surname><given-names>JR</given-names></name><name><surname>Pearson</surname><given-names>G</given-names></name><name><surname>Rizo</surname><given-names>T</given-names></name><name><surname>Newton</surname><given-names>T</given-names></name><name><surname>GÃ¼nther</surname><given-names>S</given-names></name><name><surname>Berner</surname><given-names>F</given-names></name><name><surname>Hague</surname><given-names>J</given-names></name><name><surname>Connell</surname><given-names>JW</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name><name><surname>Beetz</surname><given-names>C</given-names></name><name><surname>Winner</surname><given-names>B</given-names></name><name><surname>Reid</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Defects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegia</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>1337</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1083/jcb.201609033</pub-id><pub-id pub-id-type="pmid">28389476</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aman</surname><given-names>Y</given-names></name><name><surname>Schmauck-Medina</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>M</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Simon</surname><given-names>AK</given-names></name><name><surname>Bjedov</surname><given-names>I</given-names></name><name><surname>Palikaras</surname><given-names>K</given-names></name><name><surname>Simonsen</surname><given-names>A</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name><name><surname>Tavernarakis</surname><given-names>N</given-names></name><name><surname>Rubinsztein</surname><given-names>DC</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Labbadia</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>EF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Autophagy in healthy aging and disease</article-title><source>Nature Aging</source><volume>1</volume><fpage>634</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1038/s43587-021-00098-4</pub-id><pub-id pub-id-type="pmid">34901876</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostou</surname><given-names>G</given-names></name><name><surname>Akbar</surname><given-names>MT</given-names></name><name><surname>Paul</surname><given-names>P</given-names></name><name><surname>Angelinetta</surname><given-names>C</given-names></name><name><surname>Steiner</surname><given-names>TJ</given-names></name><name><surname>de Belleroche</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord</article-title><source>Neurobiology of Aging</source><volume>31</volume><fpage>969</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.07.005</pub-id><pub-id pub-id-type="pmid">18701194</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armulik</surname><given-names>A</given-names></name><name><surname>GenovÃ©</surname><given-names>G</given-names></name><name><surname>MÃ¤e</surname><given-names>M</given-names></name><name><surname>Nisancioglu</surname><given-names>MH</given-names></name><name><surname>Wallgard</surname><given-names>E</given-names></name><name><surname>Niaudet</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Norlin</surname><given-names>J</given-names></name><name><surname>Lindblom</surname><given-names>P</given-names></name><name><surname>Strittmatter</surname><given-names>K</given-names></name><name><surname>Johansson</surname><given-names>BR</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Pericytes regulate the blood-brain barrier</article-title><source>Nature</source><volume>468</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/nature09522</pub-id><pub-id pub-id-type="pmid">20944627</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babatz</surname><given-names>F</given-names></name><name><surname>Naffin</surname><given-names>E</given-names></name><name><surname>KlÃ¤mbt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The <italic>Drosophila</italic> blood-brain barrier adapts to cell growth by unfolding of pre-existing septate junctions</article-title><source>Developmental Cell</source><volume>47</volume><fpage>697</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.10.002</pub-id><pub-id pub-id-type="pmid">30482667</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bainton</surname><given-names>RJ</given-names></name><name><surname>Tsai</surname><given-names>LTY</given-names></name><name><surname>Schwabe</surname><given-names>T</given-names></name><name><surname>DeSalvo</surname><given-names>M</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name><name><surname>Heberlein</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>moody encodes two GPCRs that regulate cocaine behaviors and blood-brain barrier permeability in <italic>Drosophila</italic></article-title><source>Cell</source><volume>123</volume><fpage>145</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.07.029</pub-id><pub-id pub-id-type="pmid">16213219</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettencourt da Cruz</surname><given-names>A</given-names></name><name><surname>Wentzell</surname><given-names>J</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Swiss Cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>10885</fpage><lpage>10892</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3015-08.2008</pub-id><pub-id pub-id-type="pmid">18945896</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blyth</surname><given-names>BJ</given-names></name><name><surname>Farhavar</surname><given-names>A</given-names></name><name><surname>Gee</surname><given-names>C</given-names></name><name><surname>Hawthorn</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Nayak</surname><given-names>A</given-names></name><name><surname>StÃ¶cklein</surname><given-names>V</given-names></name><name><surname>Bazarian</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Validation of serum markers for blood-brain barrier disruption in traumatic brain injury</article-title><source>Journal of Neurotrauma</source><volume>26</volume><fpage>1497</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1089/neu.2008.0738</pub-id><pub-id pub-id-type="pmid">19257803</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development</source><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1242/dev.118.2.401</pub-id><pub-id pub-id-type="pmid">8223268</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bundgaard</surname><given-names>M</given-names></name><name><surname>Abbott</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>All vertebrates started out with a glial blood-brain barrier 4-500 million years ago</article-title><source>Glia</source><volume>56</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1002/glia.20642</pub-id><pub-id pub-id-type="pmid">18338790</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>n-3 PUFA and inflammation: from membrane to nucleus and from bench to bedside</article-title><source>The Proceedings of the Nutrition Society</source><volume>01</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1017/S0029665120007077</pub-id><pub-id pub-id-type="pmid">32624016</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Chtarbanova</surname><given-names>S</given-names></name><name><surname>Petersen</surname><given-names>AJ</given-names></name><name><surname>Ganetzky</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dnr1 mutations cause neurodegeneration in <italic>Drosophila</italic> by activating the innate immune response in the brain</article-title><source>PNAS</source><volume>110</volume><fpage>E1752</fpage><lpage>E1760</lpage><pub-id pub-id-type="doi">10.1073/pnas.1306220110</pub-id><pub-id pub-id-type="pmid">23613578</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>He</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Targeting lysosomes in human disease: from basic research to clinical applications</article-title><source>Signal Transduction and Targeted Therapy</source><volume>6</volume><elocation-id>379</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-021-00778-y</pub-id><pub-id pub-id-type="pmid">34744168</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carney</surname><given-names>TD</given-names></name><name><surname>Hebalkar</surname><given-names>RY</given-names></name><name><surname>Edeleva</surname><given-names>E</given-names></name><name><surname>ÃiÃ§ek</surname><given-names>IÃ</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Signaling through the dystrophin glycoprotein complex affects the stress-dependent transcriptome in <italic>Drosophila</italic></article-title><source>Disease Models &amp; Mechanisms</source><volume>16</volume><elocation-id>dmm049862</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.049862</pub-id><pub-id pub-id-type="pmid">36594281</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattenoz</surname><given-names>PB</given-names></name><name><surname>Monticelli</surname><given-names>S</given-names></name><name><surname>Pavlidaki</surname><given-names>A</given-names></name><name><surname>Giangrande</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Toward a consensus in the repertoire of hemocytes identified in <italic>Drosophila</italic></article-title><source>Front Cell Dev Biol</source><volume>01</volume><elocation-id>3712</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.643712</pub-id><pub-id pub-id-type="pmid">33748138</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Blackstone</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation</article-title><source>The Journal of Clinical Investigation</source><volume>124</volume><fpage>5249</fpage><lpage>5262</lpage><pub-id pub-id-type="doi">10.1172/JCI77598</pub-id><pub-id pub-id-type="pmid">25365221</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Heier</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterization of the interaction of neuropathy target esterase with the endoplasmic reticulum and lipid droplets</article-title><source>Biomolecules</source><volume>9</volume><elocation-id>848</elocation-id><pub-id pub-id-type="doi">10.3390/biom9120848</pub-id><pub-id pub-id-type="pmid">31835418</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>H</given-names></name><name><surname>Solomon</surname><given-names>VA</given-names></name><name><surname>Fonteh</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Involvement of lipids in alzheimerâs disease pathology and potential therapies</article-title><source>Frontiers in Physiology</source><volume>11</volume><elocation-id>598</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.00598</pub-id><pub-id pub-id-type="pmid">32581851</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitnis</surname><given-names>T</given-names></name><name><surname>Weiner</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CNS inflammation and neurodegeneration</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>3577</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1172/JCI90609</pub-id><pub-id pub-id-type="pmid">28872464</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crimmins</surname><given-names>E</given-names></name><name><surname>Vasunilashorn</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Alley</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Biomarkers related to aging in human populations</article-title><source>Advances in Clinical Chemistry</source><volume>46</volume><fpage>161</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/s0065-2423(08)00405-8</pub-id><pub-id pub-id-type="pmid">19004190</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gregorio</surname><given-names>E</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Tzou</surname><given-names>P</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Lemaitre</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The toll and imd pathways are the major regulators of the immune response in <italic>Drosophila</italic></article-title><source>The EMBO Journal</source><volume>21</volume><fpage>2568</fpage><lpage>2579</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.11.2568</pub-id><pub-id pub-id-type="pmid">12032070</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deik</surname><given-names>A</given-names></name><name><surname>Johannes</surname><given-names>B</given-names></name><name><surname>Rucker</surname><given-names>JC</given-names></name><name><surname>SÃ¡nchez</surname><given-names>E</given-names></name><name><surname>Brodie</surname><given-names>SE</given-names></name><name><surname>Deegan</surname><given-names>E</given-names></name><name><surname>Landy</surname><given-names>K</given-names></name><name><surname>Kajiwara</surname><given-names>Y</given-names></name><name><surname>Scelsa</surname><given-names>S</given-names></name><name><surname>Saunders-Pullman</surname><given-names>R</given-names></name><name><surname>PaisÃ¡n-Ruiz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Compound heterozygous pnpla6 mutations cause boucher-neuhÃ¤user syndrome with late-onset ataxia</article-title><source>Journal of Neurology</source><volume>261</volume><fpage>2411</fpage><lpage>2423</lpage><pub-id pub-id-type="doi">10.1007/s00415-014-7516-3</pub-id><pub-id pub-id-type="pmid">25267340</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiRosario</surname><given-names>J</given-names></name><name><surname>Divers</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Etter</surname><given-names>J</given-names></name><name><surname>Charrier</surname><given-names>A</given-names></name><name><surname>Jukkola</surname><given-names>P</given-names></name><name><surname>Auer</surname><given-names>H</given-names></name><name><surname>Best</surname><given-names>V</given-names></name><name><surname>Newsom</surname><given-names>DL</given-names></name><name><surname>McCarty</surname><given-names>DM</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Innate and adaptive immune activation in the brain of MPS IIIB mouse model</article-title><source>Journal of Neuroscience Research</source><volume>87</volume><fpage>978</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1002/jnr.21912</pub-id><pub-id pub-id-type="pmid">18951493</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domon</surname><given-names>MM</given-names></name><name><surname>Besson</surname><given-names>F</given-names></name><name><surname>Bandorowicz-Pikula</surname><given-names>J</given-names></name><name><surname>Pikula</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Annexin A6 is recruited into lipid rafts of Niemann-Pick type C disease fibroblasts in a Ca2+-dependent manner</article-title><source>Biochemical and Biophysical Research Communications</source><volume>405</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.12.138</pub-id><pub-id pub-id-type="pmid">21216236</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>JA</given-names></name><name><surname>Bunn</surname><given-names>JY</given-names></name><name><surname>LaMantia</surname><given-names>MA</given-names></name><name><surname>McIsaac</surname><given-names>C</given-names></name><name><surname>Senft Miller</surname><given-names>A</given-names></name><name><surname>Nop</surname><given-names>O</given-names></name><name><surname>Testo</surname><given-names>A</given-names></name><name><surname>Soares</surname><given-names>BP</given-names></name><name><surname>Mank</surname><given-names>MM</given-names></name><name><surname>Poynter</surname><given-names>ME</given-names></name><name><surname>Lawrence Kien</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Alteration of brain function and systemic inflammatory tone in older adults by decreasing the dietary palmitic acid intake</article-title><source>Aging Brain</source><volume>3</volume><elocation-id>100072</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbas.2023.100072</pub-id><pub-id pub-id-type="pmid">37408793</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Rieche</surname><given-names>F</given-names></name><name><surname>Eckl</surname><given-names>N</given-names></name><name><surname>Duch</surname><given-names>C</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Glial expression of Swiss cheese (SWS), the <italic>Drosophila</italic> orthologue of neuropathy target esterase (NTE), is required for neuronal ensheathment and function</article-title><source>Disease Models &amp; Mechanisms</source><volume>9</volume><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1242/dmm.022236</pub-id><pub-id pub-id-type="pmid">26634819</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmenlauer</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Ponti</surname><given-names>A</given-names></name><name><surname>Schwarb</surname><given-names>P</given-names></name><name><surname>Griffa</surname><given-names>A</given-names></name><name><surname>Filippi</surname><given-names>A</given-names></name><name><surname>Nitschke</surname><given-names>R</given-names></name><name><surname>Driever</surname><given-names>W</given-names></name><name><surname>Burkhardt</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>XuvTools: free, fast and reliable stitching of large 3D datasets</article-title><source>Journal of Microscopy</source><volume>233</volume><fpage>42</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2818.2008.03094.x</pub-id><pub-id pub-id-type="pmid">19196411</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emre</surname><given-names>C</given-names></name><name><surname>Do</surname><given-names>KV</given-names></name><name><surname>Jun</surname><given-names>B</given-names></name><name><surname>Hjorth</surname><given-names>E</given-names></name><name><surname>Alcalde</surname><given-names>SG</given-names></name><name><surname>Kautzmann</surname><given-names>MAI</given-names></name><name><surname>Gordon</surname><given-names>WC</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Bazan</surname><given-names>NG</given-names></name><name><surname>Schultzberg</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimerâs disease</article-title><source>Acta Neuropathologica Communications</source><volume>9</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-021-01216-4</pub-id><pub-id pub-id-type="pmid">34187579</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epand</surname><given-names>RM</given-names></name><name><surname>Epand</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Calorimetric detection of curvature strain in phospholipid bilayers</article-title><source>Biophysical Journal</source><volume>66</volume><fpage>1450</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(94)80935-X</pub-id><pub-id pub-id-type="pmid">8061194</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farmer</surname><given-names>BC</given-names></name><name><surname>Walsh</surname><given-names>AE</given-names></name><name><surname>Kluemper</surname><given-names>JC</given-names></name><name><surname>Johnson</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lipid droplets in neurodegenerative disordersipid droplets</article-title><source>Frontiers in Neuroscience</source><volume>14</volume><elocation-id>742</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2020.00742</pub-id><pub-id pub-id-type="pmid">32848541</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The machinery of macroautophagy</article-title><source>Cell Research</source><volume>24</volume><fpage>24</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/cr.2013.168</pub-id><pub-id pub-id-type="pmid">24366339</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fereshtehnejad</surname><given-names>SM</given-names></name><name><surname>Saleh</surname><given-names>PA</given-names></name><name><surname>Oliveira</surname><given-names>LM</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Bhowmick</surname><given-names>S</given-names></name><name><surname>Saranza</surname><given-names>G</given-names></name><name><surname>Kalia</surname><given-names>LV</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis</article-title><source>Neurological Sciences</source><volume>44</volume><fpage>947</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1007/s10072-022-06516-8</pub-id><pub-id pub-id-type="pmid">36441344</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Garagnani</surname><given-names>P</given-names></name><name><surname>Parini</surname><given-names>P</given-names></name><name><surname>Giuliani</surname><given-names>C</given-names></name><name><surname>Santoro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammaging: a new immune-metabolic viewpoint for age-related diseases</article-title><source>Nature Reviews. Endocrinology</source><volume>14</volume><fpage>576</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/s41574-018-0059-4</pub-id><pub-id pub-id-type="pmid">30046148</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname><given-names>HR</given-names></name><name><surname>da Ferreira</surname><given-names>GC</given-names></name><name><surname>Trevenzoli</surname><given-names>IH</given-names></name><name><surname>de Oliveira</surname><given-names>KJ</given-names></name><name><surname>de Melo Reis</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fatty acids, antioxidants and physical activity in brain aging</article-title><source>Nutrients</source><volume>9</volume><elocation-id>1263</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111263</pub-id><pub-id pub-id-type="pmid">29156608</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funk</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Prostaglandins and leukotrienes: advances in eicosanoid biology</article-title><source>Science</source><volume>294</volume><fpage>1871</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1126/science.294.5548.1871</pub-id><pub-id pub-id-type="pmid">11729303</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giepmans</surname><given-names>BNG</given-names></name><name><surname>van Ijzendoorn</surname><given-names>SCD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Epithelial cell-cell junctions and plasma membrane domains</article-title><source>Biochimica et Biophysica Acta</source><volume>1788</volume><fpage>820</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2008.07.015</pub-id><pub-id pub-id-type="pmid">18706883</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glynn</surname><given-names>P</given-names></name><name><surname>Holton</surname><given-names>JL</given-names></name><name><surname>Nolan</surname><given-names>CC</given-names></name><name><surname>Read</surname><given-names>DJ</given-names></name><name><surname>Brown</surname><given-names>L</given-names></name><name><surname>Hubbard</surname><given-names>A</given-names></name><name><surname>Cavanagh</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neuropathy target esterase: immunolocalization to neuronal cell bodies and axons</article-title><source>Neuroscience</source><volume>83</volume><fpage>295</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/s0306-4522(97)00388-6</pub-id><pub-id pub-id-type="pmid">9466418</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glynn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuropathy target esterase and phospholipid deacylation</article-title><source>Biochimica et Biophysica Acta</source><volume>1736</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2005.08.002</pub-id><pub-id pub-id-type="pmid">16137924</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grassi</surname><given-names>S</given-names></name><name><surname>Giussani</surname><given-names>P</given-names></name><name><surname>Mauri</surname><given-names>L</given-names></name><name><surname>Prioni</surname><given-names>S</given-names></name><name><surname>Sonnino</surname><given-names>S</given-names></name><name><surname>Prinetti</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases</article-title><source>Journal of Lipid Research</source><volume>61</volume><fpage>636</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1194/jlr.TR119000427</pub-id><pub-id pub-id-type="pmid">31871065</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>MT</given-names></name><name><surname>Woulfe</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Striatal blood-brain barrier permeability in Parkinsonâs disease</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>35</volume><fpage>747</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2015.32</pub-id><pub-id pub-id-type="pmid">25757748</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname><given-names>F</given-names></name><name><surname>Bucci</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiple roles of the small gtpase rab7</article-title><source>Cells</source><volume>5</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.3390/cells5030034</pub-id><pub-id pub-id-type="pmid">27548222</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartenstein</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Morphological diversity and development of glia in <italic>Drosophila</italic></article-title><source>Glia</source><volume>59</volume><fpage>1237</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1002/glia.21162</pub-id><pub-id pub-id-type="pmid">21438012</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Sado</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Akimoto</surname><given-names>A</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Aigaki</surname><given-names>T</given-names></name><name><surname>Matsuzaki</surname><given-names>F</given-names></name><name><surname>Nakagoshi</surname><given-names>H</given-names></name><name><surname>Tanimura</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Uemura</surname><given-names>T</given-names></name><name><surname>Yoshihara</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>GETDB, a database compiling expression patterns and molecular locations of a collection of Gal4 enhancer traps</article-title><source>Genesis</source><volume>34</volume><fpage>58</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1002/gene.10137</pub-id><pub-id pub-id-type="pmid">12324948</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebbar</surname><given-names>S</given-names></name><name><surname>Khandelwal</surname><given-names>A</given-names></name><name><surname>Jayashree</surname><given-names>R</given-names></name><name><surname>Hindle</surname><given-names>SJ</given-names></name><name><surname>Chiang</surname><given-names>YN</given-names></name><name><surname>Yew</surname><given-names>JY</given-names></name><name><surname>Sweeney</surname><given-names>ST</given-names></name><name><surname>Schwudke</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lipid metabolic perturbation is an early-onset phenotype in adult <italic>spinster</italic> mutants: a <italic>Drosophila</italic> model for lysosomal storage disorders</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>3728</fpage><lpage>3740</lpage><pub-id pub-id-type="doi">10.1091/mbc.E16-09-0674</pub-id><pub-id pub-id-type="pmid">29046397</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issa</surname><given-names>AR</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Petitgas</surname><given-names>C</given-names></name><name><surname>Mesquita</surname><given-names>A</given-names></name><name><surname>Dulac</surname><given-names>A</given-names></name><name><surname>Robin</surname><given-names>M</given-names></name><name><surname>Mollereau</surname><given-names>B</given-names></name><name><surname>Jenny</surname><given-names>A</given-names></name><name><surname>ChÃ©rif-Zahar</surname><given-names>B</given-names></name><name><surname>Birman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced parkinson disease-like symptoms in the <italic>Drosophila</italic> brain</article-title><source>Autophagy</source><volume>14</volume><fpage>1898</fpage><lpage>1910</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1491489</pub-id><pub-id pub-id-type="pmid">29989488</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Å½Ã­dek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with alphafold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadry</surname><given-names>H</given-names></name><name><surname>Noorani</surname><given-names>B</given-names></name><name><surname>Cucullo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity</article-title><source>Fluids and Barriers of the CNS</source><volume>17</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.1186/s12987-020-00230-3</pub-id><pub-id pub-id-type="pmid">33208141</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keating</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A research framework for the united nations decade of healthy ageing (2021-2030)</article-title><source>European Journal of Ageing</source><volume>19</volume><fpage>775</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1007/s10433-021-00679-7</pub-id><pub-id pub-id-type="pmid">35035341</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hitomi</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Mukherjee</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>1826</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl105</pub-id><pub-id pub-id-type="pmid">16644870</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Buckwalter</surname><given-names>M</given-names></name><name><surname>Soreq</surname><given-names>H</given-names></name><name><surname>Vezzani</surname><given-names>A</given-names></name><name><surname>Kaufer</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis</article-title><source>Epilepsia</source><volume>53 Suppl 6</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03701.x</pub-id><pub-id pub-id-type="pmid">23134494</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Wenger</surname><given-names>DA</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name><name><surname>Duncan</surname><given-names>ID</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice</article-title><source>PNAS</source><volume>102</volume><fpage>18670</fpage><lpage>18675</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506473102</pub-id><pub-id pub-id-type="pmid">16352725</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korbecki</surname><given-names>J</given-names></name><name><surname>Bajdak-Rusinek</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms</article-title><source>Inflammation Research</source><volume>68</volume><fpage>915</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1007/s00011-019-01273-5</pub-id><pub-id pub-id-type="pmid">31363792</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kounatidis</surname><given-names>I</given-names></name><name><surname>Chtarbanova</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Hayne</surname><given-names>M</given-names></name><name><surname>Jayanth</surname><given-names>D</given-names></name><name><surname>Ganetzky</surname><given-names>B</given-names></name><name><surname>Ligoxygakis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NF-ÎºB immunity in the brain determines fly lifespan in healthy aging and age-related neurodegeneration</article-title><source>Cell Reports</source><volume>19</volume><fpage>836</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.007</pub-id><pub-id pub-id-type="pmid">28445733</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kounatidis</surname><given-names>I</given-names></name><name><surname>Chtarbanova</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of glial immunity in lifespan determination: a <italic>Drosophila</italic> perspective</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>1362</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01362</pub-id><pub-id pub-id-type="pmid">29942319</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>MC</given-names></name><name><surname>Jung</surname><given-names>C</given-names></name><name><surname>Batelli</surname><given-names>S</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The glia of the adult <italic>Drosophila</italic> nervous system</article-title><source>Glia</source><volume>65</volume><fpage>606</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1002/glia.23115</pub-id><pub-id pub-id-type="pmid">28133822</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretzschmar</surname><given-names>D</given-names></name><name><surname>Hasan</surname><given-names>G</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Heisenberg</surname><given-names>M</given-names></name><name><surname>Benzer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The swiss cheese mutant causes glial hyperwrapping and brain degeneration in <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>7425</fpage><lpage>7432</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-19-07425.1997</pub-id><pub-id pub-id-type="pmid">9295388</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>PNPLA6/NTE, an evolutionary conserved phospholipase linked to a group of complex human diseases</article-title><source>Metabolites</source><volume>12</volume><elocation-id>284</elocation-id><pub-id pub-id-type="doi">10.3390/metabo12040284</pub-id><pub-id pub-id-type="pmid">35448471</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucherenko</surname><given-names>MM</given-names></name><name><surname>Marrone</surname><given-names>AK</given-names></name><name><surname>Rishko</surname><given-names>VM</given-names></name><name><surname>Yatsenko</surname><given-names>AS</given-names></name><name><surname>Klepzig</surname><given-names>A</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Paraffin-embedded and frozen sections of <italic>Drosophila</italic> adult muscles</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>2438</elocation-id><pub-id pub-id-type="doi">10.3791/2438</pub-id><pub-id pub-id-type="pmid">21206479</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kun-Rodrigues</surname><given-names>C</given-names></name><name><surname>Ganos</surname><given-names>C</given-names></name><name><surname>Guerreiro</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>SA</given-names></name><name><surname>Schulte</surname><given-names>C</given-names></name><name><surname>Lesage</surname><given-names>S</given-names></name><name><surname>Darwent</surname><given-names>L</given-names></name><name><surname>Holmans</surname><given-names>P</given-names></name><name><surname>Singleton</surname><given-names>A</given-names></name><name><surname>Bhatia</surname><given-names>K</given-names></name><name><surname>Bras</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A systematic screening to identify de novo mutations causing sporadic early-onset parkinsonâs disease</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>6711</fpage><lpage>6720</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv376</pub-id><pub-id pub-id-type="pmid">26362251</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurucz</surname><given-names>E</given-names></name><name><surname>MÃ¡rkus</surname><given-names>R</given-names></name><name><surname>ZsÃ¡mboki</surname><given-names>J</given-names></name><name><surname>Folkl-Medzihradszky</surname><given-names>K</given-names></name><name><surname>Darula</surname><given-names>Z</given-names></name><name><surname>Vilmos</surname><given-names>P</given-names></name><name><surname>Udvardy</surname><given-names>A</given-names></name><name><surname>Krausz</surname><given-names>I</given-names></name><name><surname>Lukacsovich</surname><given-names>T</given-names></name><name><surname>Gateff</surname><given-names>E</given-names></name><name><surname>Zettervall</surname><given-names>CJ</given-names></name><name><surname>Hultmark</surname><given-names>D</given-names></name><name><surname>AndÃ³</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nimrod, a putative phagocytosis receptor with EGF repeats in <italic>Drosophila</italic> plasmatocytes</article-title><source>Current Biology</source><volume>17</volume><fpage>649</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2007.02.041</pub-id><pub-id pub-id-type="pmid">17363253</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>SY</given-names></name><name><surname>Massey</surname><given-names>K</given-names></name><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Hussain</surname><given-names>T</given-names></name><name><surname>Volpe</surname><given-names>G</given-names></name><name><surname>Buckley</surname><given-names>CD</given-names></name><name><surname>Nicolaou</surname><given-names>A</given-names></name><name><surname>Badenhorst</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Oxidised metabolites of the omega-6 fatty acid linoleic acid activate dFOXO</article-title><source>Life Science Alliance</source><volume>3</volume><elocation-id>e201900356</elocation-id><pub-id pub-id-type="doi">10.26508/lsa.201900356</pub-id><pub-id pub-id-type="pmid">31992650</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DBN</given-names></name><name><surname>Jamgotchian</surname><given-names>N</given-names></name><name><surname>Allen</surname><given-names>SG</given-names></name><name><surname>Abeles</surname><given-names>MB</given-names></name><name><surname>Ward</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A lipid-protein hybrid model for tight junction</article-title><source>American Journal of Physiology. Renal Physiology</source><volume>295</volume><fpage>F1601</fpage><lpage>F1612</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00097.2008</pub-id><pub-id pub-id-type="pmid">18701633</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Fetter</surname><given-names>R</given-names></name><name><surname>Schwabe</surname><given-names>T</given-names></name><name><surname>Jung</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Steller</surname><given-names>H</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>The cAMP effector PKA mediates Moody GPCR signaling in <italic>Drosophila</italic> blood-brain barrier formation and maturation</article-title><source>eLife</source><volume>10</volume><elocation-id>e68275</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68275</pub-id><pub-id pub-id-type="pmid">34382936</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Qian</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Endoplasmic reticulum-plasma membrane contact sites: regulators, mechanisms, and physiological functions</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>627700</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.627700</pub-id><pub-id pub-id-type="pmid">33614657</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Inflammation and aging: signaling pathways and intervention therapies</article-title><source>Signal Transduction and Targeted Therapy</source><volume>8</volume><elocation-id>239</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-023-01502-8</pub-id><pub-id pub-id-type="pmid">37291105</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>IT</given-names></name><name><surname>Schoel</surname><given-names>LJ</given-names></name><name><surname>Cho</surname><given-names>G</given-names></name><name><surname>Golden</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hereditary spastic paraplegia-linked REEP1 modulates endoplasmic reticulum/mitochondria contacts</article-title><source>Annals of Neurology</source><volume>78</volume><fpage>679</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1002/ana.24488</pub-id><pub-id pub-id-type="pmid">26201691</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limmer</surname><given-names>S</given-names></name><name><surname>Weiler</surname><given-names>A</given-names></name><name><surname>Volkenhoff</surname><given-names>A</given-names></name><name><surname>Babatz</surname><given-names>F</given-names></name><name><surname>KlÃ¤mbt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The <italic>Drosophila</italic> blood-brain barrier: development and function of a glial endothelium</article-title><source>Frontiers in Neuroscience</source><volume>8</volume><elocation-id>365</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2014.00365</pub-id><pub-id pub-id-type="pmid">25452710</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Ziegler</surname><given-names>AC</given-names></name><name><surname>Dimitrion</surname><given-names>P</given-names></name><name><surname>Zuo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2017</volume><elocation-id>2525967</elocation-id><pub-id pub-id-type="doi">10.1155/2017/2525967</pub-id><pub-id pub-id-type="pmid">28785371</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ren</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chuang</surname><given-names>CC</given-names></name><name><surname>Kandaswamy</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Zuo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of ros and nutritional antioxidants in human diseases</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>477</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00477</pub-id><pub-id pub-id-type="pmid">29867535</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lush</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Read</surname><given-names>DJ</given-names></name><name><surname>Willis</surname><given-names>AC</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neuropathy target esterase and a homologous <italic>Drosophila</italic> neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man</article-title><source>The Biochemical Journal</source><volume>332 ( Pt 1)</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1042/bj3320001</pub-id><pub-id pub-id-type="pmid">9576844</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>LD</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>SK</given-names></name><name><surname>Ha</surname><given-names>CM</given-names></name><name><surname>Thoudam</surname><given-names>T</given-names></name><name><surname>Cha</surname><given-names>SK</given-names></name><name><surname>Wiederkehr</surname><given-names>A</given-names></name><name><surname>Wollheim</surname><given-names>CB</given-names></name><name><surname>Lee</surname><given-names>IK</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes</article-title><source>Experimental &amp; Molecular Medicine</source><volume>49</volume><elocation-id>e291</elocation-id><pub-id pub-id-type="doi">10.1038/emm.2016.157</pub-id><pub-id pub-id-type="pmid">28154371</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Moulton</surname><given-names>MJ</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>âFly-ingâ from rare to common neurodegenerative disease mechanisms</article-title><source>Trends in Genetics</source><volume>38</volume><fpage>972</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2022.03.018</pub-id><pub-id pub-id-type="pmid">35484057</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Bounader</surname><given-names>K</given-names></name><name><surname>Hanke</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Jannsen-Peters</surname><given-names>H</given-names></name><name><surname>Haverich</surname><given-names>A</given-names></name><name><surname>Schmitto</surname><given-names>JD</given-names></name><name><surname>Dogan</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Biocompatibility of an apical ring plug for left ventricular assist device explantation: results of a feasibility pre-clinical study</article-title><source>Artificial Organs</source><volume>46</volume><fpage>827</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1111/aor.14149</pub-id><pub-id pub-id-type="pmid">34904254</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFerrin</surname><given-names>J</given-names></name><name><surname>Patton</surname><given-names>BL</given-names></name><name><surname>Sunderhaus</surname><given-names>ER</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NTE/PNPLA6 is expressed in mature schwann cells and is required for glial ensheathment of Remak fibers</article-title><source>Glia</source><volume>65</volume><fpage>804</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1002/glia.23127</pub-id><pub-id pub-id-type="pmid">28206686</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>PL</given-names></name><name><surname>McGeer</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Inflammation and the degenerative diseases of aging</article-title><source>Annals of the New York Academy of Sciences</source><volume>1035</volume><fpage>104</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1196/annals.1332.007</pub-id><pub-id pub-id-type="pmid">15681803</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melentev</surname><given-names>PA</given-names></name><name><surname>Ryabova</surname><given-names>EV</given-names></name><name><surname>Surina</surname><given-names>NV</given-names></name><name><surname>Zhmujdina</surname><given-names>DR</given-names></name><name><surname>Komissarov</surname><given-names>AE</given-names></name><name><surname>Ivanova</surname><given-names>EA</given-names></name><name><surname>Boltneva</surname><given-names>NP</given-names></name><name><surname>Makhaeva</surname><given-names>GF</given-names></name><name><surname>Sliusarenko</surname><given-names>MI</given-names></name><name><surname>Yatsenko</surname><given-names>AS</given-names></name><name><surname>Mohylyak</surname><given-names>II</given-names></name><name><surname>Matiytsiv</surname><given-names>NP</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name><name><surname>Sarantseva</surname><given-names>SV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of <italic>swiss cheese</italic> in neurons contributes to neurodegeneration with mitochondria abnormalities, reactive oxygen species acceleration and accumulation of lipid droplets in <italic>Drosophila</italic> brain</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>8275</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22158275</pub-id><pub-id pub-id-type="pmid">34361042</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ruan</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Stearic acid induces proinflammatory cytokine production partly through activation of lactate-HIF1Î± pathway in chondrocytes</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>13092</elocation-id><pub-id pub-id-type="doi">10.1038/srep13092</pub-id><pub-id pub-id-type="pmid">26271607</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>SchÃ¼tze</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>ColabFold: making protein folding accessible to all</article-title><source>Nature Methods</source><volume>19</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01488-1</pub-id><pub-id pub-id-type="pmid">35637307</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Stempfl</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name><name><surname>BÃ¼ttner</surname><given-names>R</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cloning and expression of the murine sws/NTE gene</article-title><source>Mechanisms of Development</source><volume>90</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/s0925-4773(99)00239-7</pub-id><pub-id pub-id-type="pmid">10640712</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MÃ¼hlig-Versen</surname><given-names>M</given-names></name><name><surname>da Cruz</surname><given-names>AB</given-names></name><name><surname>TschÃ¤pe</surname><given-names>J-A</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>BÃ¼ttner</surname><given-names>R</given-names></name><name><surname>Athenstaedt</surname><given-names>K</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>2865</fpage><lpage>2873</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5097-04.2005</pub-id><pub-id pub-id-type="pmid">15772346</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munji</surname><given-names>RN</given-names></name><name><surname>Soung</surname><given-names>AL</given-names></name><name><surname>Weiner</surname><given-names>GA</given-names></name><name><surname>Sohet</surname><given-names>F</given-names></name><name><surname>Semple</surname><given-names>BD</given-names></name><name><surname>Trivedi</surname><given-names>A</given-names></name><name><surname>Gimlin</surname><given-names>K</given-names></name><name><surname>Kotoda</surname><given-names>M</given-names></name><name><surname>Korai</surname><given-names>M</given-names></name><name><surname>Aydin</surname><given-names>S</given-names></name><name><surname>Batugal</surname><given-names>A</given-names></name><name><surname>Cabangcala</surname><given-names>AC</given-names></name><name><surname>Schupp</surname><given-names>PG</given-names></name><name><surname>Oldham</surname><given-names>MC</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Noble-Haeusslein</surname><given-names>LJ</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>1892</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0497-x</pub-id><pub-id pub-id-type="pmid">31611708</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namekawa</surname><given-names>M</given-names></name><name><surname>Muriel</surname><given-names>MP</given-names></name><name><surname>Janer</surname><given-names>A</given-names></name><name><surname>Latouche</surname><given-names>M</given-names></name><name><surname>Dauphin</surname><given-names>A</given-names></name><name><surname>Debeir</surname><given-names>T</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Duyckaerts</surname><given-names>C</given-names></name><name><surname>Prigent</surname><given-names>A</given-names></name><name><surname>Depienne</surname><given-names>C</given-names></name><name><surname>Sittler</surname><given-names>A</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name><name><surname>Ruberg</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis</article-title><source>Molecular and Cellular Neurosciences</source><volume>35</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2007.01.012</pub-id><pub-id pub-id-type="pmid">17321752</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusrat</surname><given-names>A</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><name><surname>Verkade</surname><given-names>P</given-names></name><name><surname>Foley</surname><given-names>CS</given-names></name><name><surname>Liang</surname><given-names>TW</given-names></name><name><surname>Innis-Whitehouse</surname><given-names>W</given-names></name><name><surname>Eastburn</surname><given-names>KK</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tight junctions are membrane microdomains</article-title><source>Journal of Cell Science</source><volume>113 ( Pt 10)</volume><fpage>1771</fpage><lpage>1781</lpage><pub-id pub-id-type="doi">10.1242/jcs.113.10.1771</pub-id><pub-id pub-id-type="pmid">10769208</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ãzkan</surname><given-names>N</given-names></name><name><surname>Koppers</surname><given-names>M</given-names></name><name><surname>van Soest</surname><given-names>I</given-names></name><name><surname>van Harten</surname><given-names>A</given-names></name><name><surname>Jurriens</surname><given-names>D</given-names></name><name><surname>Liv</surname><given-names>N</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Kapitein</surname><given-names>LC</given-names></name><name><surname>Hoogenraad</surname><given-names>CC</given-names></name><name><surname>FarÃ­as</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ER - lysosome contacts at a pre-axonal region regulate axonal lysosome availability</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>4493</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24713-5</pub-id><pub-id pub-id-type="pmid">34301956</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlidaki</surname><given-names>A</given-names></name><name><surname>Panic</surname><given-names>R</given-names></name><name><surname>Monticelli</surname><given-names>S</given-names></name><name><surname>Riet</surname><given-names>C</given-names></name><name><surname>Yuasa</surname><given-names>Y</given-names></name><name><surname>Cattenoz</surname><given-names>PB</given-names></name><name><surname>Nait-Oumesmar</surname><given-names>B</given-names></name><name><surname>Giangrande</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An anti-inflammatory transcriptional cascade conserved from flies to humans</article-title><source>Cell Reports</source><volume>41</volume><elocation-id>111506</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.111506</pub-id><pub-id pub-id-type="pmid">36261018</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Minakaki</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Krainc</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Preserving lysosomal function in the aging brain: insights from neurodegeneration</article-title><source>Neurotherapeutics</source><volume>16</volume><fpage>611</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1007/s13311-019-00742-3</pub-id><pub-id pub-id-type="pmid">31183763</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pifferi</surname><given-names>F</given-names></name><name><surname>Laurent</surname><given-names>B</given-names></name><name><surname>Plourde</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lipid transport and metabolism at the blood-brain interface: implications in health and disease</article-title><source>Frontiers in Physiology</source><volume>12</volume><elocation-id>645646</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.645646</pub-id><pub-id pub-id-type="pmid">33868013</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainier</surname><given-names>S</given-names></name><name><surname>Bui</surname><given-names>M</given-names></name><name><surname>Mark</surname><given-names>E</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Tokarz</surname><given-names>D</given-names></name><name><surname>Ming</surname><given-names>L</given-names></name><name><surname>Delaney</surname><given-names>C</given-names></name><name><surname>Richardson</surname><given-names>RJ</given-names></name><name><surname>Albers</surname><given-names>JW</given-names></name><name><surname>Matsunami</surname><given-names>N</given-names></name><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Coon</surname><given-names>H</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name><name><surname>Fink</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuropathy target esterase gene mutations cause motor neuron disease</article-title><source>American Journal of Human Genetics</source><volume>82</volume><fpage>780</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.018</pub-id><pub-id pub-id-type="pmid">18313024</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>JS</given-names></name><name><surname>Rapoport</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimerâs disease brain</article-title><source>Translational Psychiatry</source><volume>7</volume><elocation-id>e1127</elocation-id><pub-id pub-id-type="doi">10.1038/tp.2017.97</pub-id><pub-id pub-id-type="pmid">28485730</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>DJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name><name><surname>Cavanagh</surname><given-names>JB</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neuropathy target esterase is required for adult vertebrate axon maintenance</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>11594</fpage><lpage>11600</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3007-09.2009</pub-id><pub-id pub-id-type="pmid">19759306</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regulska</surname><given-names>M</given-names></name><name><surname>Szuster-GÅuszczak</surname><given-names>M</given-names></name><name><surname>Trojan</surname><given-names>E</given-names></name><name><surname>LeÅkiewicz</surname><given-names>M</given-names></name><name><surname>Basta-Kaim</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The emerging role of the double-edged impact of arachidonic acid- derived eicosanoids in the neuroinflammatory background of depression</article-title><source>Current Neuropharmacology</source><volume>19</volume><fpage>278</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.2174/1570159X18666200807144530</pub-id><pub-id pub-id-type="pmid">32851950</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>RenvoisÃ©</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Yonekawa</surname><given-names>S</given-names></name><name><surname>FitzGibbon</surname><given-names>EJ</given-names></name><name><surname>Mankodi</surname><given-names>A</given-names></name><name><surname>Vanderver</surname><given-names>A</given-names></name><name><surname>Schindler</surname><given-names>A</given-names></name><name><surname>Toro</surname><given-names>C</given-names></name><name><surname>Gahl</surname><given-names>WA</given-names></name><name><surname>Mahuran</surname><given-names>DJ</given-names></name><name><surname>Blackstone</surname><given-names>C</given-names></name><name><surname>Pierson</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11</article-title><source>Annals of Clinical and Translational Neurology</source><volume>1</volume><fpage>379</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1002/acn3.64</pub-id><pub-id pub-id-type="pmid">24999486</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>RJ</given-names></name><name><surname>Hein</surname><given-names>ND</given-names></name><name><surname>Wijeyesakere</surname><given-names>SJ</given-names></name><name><surname>Fink</surname><given-names>JK</given-names></name><name><surname>Makhaeva</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neuropathy target esterase (NTE): overview and future</article-title><source>Chemico-Biological Interactions</source><volume>203</volume><fpage>238</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2012.10.024</pub-id><pub-id pub-id-type="pmid">23220002</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>RJ</given-names></name><name><surname>Fink</surname><given-names>JK</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name><name><surname>Hufnagel</surname><given-names>RB</given-names></name><name><surname>Makhaeva</surname><given-names>GF</given-names></name><name><surname>Wijeyesakere</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN)</article-title><source>Advances in Neurotoxicology</source><volume>4</volume><fpage>1</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/bs.ant.2020.01.001</pub-id><pub-id pub-id-type="pmid">32518884</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Gutierrez</surname><given-names>E</given-names></name><name><surname>MuÃ±oz-Arenas</surname><given-names>G</given-names></name><name><surname>TreviÃ±o</surname><given-names>S</given-names></name><name><surname>Espinosa</surname><given-names>B</given-names></name><name><surname>Chavez</surname><given-names>R</given-names></name><name><surname>Rojas</surname><given-names>K</given-names></name><name><surname>Flores</surname><given-names>G</given-names></name><name><surname>DÃ­az</surname><given-names>A</given-names></name><name><surname>Guevara</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Alzheimerâs disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration</article-title><source>Synapse</source><volume>71</volume><elocation-id>e21990</elocation-id><pub-id pub-id-type="doi">10.1002/syn.21990</pub-id><pub-id pub-id-type="pmid">28650104</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudnicka</surname><given-names>E</given-names></name><name><surname>NapieraÅa</surname><given-names>P</given-names></name><name><surname>Podfigurna</surname><given-names>A</given-names></name><name><surname>MÄczekalski</surname><given-names>B</given-names></name><name><surname>Smolarczyk</surname><given-names>R</given-names></name><name><surname>Grymowicz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The world health organization (WHO) approach to healthy ageing</article-title><source>Maturitas</source><volume>139</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2020.05.018</pub-id><pub-id pub-id-type="pmid">32747042</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryabova</surname><given-names>EV</given-names></name><name><surname>Melentev</surname><given-names>PA</given-names></name><name><surname>Komissarov</surname><given-names>AE</given-names></name><name><surname>Surina</surname><given-names>NV</given-names></name><name><surname>Ivanova</surname><given-names>EA</given-names></name><name><surname>Matiytsiv</surname><given-names>N</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name><name><surname>Sarantseva</surname><given-names>SV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Morpho-functional consequences of swiss cheese knockdown in glia of <italic>Drosophila melanogaster</italic></article-title><source>Cells</source><volume>10</volume><elocation-id>529</elocation-id><pub-id pub-id-type="doi">10.3390/cells10030529</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwabe</surname><given-names>T</given-names></name><name><surname>Bainton</surname><given-names>RJ</given-names></name><name><surname>Fetter</surname><given-names>RD</given-names></name><name><surname>Heberlein</surname><given-names>U</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>GPCR signaling is required for blood-brain barrier formation in <italic>Drosophila</italic></article-title><source>Cell</source><volume>123</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.08.037</pub-id><pub-id pub-id-type="pmid">16213218</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwabe</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic analysis of the mesenchymal-epithelial transition of blood-brain barrier forming glia in <italic>Drosophila</italic></article-title><source>Biology Open</source><volume>6</volume><fpage>232</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1242/bio.020669</pub-id><pub-id pub-id-type="pmid">28108476</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seehafer</surname><given-names>SS</given-names></name><name><surname>Ramirez-Montealegre</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>AM</given-names></name><name><surname>Chan</surname><given-names>C-H</given-names></name><name><surname>Castaneda</surname><given-names>J</given-names></name><name><surname>Horak</surname><given-names>M</given-names></name><name><surname>Ahmadi</surname><given-names>SM</given-names></name><name><surname>Lim</surname><given-names>MJ</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Pearce</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Immunosuppression alters disease severity in juvenile batten disease mice</article-title><source>Journal of Neuroimmunology</source><volume>230</volume><fpage>169</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2010.08.024</pub-id><pub-id pub-id-type="pmid">20937531</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segarra</surname><given-names>M</given-names></name><name><surname>Aburto</surname><given-names>MR</given-names></name><name><surname>Acker-Palmer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Blood-brain barrier dynamics to maintain brain homeostasis</article-title><source>Trends in Neurosciences</source><volume>44</volume><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2020.12.002</pub-id><pub-id pub-id-type="pmid">33423792</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sezgin</surname><given-names>E</given-names></name><name><surname>Levental</surname><given-names>I</given-names></name><name><surname>Mayor</surname><given-names>S</given-names></name><name><surname>Eggeling</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The mystery of membrane organization: composition, regulation and roles of lipid rafts</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>18</volume><fpage>361</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.16</pub-id><pub-id pub-id-type="pmid">28356571</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shcherbata</surname><given-names>HR</given-names></name><name><surname>Yatsenko</surname><given-names>AS</given-names></name><name><surname>Patterson</surname><given-names>L</given-names></name><name><surname>Sood</surname><given-names>VD</given-names></name><name><surname>Nudel</surname><given-names>U</given-names></name><name><surname>Yaffe</surname><given-names>D</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>Ruohola-Baker</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dissecting muscle and neuronal disorders in a <italic>Drosophila</italic> model of muscular dystrophy</article-title><source>The EMBO Journal</source><volume>26</volume><fpage>481</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601503</pub-id><pub-id pub-id-type="pmid">17215867</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheth</surname><given-names>J</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Treatment for lysosomal storage disorders</article-title><source>Current Pharmaceutical Design</source><volume>26</volume><fpage>5110</fpage><lpage>5118</lpage><pub-id pub-id-type="doi">10.2174/1381612826666201015154932</pub-id><pub-id pub-id-type="pmid">33059565</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigetomi</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Matsuzawa</surname><given-names>K</given-names></name><name><surname>Ikenouchi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cholesterol-rich domain formation mediated by ZO proteins is essential for tight junction formation</article-title><source>PNAS</source><volume>120</volume><elocation-id>e2217561120</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2217561120</pub-id><pub-id pub-id-type="pmid">36791108</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Yue</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Heterochromatic silencing of immune-related genes in glia is required for BBB integrity and normal lifespan in <italic>Drosophila</italic></article-title><source>Aging Cell</source><volume>22</volume><elocation-id>e13947</elocation-id><pub-id pub-id-type="doi">10.1111/acel.13947</pub-id><pub-id pub-id-type="pmid">37594178</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silies</surname><given-names>M</given-names></name><name><surname>Yuva</surname><given-names>Y</given-names></name><name><surname>Engelen</surname><given-names>D</given-names></name><name><surname>Aho</surname><given-names>A</given-names></name><name><surname>Stork</surname><given-names>T</given-names></name><name><surname>KlÃ¤mbt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Glial cell migration in the eye disc</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>13130</fpage><lpage>13139</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3583-07.2007</pub-id><pub-id pub-id-type="pmid">18045907</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Vaz</surname><given-names>WLC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Model systems, lipid rafts, and cell membranes</article-title><source>Annual Review of Biophysics and Biomolecular Structure</source><volume>33</volume><fpage>269</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.32.110601.141803</pub-id><pub-id pub-id-type="pmid">15139814</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soardo</surname><given-names>G</given-names></name><name><surname>Donnini</surname><given-names>D</given-names></name><name><surname>Domenis</surname><given-names>L</given-names></name><name><surname>Catena</surname><given-names>C</given-names></name><name><surname>De Silvestri</surname><given-names>D</given-names></name><name><surname>Cappello</surname><given-names>D</given-names></name><name><surname>Dibenedetto</surname><given-names>A</given-names></name><name><surname>Carnelutti</surname><given-names>A</given-names></name><name><surname>Bonasia</surname><given-names>V</given-names></name><name><surname>Pagano</surname><given-names>C</given-names></name><name><surname>Sechi</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Oxidative stress is activated by free fatty acids in cultured human hepatocytes</article-title><source>Metabolic Syndrome and Related Disorders</source><volume>9</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1089/met.2010.0140</pub-id><pub-id pub-id-type="pmid">21561340</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>JI</given-names></name><name><surname>Bell</surname><given-names>JS</given-names></name><name><surname>DeLuca</surname><given-names>GC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier</article-title><source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>89</volume><fpage>42</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2017-316011</pub-id><pub-id pub-id-type="pmid">28860328</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prostaglandins and other eicosanoids in insects: biosynthesis and biological actions</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1927</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01927</pub-id><pub-id pub-id-type="pmid">30792667</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sujkowski</surname><given-names>A</given-names></name><name><surname>Rainier</surname><given-names>S</given-names></name><name><surname>Fink</surname><given-names>JK</given-names></name><name><surname>Wessells</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Delayed induction of human nte (pnpla6) rescues neurodegeneration and mobility defects of <italic>Drosophila</italic> swiss cheese (sws) mutants</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0145356</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0145356</pub-id><pub-id pub-id-type="pmid">26671664</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderhaus</surname><given-names>ER</given-names></name><name><surname>Law</surname><given-names>AD</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ER responses play a key role in swiss-cheese/neuropathy target esterase-associated neurodegeneration</article-title><source>Neurobiology of Disease</source><volume>130</volume><elocation-id>104520</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2019.104520</pub-id><pub-id pub-id-type="pmid">31233884</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>MD</given-names></name><name><surname>Sagare</surname><given-names>AP</given-names></name><name><surname>Zlokovic</surname><given-names>BV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Blood-brain barrier breakdown in alzheimer disease and other neurodegenerative disorders</article-title><source>Nature Reviews. Neurology</source><volume>14</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2017.188</pub-id><pub-id pub-id-type="pmid">29377008</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synofzik</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>MA</given-names></name><name><surname>Lourenco</surname><given-names>CM</given-names></name><name><surname>Coutelier</surname><given-names>M</given-names></name><name><surname>Haack</surname><given-names>TB</given-names></name><name><surname>Rebelo</surname><given-names>A</given-names></name><name><surname>Hannequin</surname><given-names>D</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Kernstock</surname><given-names>C</given-names></name><name><surname>Durr</surname><given-names>A</given-names></name><name><surname>SchÃ¶ls</surname><given-names>L</given-names></name><name><surname>Lima-MartÃ­nez</surname><given-names>MM</given-names></name><name><surname>Farooq</surname><given-names>A</given-names></name><name><surname>SchÃ¼le</surname><given-names>R</given-names></name><name><surname>Stevanin</surname><given-names>G</given-names></name><name><surname>Marques</surname><given-names>W</given-names></name><name><surname>ZÃ¼chner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PNPLA6 mutations cause boucher-neuhauser and gordon holmes syndromes as part of a broad neurodegenerative spectrum</article-title><source>Brain</source><volume>137</volume><fpage>69</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1093/brain/awt326</pub-id><pub-id pub-id-type="pmid">24355708</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synofzik</surname><given-names>M</given-names></name><name><surname>Kernstock</surname><given-names>C</given-names></name><name><surname>Haack</surname><given-names>TB</given-names></name><name><surname>SchÃ¶ls</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ataxia meets chorioretinal dystrophy and hypogonadism: boucher-neuhÃ¤user syndrome due to PNPLA6 mutations</article-title><source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>86</volume><fpage>580</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2014-307793</pub-id><pub-id pub-id-type="pmid">24790214</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>F</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>J</given-names></name><name><surname>Dohgu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of bbb dysfunction</article-title><source>Frontiers in Cellular Neuroscience</source><volume>15</volume><elocation-id>661838</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2021.661838</pub-id><pub-id pub-id-type="pmid">34588955</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tessitore</surname><given-names>A</given-names></name><name><surname>del P Martin</surname><given-names>M</given-names></name><name><surname>Sano</surname><given-names>R</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Mann</surname><given-names>L</given-names></name><name><surname>Ingrassia</surname><given-names>A</given-names></name><name><surname>Laywell</surname><given-names>ED</given-names></name><name><surname>Steindler</surname><given-names>DA</given-names></name><name><surname>Hendershot</surname><given-names>LM</given-names></name><name><surname>dâAzzo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis</article-title><source>Molecular Cell</source><volume>15</volume><fpage>753</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.08.029</pub-id><pub-id pub-id-type="pmid">15350219</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thelen</surname><given-names>AM</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Emerging roles for the lysosome in lipid metabolism</article-title><source>Trends in Cell Biology</source><volume>27</volume><fpage>833</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.07.006</pub-id><pub-id pub-id-type="pmid">28838620</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topaloglu</surname><given-names>AK</given-names></name><name><surname>Lomniczi</surname><given-names>A</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name><name><surname>Dissen</surname><given-names>GA</given-names></name><name><surname>Kotan</surname><given-names>LD</given-names></name><name><surname>McArdle</surname><given-names>CA</given-names></name><name><surname>Koc</surname><given-names>AF</given-names></name><name><surname>Hamel</surname><given-names>BC</given-names></name><name><surname>Guclu</surname><given-names>M</given-names></name><name><surname>Papatya</surname><given-names>ED</given-names></name><name><surname>Eren</surname><given-names>E</given-names></name><name><surname>Mengen</surname><given-names>E</given-names></name><name><surname>Gurbuz</surname><given-names>F</given-names></name><name><surname>Cook</surname><given-names>M</given-names></name><name><surname>Castellano</surname><given-names>JM</given-names></name><name><surname>Kekil</surname><given-names>MB</given-names></name><name><surname>Mungan</surname><given-names>NO</given-names></name><name><surname>Yuksel</surname><given-names>B</given-names></name><name><surname>Ojeda</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>99</volume><fpage>E2067</fpage><lpage>E2075</lpage><pub-id pub-id-type="doi">10.1210/jc.2014-1836</pub-id><pub-id pub-id-type="pmid">25033069</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>TrÃ©buchet</surname><given-names>G</given-names></name><name><surname>Cattenoz</surname><given-names>PB</given-names></name><name><surname>ZsÃ¡mboki</surname><given-names>J</given-names></name><name><surname>Mazaud</surname><given-names>D</given-names></name><name><surname>Siekhaus</surname><given-names>DE</given-names></name><name><surname>Fanto</surname><given-names>M</given-names></name><name><surname>Giangrande</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The repo homeodomain transcription factor suppresses hematopoiesis in <italic>Drosophila</italic> and preserves the glial fate</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>238</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1059-18.2018</pub-id><pub-id pub-id-type="pmid">30504274</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Schroder</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?</article-title><source>Nature Reviews. Immunology</source><volume>10</volume><fpage>210</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/nri2725</pub-id><pub-id pub-id-type="pmid">20168318</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udayar</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sidransky</surname><given-names>E</given-names></name><name><surname>Jagasia</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Lysosomal dysfunction in neurodegeneration: emerging concepts and methods</article-title><source>Trends in Neurosciences</source><volume>45</volume><fpage>184</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2021.12.004</pub-id><pub-id pub-id-type="pmid">35034773</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugur</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Drosophila</italic> tools and assays for the study of human diseases</article-title><source>Disease Models &amp; Mechanisms</source><volume>9</volume><fpage>235</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1242/dmm.023762</pub-id><pub-id pub-id-type="pmid">26935102</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vainio</surname><given-names>S</given-names></name><name><surname>Bykov</surname><given-names>I</given-names></name><name><surname>Hermansson</surname><given-names>M</given-names></name><name><surname>Jokitalo</surname><given-names>E</given-names></name><name><surname>Somerharju</surname><given-names>P</given-names></name><name><surname>Ikonen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes</article-title><source>The Biochemical Journal</source><volume>391</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1042/BJ20050460</pub-id><pub-id pub-id-type="pmid">15943586</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Alphen</surname><given-names>B</given-names></name><name><surname>Stewart</surname><given-names>S</given-names></name><name><surname>Iwanaszko</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Rozenfeld</surname><given-names>S</given-names></name><name><surname>Ramakrishnan</surname><given-names>A</given-names></name><name><surname>Itoh</surname><given-names>TQ</given-names></name><name><surname>Sisobhan</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>Z</given-names></name><name><surname>Lear</surname><given-names>BC</given-names></name><name><surname>Allada</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Glial immune-related pathways mediate effects of closed head traumatic brain injury on behavior and lethality in <italic>Drosophila</italic></article-title><source>PLOS Biology</source><volume>20</volume><elocation-id>e3001456</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001456</pub-id><pub-id pub-id-type="pmid">35081110</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Lee</surname><given-names>SJ</given-names></name><name><surname>Teunissen</surname><given-names>CE</given-names></name><name><surname>Pool</surname><given-names>R</given-names></name><name><surname>Shipley</surname><given-names>MJ</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Chouraki</surname><given-names>V</given-names></name><name><surname>Melo van Lent</surname><given-names>D</given-names></name><name><surname>Tynkkynen</surname><given-names>J</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Hernesniemi</surname><given-names>J</given-names></name><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Singh-Manoux</surname><given-names>A</given-names></name><name><surname>Verhoeven</surname><given-names>A</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>de Leeuw</surname><given-names>FA</given-names></name><name><surname>Wagner</surname><given-names>H</given-names></name><name><surname>van Dongen</surname><given-names>J</given-names></name><name><surname>Hertel</surname><given-names>J</given-names></name><name><surname>Budde</surname><given-names>K</given-names></name><name><surname>Willems van Dijk</surname><given-names>K</given-names></name><name><surname>Weinhold</surname><given-names>L</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Pietzner</surname><given-names>M</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Friedrich</surname><given-names>N</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Gertzen</surname><given-names>RE</given-names></name><name><surname>Egert</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Hankemeier</surname><given-names>T</given-names></name><name><surname>van Beijsterveldt</surname><given-names>CEM</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Peeters</surname><given-names>CFW</given-names></name><name><surname>JÃ¶rgen Grabe</surname><given-names>H</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>KivimÃ¤ki</surname><given-names>M</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>van der Flier</surname><given-names>WM</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies</article-title><source>Alzheimerâs &amp; Dementia</source><volume>14</volume><fpage>707</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2017.11.012</pub-id><pub-id pub-id-type="pmid">29316447</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Hanstein</surname><given-names>AS</given-names></name><name><surname>Tsikas</surname><given-names>D</given-names></name><name><surname>Lenzen</surname><given-names>S</given-names></name><name><surname>JÃ¶rns</surname><given-names>A</given-names></name><name><surname>PlÃ¶tz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Potentiation of lipotoxicity in human endoc-Î²h1 Î²-cells by glucose is dependent on the structure of free fatty acids</article-title><source>Molecular Nutrition &amp; Food Research</source><volume>67</volume><elocation-id>e2200582</elocation-id><pub-id pub-id-type="doi">10.1002/mnfr.202200582</pub-id><pub-id pub-id-type="pmid">36629272</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wentzell</surname><given-names>JS</given-names></name><name><surname>Cassar</surname><given-names>M</given-names></name><name><surname>Kretzschmar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Organophosphate-induced changes in the PKA regulatory function of swiss cheese/NTE lead to behavioral deficits and neurodegeneration</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e87526</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0087526</pub-id><pub-id pub-id-type="pmid">24558370</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitson</surname><given-names>HE</given-names></name><name><surname>Colton</surname><given-names>C</given-names></name><name><surname>El Khoury</surname><given-names>J</given-names></name><name><surname>Gate</surname><given-names>D</given-names></name><name><surname>Goate</surname><given-names>A</given-names></name><name><surname>Heneka</surname><given-names>MT</given-names></name><name><surname>Kaddurah-Daouk</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>RS</given-names></name><name><surname>Shinohara</surname><given-names>ML</given-names></name><name><surname>Sisodia</surname><given-names>S</given-names></name><name><surname>Spudich</surname><given-names>SS</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name><name><surname>Tanzi</surname><given-names>R</given-names></name><name><surname>Ting</surname><given-names>JP</given-names></name><name><surname>Garden</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Infection and inflammation: new perspectives on alzheimerâs disease</article-title><source>Brain, Behavior, &amp; Immunity - Health</source><volume>22</volume><elocation-id>100462</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbih.2022.100462</pub-id><pub-id pub-id-type="pmid">36118272</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EL</given-names></name><name><surname>Metzakopian</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ER-mitochondria contact sites in neurodegeneration: genetic screening approaches to investigate novel disease mechanisms</article-title><source>Cell Death and Differentiation</source><volume>28</volume><fpage>1804</fpage><lpage>1821</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00705-8</pub-id><pub-id pub-id-type="pmid">33335290</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>B</given-names></name><name><surname>Funke</surname><given-names>D</given-names></name><name><surname>Benmimoun</surname><given-names>B</given-names></name><name><surname>SpÃ©der</surname><given-names>P</given-names></name><name><surname>Rey</surname><given-names>S</given-names></name><name><surname>Logan</surname><given-names>MA</given-names></name><name><surname>KlÃ¤mbt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Brain inflammation triggers macrophage invasion across the blood-brain barrier in <italic>Drosophila</italic> during pupal stages</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabh0050</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abh0050</pub-id><pub-id pub-id-type="pmid">34705495</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Whiteus</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>CS</given-names></name><name><surname>Hayworth</surname><given-names>KJ</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><name><surname>Hess</surname><given-names>HF</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Contacts between the endoplasmic reticulum and other membranes in neurons</article-title><source>PNAS</source><volume>114</volume><fpage>E4859</fpage><lpage>E4867</lpage><pub-id pub-id-type="doi">10.1073/pnas.1701078114</pub-id><pub-id pub-id-type="pmid">28559323</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Stern</surname><given-names>M</given-names></name><name><surname>McNew</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Beneficial effects of rapamycin in a <italic>Drosophila</italic> model for hereditary spastic paraplegia</article-title><source>Journal of Cell Science</source><volume>130</volume><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1242/jcs.196741</pub-id><pub-id pub-id-type="pmid">27909242</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Nicolson</surname><given-names>S</given-names></name><name><surname>Sandow</surname><given-names>JJ</given-names></name><name><surname>Dayan</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Manning</surname><given-names>JA</given-names></name><name><surname>Webb</surname><given-names>AI</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Denton</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cp1/cathepsin L is required for autolysosomal clearance in <italic>Drosophila</italic></article-title><source>Autophagy</source><volume>17</volume><fpage>2734</fpage><lpage>2749</lpage><pub-id pub-id-type="doi">10.1080/15548627.2020.1838105</pub-id><pub-id pub-id-type="pmid">33112206</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Fairn</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phospholipid subcellular localization and dynamics</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>6230</fpage><lpage>6240</lpage><pub-id pub-id-type="doi">10.1074/jbc.R117.000582</pub-id><pub-id pub-id-type="pmid">29588369</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Kume</surname><given-names>S</given-names></name><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Chin-Kanasaki</surname><given-names>M</given-names></name><name><surname>Araki</surname><given-names>H</given-names></name><name><surname>Isshiki</surname><given-names>K</given-names></name><name><surname>Araki</surname><given-names>S</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name><name><surname>Haneda</surname><given-names>M</given-names></name><name><surname>Kashiwagi</surname><given-names>A</given-names></name><name><surname>Maegawa</surname><given-names>H</given-names></name><name><surname>Uzu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes</article-title><source>Biochimica et Biophysica Acta</source><volume>1842</volume><fpage>1097</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2014.04.001</pub-id><pub-id pub-id-type="pmid">24726883</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatsenko</surname><given-names>AS</given-names></name><name><surname>Kucherenko</surname><given-names>MM</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Exocyst-mediated membrane trafficking of the lissencephaly-associated ECM receptor dystroglycan is required for proper brain compartmentalization</article-title><source>eLife</source><volume>10</volume><elocation-id>e63868</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.63868</pub-id><pub-id pub-id-type="pmid">33620318</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatsenko</surname><given-names>AS</given-names></name><name><surname>Shcherbata</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Distant activation of notch signaling induces stem cell niche assembly</article-title><source>PLOS Genetics</source><volume>17</volume><elocation-id>e1009489</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009489</pub-id><pub-id pub-id-type="pmid">33780456</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>AN</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Heterotrimeric G proteins regulate a noncanonical function of septate junction proteins to maintain cardiac integrity in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>15</volume><fpage>704</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.10.001</pub-id><pub-id pub-id-type="pmid">19000835</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yildirim</surname><given-names>K</given-names></name><name><surname>Petri</surname><given-names>J</given-names></name><name><surname>Kottmeier</surname><given-names>R</given-names></name><name><surname>KlÃ¤mbt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Drosophila</italic> glia: few cell types and many conserved functions</article-title><source>Glia</source><volume>67</volume><fpage>5</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1002/glia.23459</pub-id><pub-id pub-id-type="pmid">30443934</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaccheo</surname><given-names>O</given-names></name><name><surname>Dinsdale</surname><given-names>D</given-names></name><name><surname>Meacock</surname><given-names>PA</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>24024</fpage><lpage>24033</lpage><pub-id pub-id-type="doi">10.1074/jbc.M400830200</pub-id><pub-id pub-id-type="pmid">15044461</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>D</given-names></name><name><surname>Mao</surname><given-names>Q</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Role of neuroinflammation in neurodegeneration development</article-title><source>Signal Transduction and Targeted Therapy</source><volume>8</volume><elocation-id>267</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-023-01486-5</pub-id><pub-id pub-id-type="pmid">37433768</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>YN</given-names></name><name><surname>Ren</surname><given-names>XY</given-names></name><name><surname>Zhang</surname><given-names>XF</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Inactivation of microglia dampens blood-brain barrier permeability and loss of dopaminergic neurons in paraquat-lesioned mice</article-title><source>Food and Chemical Toxicology</source><volume>174</volume><elocation-id>113692</elocation-id><pub-id pub-id-type="doi">10.1016/j.fct.2023.113692</pub-id><pub-id pub-id-type="pmid">36842752</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>L</given-names></name><name><surname>Prather</surname><given-names>ER</given-names></name><name><surname>Stetskiv</surname><given-names>M</given-names></name><name><surname>Garrison</surname><given-names>DE</given-names></name><name><surname>Meade</surname><given-names>JR</given-names></name><name><surname>Peace</surname><given-names>TI</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>4472</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20184472</pub-id><pub-id pub-id-type="pmid">31510091</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1âkey resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Repo (mouse monoclonal)</td><td align="left" valign="top">Developmental Studies Hybridoma Bank</td><td align="left" valign="top">#8D12</td><td align="left" valign="top">IF(1:50)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-CoraC (mouse monoclonal)</td><td align="left" valign="top">Developmental Studies Hybridoma Bank</td><td align="left" valign="top">#C566.9</td><td align="left" valign="top">IF(1:50)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Rab7 (mouse monoclonal)</td><td align="left" valign="top">Developmental Studies Hybridoma Bank</td><td align="left" valign="top">#AB2722471</td><td align="left" valign="top">IF(1:50)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-DE-Cad (rat monoclonal)</td><td align="left" valign="top">Developmental Studies Hybridoma Bank</td><td align="left" valign="top">#DCAD2</td><td align="left" valign="top">IF(1:50)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-GFP (chicken polyclonal)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">#ab13970</td><td align="left" valign="top">IF(1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-mCherry (rabbit polyclonal)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">#ab167453</td><td align="left" valign="top">IF(1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Î²-Galactosidase (mouse monoclonal)</td><td align="left" valign="top">Promega</td><td align="left" valign="top">#Z3781</td><td align="left" valign="top">IF(1:200)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-CathepsinL (mouse)</td><td align="left" valign="top">R&amp;D Systems</td><td align="left" valign="top">#1515-CY-010</td><td align="left" valign="top">IF(1:400)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-NrxIV (rabbit polyclonal)</td><td align="left" valign="top">Gift from Christian KlÃ¤mbt</td><td align="left" valign="top">Anti-NrxIV</td><td align="left" valign="top">IF(1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-SWS (rabbit polyclonal)</td><td align="left" valign="top">Gift from Doris Kretzschmar</td><td align="left" valign="top">Anti-SWS</td><td align="left" valign="top">IF(1:1000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-NimC1 (mouse)</td><td align="left" valign="top">Gift from IstvÃ¡n AndÃ³</td><td align="left" valign="top">Anti-NimC1</td><td align="left" valign="top">IF(1:300)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-chicken Alexa 488 (goat polyclonal)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">#A-11039</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rat Alexa 488 (goat polyclonal)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">#A-11077</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rat Alexa 647 (goat polyclonal)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">#A-21247</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rabbit Alexa 488 (goat polyclonal)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">#A-11034</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-rabbit Alexa 568 (goat polyclonal)</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">#A-11011</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-mouse IgG2a Cy3 (goat polyclonal)</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">#115-165-206</td><td align="left" valign="top">Secondary antibody IF(1:400)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-mouse IG1 Cy3 (goat polyclonal)</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">#115-165-205</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-mouse IgG1 647 (goat polyclonal)</td><td align="left" valign="top">Jackson ImmunoResearch</td><td align="left" valign="top">#115-605-205</td><td align="left" valign="top">Secondary antibody IF(1:500)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">w[1118]</td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 5905</td><td align="left" valign="top">Wild type strain</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">Oregon-R</td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 5</td><td align="left" valign="top">Wild type strain</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">sws<sup>1</sup></td><td align="left" valign="top">Gift from Doris Kretzschmar</td><td align="left" valign="top">sws<sup>1</sup></td><td align="left" valign="top">sws[1]/FM7a(null mutant)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">sws<sup>4</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 28121</td><td align="left" valign="top">sws[4]/C(1)DX, y[1] w[1] f[1] (Amino acid replacement: G956D)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-sws</td><td align="left" valign="top">Gift from Doris Kretzschmar</td><td align="left" valign="top">UAS-sws</td><td align="left" valign="top">UAS-sws (sws gene under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">sws-Gal4</td><td align="left" valign="top">Kyoto Stock Center</td><td align="char" char="." valign="top">104592</td><td align="left" valign="top">y* w* P{GawB}swsNP4072/FM7c</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-nlsLacZ, UAS-CD8::GFP</td><td align="left" valign="top">Gift from Frank Hirth</td><td align="left" valign="top">UAS-nLacZ, UAS-GFP</td><td align="left" valign="top">UAS-nlsLacZ, UAS-CD8::GFP(nLacZ and GFP constructs under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-hNTE</td><td align="left" valign="top">Gift from Robert Wessells</td><td align="left" valign="top">UAS-hNTE</td><td align="left" valign="top">w[1118]; p[PUAST]-hNTE/CyO(Human NTE undercontrol of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-sws<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 61338</td><td align="left" valign="top">y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMJ23229}attP40 (sws RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">repo-Gal4, UAS-CD8::GFP/TM6B</td><td align="left" valign="top">Gift from Mikael Simons</td><td align="left" valign="top">repo-Gal4</td><td align="left" valign="top">repo-Gal4, UAS-CD8::GFP/TM6B</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">Gliotactin-Gal4, UAS-CD8::GFP</td><td align="left" valign="top">Gift from Mikael Simons</td><td align="left" valign="top">Gli-Gal4</td><td align="left" valign="top">Gliotactin-Gal4, UAS-CD8::GFP</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">moody-Gal4, UAS-CD8::GFP</td><td align="left" valign="top">Gift from Mikael Simons</td><td align="left" valign="top">moody-Gal4</td><td align="left" valign="top">moody-Gal4, UAS-CD8::GFP</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">nSyb-Gal4</td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 51945</td><td align="left" valign="top">y[1] w[1118]; P{y[+t7.7] w[+mC]=nSyb-GAL4.DBD::QF.AD}attP2</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">repo-Gal4, nSyb-Gal4, UAS-CD8::GFP/TM6B,Sb</td><td align="left" valign="top">This study</td><td align="left" valign="top">repo-Gal4, nSyb-Gal4</td><td align="left" valign="top">repo-Gal4, nSyb-Gal4, UAS-CD8::GFP/TM6B,Sb</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">tub-Gal80<sup>ts</sup>; repo-Gal4/TM6B</td><td align="left" valign="top">This study</td><td align="left" valign="top">tub-Gal80<sup>ts</sup>; repo-Gal4/TM6B</td><td align="left" valign="top">tub-Gal80<sup>ts</sup>; repo-Gal4/TM6B(temperature sensitive)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">moody<sup>ÎC17</sup></td><td align="left" valign="top">Gift from Christian KlÃ¤mbt</td><td align="left" valign="top">moody<sup>ÎC17</sup></td><td align="left" valign="top">Null mutant</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-moody<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 66326</td><td align="left" valign="top">y[1] sc[*] v[1] sev[21]; P{y[+t7.7] v[+t1.8]=TRiP.HMC06237}attP2(moody RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-Dysb<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 67316</td><td align="left" valign="top">y[1] sc[*] v[1] sev[21]; P{y[+t7.7] v[+t1.8]=TRiP.HMC06420}attP40/CyO(Dysb RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-Npc1a<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 37504</td><td align="left" valign="top">y[1] sc[*] v[1] sev[21]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01646}attP40 (Npc1a RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-Pldn<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 67884</td><td align="left" valign="top">y[1] sc[*] v[1] sev[21]; P{y[+t7.7] v[+t1.8]=TRiP.HMS05728}attP40 (Pldn RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">UAS-spin<sup>RNAi</sup></td><td align="left" valign="top">Bloomington <italic>Drosophila</italic> Stock Center</td><td align="left" valign="top">BDSC 27702</td><td align="left" valign="top">y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02782}attP2 (spin RNAi construct under control of UAS promotor)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="top">srp(Hemo) 3xmCherry</td><td align="left" valign="top">Gift from Angela Giangrande</td><td align="left" valign="top">srp(Hemo)<break/>3xmCherry</td><td align="left" valign="top">srp(Hemo) 3xmCherry</td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Microsoft Excel</td><td align="left" valign="top">Microsoft</td><td align="left" valign="top">Microsoft Excel</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Adobe Photoshop</td><td align="left" valign="top">Adobe</td><td align="left" valign="top">Adobe CC</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Zen 2011 (black edition)</td><td align="left" valign="top">Carl Zeiss; <xref ref-type="bibr" rid="bib28">Emmenlauer et al., 2009</xref></td><td align="left" valign="top">Zen 2011</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">AlphaFold2 v1.5.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib79">Mirdita et al., 2022</xref>; <ext-link ext-link-type="uri" xlink:href="https://colab.research.google.com/github/sokrypton/ColabFold/blob/main/AlphaFold2.ipynb">https://colab.research.google.com/github/sokrypton/ColabFold/blob/main/AlphaFold2.ipynb</ext-link></td><td align="left" valign="bottom">AlphaFold2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">The PyMOL Molecular Graphics System, v2.5.5</td><td align="left" valign="bottom">SchrÃ¶dinger, LLC; <ext-link ext-link-type="uri" xlink:href="https://pymol.org/">https://pymol.org/</ext-link></td><td align="left" valign="bottom">PyMol</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">StepOne Software v2.3</td><td align="left" valign="top">Applied Biosystems</td><td align="left" valign="top">StepOne</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">TRIzol reagent</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">#15596018</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">High Capacity cDNA Reverse Transcription kit</td><td align="left" valign="top">Applied Biosystems</td><td align="left" valign="top">#4368813</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">FastSYBR Green master mix</td><td align="left" valign="top">Applied Biosystems</td><td align="left" valign="top">#435612</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">TUDCA</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#580549</td><td align="left" valign="top">Tauroursodeoxycholic acid</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="char" char="hyphen" valign="top">4-PBA</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#567616</td><td align="left" valign="top">4-Phenylbutyric acid</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Valsartan</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#PHR1315</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Fenofibrate</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#F6020</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sodium salicylate</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#S3007</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Rapamycin</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#R0395</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Deferoxamine mesylate salt</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#D9533</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Liproxstatin-1</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#SML1414</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sphingosine</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#860025P</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Brilliant Blue</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#80717</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Acetic acid</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#27225-1L-M</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Chloroform</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#288306-2L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Glycerol</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#G6279-1L</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sodium azide</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#S2002-25G</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Formaldehyde, 16%</td><td align="left" valign="top">Polysciences Inc</td><td align="left" valign="top">#18814-20</td><td align="left" valign="top">Methanol free, ultra pure</td></tr><tr><td align="left" valign="top">Other</td><td align="char" char="." valign="top">10 kDa Dextran</td><td align="left" valign="top">Molecular Probes</td><td align="left" valign="top">#D1864</td><td align="left" valign="top">Dye labeled with Texas Red</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">DAPI stain</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#D9542-10MG</td><td align="left" valign="top">IF concentration used: 1 Âµg/mL</td></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Normal Goat Serum</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">#ab7481</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Paraplast Plus</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#76258-1KG</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Casein Blocking Buffer 10Ã</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#B6429-500ML</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Hematoxylin Solution, Mayerâs</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#MHS16-500ML</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Eosin Y solution, aqueous</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#HT110232</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">DPX Mountant for histology</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#06522-100ML</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">PBS buffer (10Ã Dulbecco's)</td><td align="left" valign="top">AppliChem</td><td align="left" valign="top">#A0965,9010</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">LSM700 confocal laser-scanning microscope</td><td align="left" valign="top">Carl Zeiss</td><td align="left" valign="top">LSM700</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Hyrax M25 microtome</td><td align="left" valign="top">Carl Zeiss</td><td align="left" valign="top">Hyrax M25</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Zeiss EM 900 microscope</td><td align="left" valign="top">Carl Zeiss</td><td align="left" valign="top">Zeiss EM 900</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Step One Plus 96 well system</td><td align="left" valign="top">Applied Biosystems</td><td align="left" valign="top">Step One Plus</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Acetonitrile</td><td align="left" valign="top">Honeywell</td><td align="left" valign="top">#34851</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Toluene</td><td align="left" valign="top">Supelco</td><td align="left" valign="top">#1.08325.1000</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Pentafluoro-benzyl bromide</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#101052</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Diisopropyl-ethylamine</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#496219</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">GC-MS ISQ</td><td align="left" valign="top">Thermo Fisher</td><td align="left" valign="top">Trace 1210 series</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Optima 17</td><td align="left" valign="top">Macherey-Nagel</td><td align="left" valign="top">#MN726022.15</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">C12:0; C12:1; C14:0; C14:1; C16:0; C16:1; C17:0; C17:1; C18:0; C18:1; C18:2; C18:3; C20:4; C20:5; C21:0; C22:0; C24:0</td><td align="left" valign="top">Merck (Darmstadt, Germany)</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">C19:1; C20:0; C21:1</td><td align="left" valign="top">Larodan AB (Solna, Sweden)</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Paraformaldehyde</td><td align="left" valign="top">Merck</td><td align="left" valign="top">#1.04005.1000</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Glutaraldehyde</td><td align="left" valign="top">Merck</td><td align="left" valign="top">#1.04239.0250</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Osmiumtetroxide</td><td align="left" valign="top">Electron Microscopy Sciences</td><td align="left" valign="top">#22400-56</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">HEPES</td><td align="left" valign="top">Roth</td><td align="left" valign="top">#7020.2</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Acetone puriss.p.a. ACS reagent, reag.ISO 99, 5%</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">#:32201-2.5</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Agar 100 Premix Kit â Hard</td><td align="left" valign="top">Agar Scientific</td><td align="left" valign="top">#R1140</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Tri-Natriumcitrat-Dihydrat</td><td align="left" valign="top">Merck</td><td align="left" valign="top">#1-06448.0500</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Lead (II) nitrate for analysis</td><td align="left" valign="top">Merck</td><td align="left" valign="top">#1.07398.0100</td><td align="left" valign="top"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98020.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kapahi</surname><given-names>Pankaj</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The study underscores the essential role of Neuropathy Target Esterase (NTE)/Swiss Cheese (SWS) in preserving the blood-brain barrier (BBB) integrity and links its dysfunction to symptoms akin to lysosomal storage diseases, elevated fatty acid levels leading to abnormal cellular architecture, and inflammation. It further elaborates on how a compromised BBB facilitates an inflammatory response and fatty acid accumulation, exacerbating neurodegenerative conditions. These important findings backed by solid evidence suggest that targeting inflammation and fatty acid dysregulation may offer therapeutic strategies for age-related neurodegeneration.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98020.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kapahi</surname><given-names>Pankaj</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98020.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>We would like to sincerely thank the reviewers for the positive evaluation of our work, careful reading of our manuscript, and helpful suggestions. In the revised version of our manuscript, we have introduced the proposed changes and added the new data based on the suggested experiments to address the reviewersâ concerns. We hope that this modified version of the manuscript is now acceptable for publication.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Evidence, reproducibility and clarity (Required)):</p><p>Summary</p><p>Elucidating the cellular and molecular mechanisms underlying age-related neurodegeneration remains a key challenge for neurobiologists. In this manuscript, Mariana Tsap and colleagues in the team of Halyna Shcherbata focus on the function of the neuropathy target esterase NTE/Swiss Cheese (Sws) in the <italic>Drosophila</italic> brain. The authors use an elegant combination of genetics, light and electron microscopy, RT-qPCR and GS-MS mass spectrometry to determine the complex role of Sws in cellular blood brain barrier (BBB) integrity, the brain inflammatory response and fatty acid metabolism. The study provides a detailed characterisation as to how the loss of sws affects glial cell morphology in the BBB revealing abnormal membrane accumulations and tight junctions, and in consequence causing permeability issues. Importantly, they observed the upregulation of antimicrobial peptides in the brain, indicative of neuroinflammation, as well as of fatty acids, equally connected with the inflammatory response.</p><p>Major comments</p><p>The study provides a detailed and comprehensive characterization of the sws mutant phenotype, and in particular the role of this gene in blood-brain barrier forming glia.</p><p>â¢ The study connects neurodegeneration and inflammation, but also makes a particular point about &quot;inflammaging&quot;. However, the age contribution has not been studied in detail. Indeed, the flies analyzed are 15 days old (according to the Material and Methods section, with the exception of Figure 1 where flies are 30 days old), and hence have not been compared with younger or older flies to make a point of age as evoked in the abstract, introduction or discussion. The authors should either add experiments comparing differently aged flies or de-emphasize this point to a brief consideration in the discussion. Instead, it would be very helpful to provide concise information about the current knowledge concerning the inflammatory response in the <italic>Drosophila</italic> brain.</p></disp-quote><p>We thank the reviewer for raising this point. The decision to use 15-day-old flies was made due to the high mortality of <italic>sws</italic> mutants after two weeks and because age-dependent character of <italic>sws</italic> neurodegeneration has been previously well described. As the reviewer suggested, now we also included old animals in our experiments to show a connection between age-dependent neurodegeneration and inflammation. We measured and compared the mRNA levels of expression of the antimicrobial peptides (AMPs) Attacin A, Cecropin A, and Diptericin in the heads of 15- and 30-day-old <italic>sws</italic> loss-of-function mutants, in the heads of flies that had <italic>sws</italic> downregulation only in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>) and in the heads of flies expressing NTE/SWS in SPG cells in <italic>sws</italic> mutant background. We found that the expression levels of the antimicrobial peptides are increased in the age-dependent manner in the tested mutants. In addition, we found that the expression of NTE/SWS in SPG in <italic>sws</italic> mutant background reduces inflammatory response in aging animals (see Figure 5D). Also, as the reviewer suggested, we provide brief information on the current understanding of the inflammatory response in the <italic>Drosophila</italic> brain in the Introduction and Results sections.</p><disp-quote content-type="editor-comment"><p>â¢ Related to this point, the authors convincingly show that sws is required in surface glia using rescue experiments. Nevertheless, all experiments rely on drivers and mutants that could cause the emergence of phenotypes during development. Thus, to strengthen the causative link between the breakdown of the BBB and the neuroinflammatory response, it would be helpful to consider an acute knock-down in adults after BBB formation has been completed.</p></disp-quote><p>To strengthen the causative link between the breakdown of the BBB and the neuroinflammatory response during adulthood, we performed qPCR analysis and measured the mRNA levels of the antimicrobial peptides Attacin A, Cecropin A, and Diptericin in the heads of flies with <italic>sws</italic> downregulation in glia cells induced after the blood-brain barrier was formed using the <italic>Gal80<sup>ts</sup></italic> tool. We found that <italic>sws</italic> downregulation in glial cells during adulthood, after the BBB is formed, leads to the increased inflammatory response (Figure 5 âfigure supplement 1E).</p><disp-quote content-type="editor-comment"><p>â¢ To test the brain permeability barrier, the study uses a 10 KDa dextran permeability assay. Almost 25% of brain in controls show a leaky barrier. It would be helpful to describe the causes for this relatively high occurrence.</p></disp-quote><p>The observed relatively high occurrence of a leaky barrier phenotype in our control group may be attributed to our experimental procedure. We injected flies peritoneally and waited for over 12 hours before dissecting their brains for the permeability assay. Typically, such analyses are conducted after shorter periods, often around 2 hours. Additionally, we used Dextran with the smallest molecular weight (10kDa). The blood-brain barrier (BBB) is not 100% impermeable, and small molecules can gradually enter the brain over time. Recent studies have shown that this entry could be facilitated by endocytosis (Artiushin <italic>et al.,</italic> 2018), which could partially explain the presence of Dextran 10kDa in control brains. Considering this, using a larger Dextran (70kDa) in our experiments could have been more accurate. Importantly, we always compared mutants and controls that underwent identical treatment, dissection, and analysis. We conducted experiments in multiple biological replicates to accurately assess the significance of the differences between mutants and controls. Therefore, we are confident that the differences we observed between controls and mutant flies in the BBB permeability are significant. We included all relevant numbers and statistics for these experiments in Supplementary file 4.</p><disp-quote content-type="editor-comment"><p>â¢ An important point in the study concerns the increase of free fatty acids as cause of the inflammatory response. The measurements were based on measurements of whole heads, which could include the hemolymph and fat body within the head in addition to brain. However, the causative relationship remains unclear and the question why a leaky blood brain barrier would increase the free fatty acid levels in the body or brain remains mainly an observation at the descriptive level. Here, it would be helpful to design an experiment, which could test the causative links or to modify the interpretation in scheme 6D and adjust the wording in the text.</p></disp-quote><p>We agree that the causative relationship between a leaky blood-brain barrier and increased free fatty acid levels in the body or brain is currently an observation at the descriptive level and that it would be important to investigate the correlation between a leaky blood-brain barrier, inflammation, and increased free fatty acid levels in greater detail in future studies. In the modified manuscript, we have changed the scheme in Figure 5G and adjusted the wording in the text.</p><disp-quote content-type="editor-comment"><p>â¢ Related to this, how do the levels of AMP caused by a leaky BBB would compare to an elicited neuroinflammation by the presence of bacteria? The neuroinflammatory response can be accompanied by macrophage entry into the brain following AMP induction. Could the authors detect this response (which could be envisioned as manipulations include pupal development, provided macrophages would persist into adulthood)? This would make a strong point regardless of the outcome.</p></disp-quote><p>We thank the reviewer for suggesting this excellent experiment. To detect macrophage entry into the mutant brains, we used antibodies (NimC1) and <italic>srp(Hemo)&gt;mCherry</italic> that label the macrophage cells. We found macrophages in the larval and adult <italic>sws</italic> mutant brains and also in adult brains upon downregulation of <italic>sws</italic> in SPG cells (Figure 5E-F and Figure 5 âfigure supplement 1F-G). These data additionally support our hypothesis that a leaky BBB in <italic>sws</italic> mutants induces neuroinflammation, which is accompanied by macrophage entry into the brain following AMP expression.</p><disp-quote content-type="editor-comment"><p>â¢ Expression of sws is determined using sws-Gal4 driving membrane-tethered GFP. As sws is expressed very widely and classical Gal4 lines tend to be active in the BBB, it is important to provide the exact information about the nature of this driver.</p></disp-quote><p>We appreciate the reviewer for bringing this to our attention. We have now included information about the line we used to express transgenes in a <italic>sws</italic>-dependent manner. Specifically, we utilized the <italic>y*w*P{GawB}swsNP4072/FM7c</italic> line (Kyoto Stock Center 104592), which was generated using the Gal4 enhancer trap element P{GawB} insertion strategy.</p><disp-quote content-type="editor-comment"><p>â¢ The Material and Methods section should contain a proper Quantification and Statistical analysis section. In the Figures, it would be helpful to refer to the Table reporting sample numbers.</p></disp-quote><p>As the reviewer suggested, we have now included a Quantification and Statistical analysis section in the Materials and methods. Additionally, we ensured that all figure legends include a reference to the corresponding tables reporting sample numbers and statistics.</p><disp-quote content-type="editor-comment"><p>â¢ In Figure 5, it would be important to indicate sample numbers, the nature of the error bar, and show data points together with columns.</p></disp-quote><p>We agree with the reviewer that it is important to report all sample numbers and statistics. We generated a new Supplementary file 1 for all qRT-PCT data, and Supplementary file 5 containing all &quot;n&quot; values and corresponding p-values. In the Figure Legends, we denoted the type of error bars and deviations, included p-values, and referred to the relevant tables for comprehensive numerical data.</p><disp-quote content-type="editor-comment"><p>Minor comments</p><p>â¢ On page 8, cell death is visualized using &quot;the apoptotic marker Cas3&quot;. It should be Caspase-3. Moreover, it is not clear whether this antibody (directed against vertebrate Caspase-3) recognizes indeed Caspase-3 in <italic>Drosophila</italic>? This should be formulated more carefully.</p></disp-quote><p>As the reviewer correctly noted, the Caspase-3 antibody is designed for human Caspase-3. While it has been employed in <italic>Drosophila</italic> apoptosis research, its specificity for Caspase-3 in <italic>Drosophila</italic> is unclear. Given the very well-documented apoptosis in <italic>sws</italic> mutants (Kretzschmar <italic>et al.,</italic> 1997; Muhlig-Versen <italic>et al.,</italic> 2005) and the non-focus on neuronal cell death in this research, we have opted to exclude this information from the supplementary figure. We appreciate the reviewer for bringing this to our attention and for the valuable suggestion.</p><disp-quote content-type="editor-comment"><p>â¢ On Page 9 (3rd paragraph), the authors report that they &quot;want to understand what signaling pathway is activated.&quot; However, the described experiments do not lead to a signaling pathway, but conclude that an antiflammatory response is evoked. This should thus be reworded.</p></disp-quote><p>Thank you for pointing this out. In the revised version, we state that we wanted to understand whether the compromised brain barrier in <italic>sws</italic> mutants triggers the activation of any cellular stress pathways, including apoptosis, ferroptosis, oxidative stress, ER stress, and inflammation.</p><disp-quote content-type="editor-comment"><p>â¢ Figure 1 reports the expression pattern and phenotype of sws; thus, the title of the figure should be extended.</p></disp-quote><p>Thank you for the suggestion. We have updated the title of Figure 1 to more accurately reflect its content. The revised title is now: NTE/SWS is expressed in <italic>Drosophila</italic> brain and its loss leads to severe neurodegeneration.</p><disp-quote content-type="editor-comment"><p>â¢ Concerning the description of phenotypes, the authors use the term &quot;clumps&quot;, but it is not clear what this entails (e.g., Page 6, or Figure 6). For the reader, it is also necessary to refer to original studies of moody to understand the septate junction phenotype represented in the figure.</p></disp-quote><p>As the reviewer suggested, we changed the word âclumpsâ to âclustersâ. We also agree with the reviewerâs recommendation to cite the original work on Moody to acknowledge previous research and enhance the understanding of <italic>moody</italic> phenotypes. We have now included the relevant citations in the manuscript.</p><disp-quote content-type="editor-comment"><p>Referees cross-commenting</p><p>I fully agree with the comments of the other two reviewers, as they were complementary and overlapping with mine (e.g. the contribution of age).</p><p>Reviewer #1 (Significance (Required)):</p><p>This study provides a detailed cellular and functional characterization of the swiss cheese phenotype in the blood-brain barrier so far not reported in previous studies, including the team's own earlier publications (e.g., Kretzschmar et al., 1997; Melentev et al., 2021 and Ryabova et al., 2021). Furthermore, it uses cutting-edge technology to provide links to neuroinflammation and neurodegeneration, Previous studies explored neuroinflammation in the brain of <italic>Drosophila</italic> by challenging the organism with bacteria to mount an inflammatory response (Winkler et al., 2021). Intriguingly, this current study provides evidence, that a leaky blood brain barrier alone could lead to an inflammatory response, and that in turn, treatment with anti-inflammatory agents could reduce the cellular defects in glia and in consequence neurodegeneration. This represents an important conceptual advance that will be of wide interest to neurobiologists interested in glial biology, neuroinflammation and neurodegeneration in <italic>Drosophila</italic> and in vertebrates. One possible limitation of the study may be that while complex cellular processes have been pinpointed, some of the causative links of the BBB with neuroinflammation remain unexplored, in particular the aspect of elevated free fatty acids/antimicrobial peptides.</p></disp-quote><p>We appreciate the reviewer's recognition of the conceptual significance of our study, revealing that a leaky blood-brain barrier alone can induce an inflammatory response, with subsequent treatment using anti-inflammatory agents and the importance of these findings for neurobiologists. We also thank the reviewer for thorough examination and insightful suggestions. Given that prior studies have demonstrated the induction of neurodegeneration by the overactivation of innate immune-response pathways, especially elevated expression of antimicrobial peptides (Cao <italic>et al.,</italic> 2013), our new experimental data showing increased levels of antimicrobial peptides in aging flies with a defective BBB further strengthen the connection between the BBB, AMPs and neuroinflammation. This link is even more enhanced by the rescue experiments and the detection of macrophage entry in the mutant brains. We trust that the implemented revisions, accompanied by supplementary experimental data, enhance the suitability of our manuscript for publication.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Evidence, reproducibility and clarity (Required)):</p><p>The manuscript by Tsap et al. describes a role of NTE/SWS in forming the BBB in <italic>Drosophila</italic>. Disruption of the BBB in SWS mutants and knockdown flies results in morphological changes of the glia forming the BBB, increased brain permeability, altered lysosomes, and an upregulation of innate immune genes. The experiments to show a function of SWS in surface glia and the resulting changes in permeability are well supported by the experiments and the statistics appears appropriate.</p><p>The authors also show changes in innate immune genes and some fatty acids and that similar changes are found in another mutant affecting the BBB. They discuss that these changes are a consequence of the disruptions of the BBB but also that these changes induce changes in the BBB. To address this and confirm that the changes in immune genes and fatty acids is a consequence of the altered BBB, they should include experiment expressing SWS in the surface glia and measure if that normalizes these changes. Another major aspect that should be addressed is the effect of aging. As the authors point out, loss of SWS causes age-dependent phenotypes (shown by the author and others) and with the exception of figure 3F, the age isn't even mentioned in any of the other figures. Furthermore, at least some of the experiments should be done at different ages to determine whether the phenotype is progressive; this includes the permeability assays and the measurements of immune genes (the latter could also support whether changes in the immune genes affect the BBB or vice versa the BBB changes cause the upregulation of immune genes).</p></disp-quote><p>As the reviewer suggested, in order to establish a connection between age-dependent correlation between neurodegeneration and inflammation, we analyzed the mRNA expression levels of antimicrobial peptides in the heads of both 15- and 30-day-old <italic>sws</italic> loss-of-function mutants, as well as in flies with <italic>sws</italic> downregulation specifically in SPG cells (<italic>moody&gt;sws<sup>RNAi</sup></italic>). We found that the expression levels of the antimicrobial peptides are increased in the age-dependent manner in the tested mutants (Figure 5D, red and orange bars). Following the reviewerâs recommendation, we also performed an experiment where we expressed NTE/SWS in the surface glia in a <italic>sws</italic> mutant background (<italic>sws<sup>1</sup>; moody&gt;sws</italic>, rescue). We measured mRNA levels of Attacin A, Cecropin A, and Diptericin in the heads of 15- and 30-day-old flies (Figure 5D, blue bars). The results showed that the levels of all three AMPs were not significantly different or slightly upregulated in the heads of ârescueâ animals compared to <italic>Oregon R</italic> controls (Figure 5D, compare green and blue bars, and see Supplementary file 1). Importantly, the levels of all AMPs were significantly lower in the heads of 30-day-old rescue animals than in the heads of the same age <italic>sws<sup>1</sup></italic> mutants (Figure 5D, compare red and blue bars, green stars, see also Supplementary file 1). These findings further support our hypothesis that <italic>sws</italic> deficit in the surface glia induces an immune response in age-dependent manner. We did not conduct the Dextran permeability assay in older flies because approximately 90% of the 15-day-old flies with <italic>sws</italic> deregulation already exhibited impaired permeability of the BBB. This suggests that the phenotype is quite severe and may not show significant age-dependent progression. Moreover, older mutant flies were extremely weal, and it is likely that they would not have survived the peritoneal injection procedure.</p><disp-quote content-type="editor-comment"><p>Lastly, the authors claim that septate junctions are defective in sws mutants. However, this should be confirmed by EM studies (which the authors have already done) besides immunohistochemistry which doesn't provide enough resolution.</p></disp-quote><p>As the reviewer suggested, for a more detailed detection of septate junctions, we conducted additional electron microscopy experiments. The images included in Figure 6D-F show irregular aggregates and disruptions in the structures of septate junctions and membranes in <italic>sws</italic> mutants compared to controls. Additionally, we display the appearance of tight junctions in <italic>moody</italic> mutants (Figure 5 âfigure supplement 2E-F), which look dramatically different compared to <italic>sws</italic> junctions and, as previously described, appear overgrown.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Significance (Required)):</p><p>A role of SWS in maintaining the BBB and what consequences this has provides another insight how this protein (and its homolog NTE) affects brain health. Although a function of SWS in glia (as well as in neurons) has previously been described, changes in the surface glia and the BBB is a novel aspect. However, the causative role of SWS on some of the described consequences (see above) should be confirmed. Although the manuscript can add to a better understanding of the connection between disruptions of the BBB and neurodegenerative diseases, which is of interest for a broader field of researchers, the discussion of the results is quite speculative.</p></disp-quote><p>We appreciate the recognition of the novelty of this work and its potential contribution of our manuscript to a better understanding of the connection between disruptions of the BBB and neurodegenerative diseases. We thank the reviewer for the constructive feedback and hope that introduced changes, along with additional experimental data that address the concerns raised, strengthen the proposed role of <italic>sws</italic> in the formation of tight junctions in the BBB and its age-dependent maintenance.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Evidence, reproducibility and clarity (Required)):</p><p>Summary:</p><p>The study of the formation and maintenance of the blood-brain barrier (BBB) is a growing field of study, partly due to its strong link with neurological disorders. The BBB depends on the role of multiple cell types and mechanisms. Mutations in the conserved phospholipase NTE/SWS can lead to neurodegeneration, and previous work from the authors shows that SWS loss leads to abnormal glial morphology. In this work, authors use <italic>Drosophila</italic> to further study this phenotype, showing that SWS is mostly expressed in the BBB-related glia and that its loss leads to abnormal BBB permeability, increased inflammatory response and neural cell death. Interestingly, authors observed a dependence for the BBB-defective phenotype on aging, with important implications for SWS/NTE and neurodegeneration. Overall, the work represents a clear advance in the poorly explored role of NTE/SWS in neurodegeneration, with a broad impact on the understanding of BBB maintenance. This work shows a combination of multiple and appropriate experimental approaches, including confocal microscopy, EM, RT-qPCR, or gas chromatography-mass spectrometry among others.</p><p>Major comments:</p><p>The use of sws1 and sws1/sws4 transheterozygous animals, together with the use of sws RNAi is a solid approach to validate that the reported phenotypes are due to SWS loss. Using these models, the authors performed a convincing structural analysis of the subperineurial glia phenotype, and showed that it is accompanied by a defective BBB, inflammation and neuronal cell death. The key conclusions are properly supported by the data. However, there are some claims in the text that are not supported by any data in the Figures, but only qualifications. This needs to be fixed:</p><p>-Page 6, third paragraph:</p><p>&quot;â¦we specifically downregulated sws in the nervous system using the double driver line that allows downregulation of sws in glia and neurons (repo, nsyb-Gal4, Suppl. Figure 2C-CÊ¹). Since these animals had the same disorganized structure of brain surface as the loss-of-function mutantâ¦&quot;</p><p>Supp. Figure 2C-C' only shows expression of CD8:GFP and nlacZ reporters by repo and nsyb-Gal4, but there is no data showing sws RNAi expression by these drivers.</p></disp-quote><p>We thank the reviewer for noticing these referencing mistakes. We have corrected the references to the expression patterns of the glial and/or neuronal <italic>Gal4</italic> drivers (Figure 2 âfigure supplement 1D, E and F). Bar graph in Figure 2 âfigure supplement 1C shows RT-qPCR analysis of <italic>sws</italic> mRNA levels from flies with glial and/or neuronal <italic>sws</italic> downregulation (repo<italic>&gt;sws<sup>RNAi</sup>, nsyb&gt;sws<sup>RNAi</sup></italic> and <italic>repo, nsyb&gt;sws<sup>RNAi</sup></italic>), and the images of mutant brains in Figure 2 âfigure supplement 2 and Figure 2A-C show the surface glia phenotypes in these mutants.</p><disp-quote content-type="editor-comment"><p>&quot;â¦Moreover, downregulation of sws in all glial cells (repo&gt;swsRNAi) resulted in the same phenotype. At the same time, upon sws downregulation in neurons,â¦ (Suppl. Figure 4)â¦&quot;</p><p>Suppl. Figure 4 only shows nsyb&gt;swsRNAi data but not repo&gt;swsRNAi</p></disp-quote><p>We show now both <italic>repo&gt;sws<sup>RNAi</sup></italic> and <italic>nsyb&gt;sws<sup>RNAi</sup></italic> (Figure 2 âfigure supplement 2C and 2E, respectively).</p><disp-quote content-type="editor-comment"><p>-Page 6, fourth paragraph:</p><p>&quot;Importantly, expression of <italic>Drosophila</italic> or human NTE in these glia cells rescued this phenotype (Figure 2H)&quot;</p><p>In addition to the indicated quantifications, it is essential to show some representative data showing the phenotype when <italic>Drosophila</italic> or human NTE are expressed in glial cells of sws mutant animals.</p></disp-quote><p>We agree with the reviewer that it is important to show the rescue phenotypes. We have included images of the brain surface of <italic>sws</italic> mutants that have <italic>Drosophila</italic> or human NTE expressed in glial cells (Figure 2D and Figure 2 âfigure supplement 2F).</p><disp-quote content-type="editor-comment"><p>-Page 9, last paragraph: &quot;We found that in moody mutants, the surface glia phenotype analyzed using CoraC as a marker could also be suppressed by NSAID and rapamycin (Figure 5A).&quot;</p><p>In addition to the indicated quantifications, it is essential to show some representative data showing the phenotype with and without treatments.</p></disp-quote><p>We appreciate the reviewer's suggestion, and as recommended, we have included representative data showing the phenotype with and without treatments in Figure 5 âfigure supplement 1C-D.</p><disp-quote content-type="editor-comment"><p>A more detailed analysis of two aspects of the data would clearly improve the manuscript, whose findings are a bit superficial in the current state:</p><p>- The exact mechanism by which BBB permeability leads to brain inflammation remains unknown. Authors show that accumulation of polyunsaturated fatty acids (known to regulate inflammation) occurs in sws-depleted animals. However, they only observed a correlation between this phenotype and the inflammatory response, while is not clear whether the accumulation of polyunsaturated fatty acids causes inflammation in this model or is a consequence of it. An attempt to rescue the accumulation of polyunsaturated fatty acids (i.e., knocking down a required enzyme for their production) in sws mutants might help to understand this. Also, the fact that the defective BBB phenotype observed in either sws KO and glia-specific KD can only be partially rescued by the use of inflammation inhibitors, suggests that other pathways are involved.</p></disp-quote><p>We agree with reviewer that since the use of inflammation inhibitors only partially rescue the defective BBB phenotype in <italic>sws</italic> mutants, it implies the involvement of additional pathways. While our data reveal a correlation between the accumulation of polyunsaturated fatty acids and the inflammatory response, whether this accumulation causes inflammation in our system remains to be studied. We have revised the text to ensure that this explanation is clearly stated without overemphasis.</p><disp-quote content-type="editor-comment"><p>- While the differences between the phenotypes caused by sws or moody loss are well characterized, it would be key for this work to further study the mechanisms by which sws controls septate junctions. The authors propose the organization of lipid rafts, but some experiments in that direction to check this hypothesis. For example, can authors reproduce the septate junction phenotype of sws mutant (Figure 6C) by using a different approach to induce defective lysosomes in subperineurial glia?</p></disp-quote><p>We appreciate the reviewer's suggestion for such an insightful experiment. To investigate whether the septate junction phenotype observed in <italic>sws</italic> mutants can be replicated in mutants with defective lysosomes in subperineurial glia, we downregulated several key lysosomal genes in SPG cells: <italic>moody&gt;Dysb<sup>RNAi</sup>, moody&gt;Npc1a<sup>RNAi</sup>, moody&gt;Pldn<sup>RNAi</sup>,</italic> and <italic>moody&gt;spin<sup>RNAi</sup></italic> (Figure 6 âfigure supplement 1A-E). We were happy to see that downregulation of any of these genes resulted in abnormal formation of SJs and membrane organization in SPG cells. These additional experiments strongly support our hypothesis that lysosomal control of membrane homeostasis significantly impacts the appearance of SJs. Thank you for this excellent idea.</p><disp-quote content-type="editor-comment"><p>The attempt of the proposed approaches above should require about 3-6 months of investment, with limited economic effort, given the availability and diversity of lines found in the existing stock centres such as Bloomington or Vienna.</p><p>The data is presented very clearly, and the methods are adequately detailed, and the experiments and statistical analysis are adequate.</p><p>Minor comments:</p><p>Prior studies are referenced appropriately, but there is a case that should be addressed. On Page 3, first paragraph, regarding the sentence: &quot;However, the molecular mechanisms underlying inflammaging remain unclear&quot;. I recommend specifying what is known and what is unknown in the field. Ideally describing (briefly) the knowledge about lipids, inflammaging and neurodegeneration, which are the specific topics of the research. Otherwise, the current sentence is too vague, while there is a lot of work published about it.</p></disp-quote><p>As the reviewer suggested we have extended the first part of our introduction to briefly describe how inflammaging is connected with the BBB, fatty acid metabolism and lysosomal functions.</p><disp-quote content-type="editor-comment"><p>The text and figures are clear and accurate. The logic of the experiments and the results are exposed very clearly (for example, the Suppl. Tables are very helpful). There are a few minor issues, however, that should be addressed:</p><p>- Page 4, first paragraph: regarding the sentence: &quot;For various obvious reasons, humans are not ideal subjects for age-related research.&quot;, I recommend specifying the main reasons (i.e. life cycle, ethical issues, etc.?).</p></disp-quote><p>Thank you, the main reasons are specified now.</p><disp-quote content-type="editor-comment"><p>- I would recommend moving the text &quot;For various obvious reasonsâ¦disrupted upon ageing.&quot; From its current position to just before &quot;<italic>Drosophila melanogaster</italic> is an excellentâ¦&quot;. This would keep a better logic in the text by explaining NTE first and later introducing the models to study its function. Presenting then <italic>Drosophila</italic>.</p></disp-quote><p>Thank you, done.</p><disp-quote content-type="editor-comment"><p>- To support the sentence &quot;Together, <italic>Drosophila</italic> satisfiesâ¦neurodegeneration during aging&quot;, instead of citing so many papers, I recommend citing just one current review about it, since the amount of literature supporting the claim is huge and should not be limited to a few &quot;random&quot; articles. An alternative might be indicating that the lab has used <italic>Drosophila</italic> for this aim before, and then citing the examples from the literature.</p></disp-quote><p>Thank you for this suggestion, now we referenced few recent reviews and referred to our previous work on the topic.</p><disp-quote content-type="editor-comment"><p>- Page 4, second paragraph: if NTE/SWS is going to be used as a synonym for NTE/SWS loss of function (or other type) model, it needs to be specified. Otherwise, refers to the proteins and sentences like &quot;NTE/SWS has been shown to result in lipid droplet accumulationâ¦&quot; are misleading.</p></disp-quote><p>Thank you for the suggestion; we have now specified that NTE/SWS is used as a synonym for the SWS protein in <italic>Drosophila</italic> and corrected this throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>- Page 4, last paragraph: the first time that &quot;BBB&quot; is used, its meaning should be specified. And three lines below use &quot;BBB&quot; instead of blood-brain barrier.</p></disp-quote><p>Thank you, corrected.</p><disp-quote content-type="editor-comment"><p>Referees cross-commenting</p><p>I agree with the comments provided by the other reviewers. They are well reasoned and cover some aspects of the work that I did not see. Regarding the main issue, the three revisions point at the same direction, that is the limited analysis about the mechanism underlying the phenotypes.</p><p>Reviewer #3 (Significance (Required)):</p><p>- Describe the nature and significance of the advance (e.g. conceptual, technical, clinical) for the field.</p><p>This work represents a substantial advance in the understanding of NTE/SWS function in the context of neurodegeneration, and opens potential approaches to treat related disorders (they successfully use anti-inflammatory compounds to ameliorate some of the key phenotypes). However, the findings are a bit superficial in terms of mechanisms, and further analysis (see major comments) would notably improve the significance of the manuscript. This should be realistic and suitable, given the advantages of the <italic>Drosophila</italic> model and the availability of tools.</p><p>- Place the work in the context of the existing literature.</p><p>The role of SWS in regulating lysosomal function is potentially supported by NTE-deficient mice data (Akassoglou et al., 2004; Read et al., 2009), where different types of neurons show similar dense bodies containing concentrically laminated and multilayered membranes than those observed in this work in <italic>Drosophila</italic> sws mutant. Potentially, the rest of the work has a translation to mammals, which is supported by the fact that ectopic expression of NTE rescues some of the key phenotypes described in the manuscript.</p><p>- State what audience might be interested in and influenced by the reported findings.</p><p>Neuroscience in general, since the study of BBB and neurodegeneration has a clear general interest in the whole field.</p><p>- Define your field of expertise with a few keywords to help the authors contextualize your point of view. Indicate if there are any parts of the paper that you do not have sufficient expertise to evaluate.</p><p><italic>Drosophila</italic>; Neurodegeneration; Hereditary Spastic Paraplegia; Alzheimer's disease; Motor neurons; Microglia; Endoplasmic reticulum; Mitochondria.</p><p>Lipid metabolism is the part of the manuscript where I have less expertise to evaluate, only having general knowledge about it.</p></disp-quote><p>We appreciate the positive evaluation of our work, the careful reading, and the valuable suggestions provided by the reviewer, including recommendations for additional experiments and changes in the text. We believe that the implemented changes, combined with the new experimental data, have improved the manuscript, making it ready for publication.</p><p>References</p><p>Artiushin G, Zhang SL, Tricoire H, Sehgal A (2018) Endocytosis at the <italic>Drosophila</italic> blood-brain barrier as a function for sleep. <italic>ELife</italic> 7</p><p>Cao Y, Chtarbanova S, Petersen AJ, Ganetzky B (2013) Dnr1 mutations cause neurodegeneration in <italic>Drosophila</italic> by activating the innate immune response in the brain. <italic>Proc Natl Acad Sci U S A</italic> 110: E1752-1760</p><p>Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S (1997) The swiss cheese mutant causes glial hyperwrapping and brain degeneration in <italic>Drosophila</italic>. <italic>J Neurosci</italic> 17: 7425-7432</p><p>Muhlig-Versen M, da Cruz AB, Tschape JA, Moser M, Buttner R, Athenstaedt K, Glynn P, Kretzschmar D (2005) Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult <italic>Drosophila</italic>. <italic>J Neurosci</italic> 25: 2865-2873</p></body></sub-article></article>